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Abstract
Pantothenate (vitamin B5), which is the invariable metabolic precursor
to coenzyme A, is synthesized from L-aspartate and α-ketoisovalerate in
a converging four-step process in bacteria. Here, structural studies of
two enzymes of pantothenate biosynthesis in Escherichia coli, L-aspartate-
α-decarboxylase and ketopantoate hydroxymethyltransferase, are de-
scribed.
Ketopantoate hydroxymethyltransferase catalyzes the transfer of a hy-
droxymethyl group on to α-ketoisovalerate, assisted by the cofactor 5,10-
methylene-5,6,7,8-tetrahydrofolate. In order to determine the mode of co-
factor binding to the protein, ketopantoate hydroxymethyltransferase was
crystallized in the presence of two 5,10-methylene-5,6,7,8-tetrahydrofolate
analogues and α-ketoisovalerate. X-ray diffraction patterns, collected on
the in-house X-ray diffraction data collection facility, extended to ∼4.0 A˚.
Unit cell dimensions derived from these diffraction patterns indicate an
asymmetric unit with one decameric enzyme.
A detailed comparative structural analysis of the fold of ketopantoate
hydroxymethyltransferase was carried out. Based on this investigation it
was possible to assign the enzyme to the phosphoenolpyruvate/pyruvate
enzyme superfamily. Furthermore, similarities in themode of ligand bind-
ing to the catalytic magnesium, as well as differences in the mechanisms
between the enzymes within this superfamily could be delineated.
xv
In common with a small, but widely distributed, group of
mechanistically-related enzymes, L-aspartate-α-decarboxylase is trans-
lated as an inactive pro-enzyme, which self-processes at a specific site.
In this process of intra-molecular protein maturation a covalently bound
pyruvoyl cofactor is formed. A fast purification system for eight L-
aspartate-α-decarboxylase mutants was established that allows produc-
tion of large amounts of enzyme. In order to gain insights into the molec-
ular mechanism of self-processing, crystallographic studies were carried
out. Several of the purified mutants have been crystallized. X-ray diffrac-
tion data from glycine 24 to serine and serine 25 to threonine mutants were
collected, to a maximum resolution of 1.26 A˚. The respective crystal struc-
tures were solved by molecular replacement. Along with the structures
of an unprocessed, native precursor form of L-aspartate-α-decarboxylase
and a serine 25 to alanine mutation, the structure models were refined and
evaluated, and the models deposited in the Protein Data Bank.
Analysis of these four structures together with four other L-aspartate-
α-decarboxylase mutant structures revealed specific conformational con-
straints on the self-processingmechanism. Threonine 57 and awatermole-
cule could be identified as catalytic elements, most likely essential for acid-
base catalysis, and stabilization of the oxyoxazolidine intermediate in the
self-processing reaction. A molecular mechanism for self-processing in L-
aspartate-α-decarboxylase, largely based on the threonine 57 and a water
molecule, is proposed. The differences in the structures of the cleavage
site of the serine 25 to alanine and serine 25 to threonine mutants, relative
to the structure of the unprocessed native precursor, suggest that molecu-
lar models of the cleavage site and mechanisms, based solely on serine to
alanine and serine to threonine mutants, may lead to erroneous interpre-
tations of the mechanism. On comparison with other self-processing sys-
tems, particularly, glycosylasparaginase, remarkable parallels in the struc-
tural features of the environment of the cleavage site were identified.
xvi
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Part I
Introduction
1
1 Small molecule metabolic
pathways
1.1 Biological metabolism
All living biological organisms require a continuous input of free energy
to sustain their own and their genes’ existence on this planet. In order to
accomplish the variety of tasks that the biological cells of these organisms
have to carry out, the free energy has to be converted and distributed. This
occurs in the form of chemical molecules within and between the cells in
specific ways (see Stryer, 1995, pg. 91-100, for an introduction). Both the
transport and the conversion of free energy are predominantly facilitated
by specific proteins, and enzymes, which are the most common biological
catalysts. The accompanying chemical processes are coordinated in space
and time, often in highly integrated and specific networks of (bio)chemical
reactions. These biological processes are collectively known as metabolism.
Metabolism can be viewed as being schematically organized in inter-
connected functional units, which are called pathways (see Schilling et al.,
2000; Schilling and Palsson, 1998, for amathematical definition). The parti-
tion of the metabolism into distinct pathways is somewhat arbitrary (Ger-
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rard et al., 2001), in that it is often difficult to define a beginning and an
end of a pathway. As a consequence, the definition of a pathway is not
straightforward and several may exist. However, a pathway can, gener-
ally, be defined as a series of coupled and consecutive biochemical reac-
tions, the enzymes of which are expressed together (Schuster et al., 2000;
Selkov et al., 1998). The degradative processes breaking down more com-
plex molecules to simpler compounds, to release free energy, are referred
to as catabolic metabolism, whereas those consuming free energy to build
more complex molecules from simpler ones are defined as anabolic meta-
bolism.
More than two thousand different chemical reactions take place in as
simple an organism as Escherichia coli (Karp et al., 2002c). Whereas the
complexity of metabolism may appear overwhelmingly vast, closer in-
vestigation reveals that metabolism contains many common motifs (Rison
and Thornton, 2002; Teichmann et al., 2001b). Consequently, although the
overall number of biochemical reactions in metabolism is large, the num-
ber of unique reactions is relatively small (Stryer, 1995, p.443). It appears
that biochemical pathways require a small number of different enzyme
types to accomplish the chain of chemical transformations essential for
life (Tsoka and Ouzounis, 2001). Likewise, related mechanisms of regu-
lation can be observed in many different metabolic pathways. Activation
and inhibition of genes and proteins by biochemical molecules, and post-
translational modifications of RNA and proteins are the main mechanisms
for regulation of metabolism.
1.2 Small molecule metabolism
Metabolism can be schematically divided into primary and secondary me-
tabolism. Primary metabolism forms the core, and includes the sum of the
essential processes that keep every cell alive. By and large, primary me-
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tabolism is shared by all cells within an organism. Although it is modi-
fied by losses, substitutions and innovations during evolution (Dandekar
et al., 1999; Huynen et al., 1999; Makarova et al., 1999), it has remained
largely conserved in all living eukaryotic and prokaryotic organisms. In
contrast, secondarymetabolism is usually highly organism- as well as cell-
specific. In general, it involves more complex molecules, which are not
directly essential for the function of the cell but for the survival of the or-
ganism. Examples of secondary metabolites are antibiotics and toxins. An
elementary part, predominantly of the primary biological metabolism, is
formed by the small molecule metabolic pathways. These refer to the me-
tabolism involving small, non-polymeric, predominantly organic, chemi-
cal compounds as substrates. Examples of small molecules are glucose or
pyruvate, but the definition does not include biopolymers, such as pro-
teins, DNA, or RNA (for an approximate partition of the small molecule
metabolism see 1).
Small molecule metabolism is composed of a complex network of en-
zymes, substrates, and cofactors, the specific characteristics of which can
differ between organisms, particularly between eukaryotes and prokary-
otes. Traditionally, the metabolic pathways of the prokaryotic organism E.
coli have been among the most thoroughly studied and consequently the
most popular ones. Almost all of the enzymes in small molecule meta-
bolism have been characterized, and their positions in a pathway verified,
experimentally (Riley, 1998)2. Additionally, the entire E. coli genome has
been sequenced (Blattner et al., 1997), and several aspects of the global
properties of the organism’s metabolic map, such as the frequency of mul-
tifunctional enzymes (∼16%), have been determined (Ouzounis and Karp,
2000; Simeonidis et al., 2003; Tsoka and Ouzounis, 2001).
The EcoCyc database3 (Karp et al., 2002a) provides comprehensive, and
1http://www.genome.ou.edu/act/small_molecule_metabolism.html
2http://genprotec.mbl.edu/
3http://www.ecocyc.org/
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presumably close to complete, information on the 106 small molecule
metabolic pathways in E. coli and the corresponding 581 enzymes as well
as their genes. Several other databases are available, such as the PATH-
WAY database from KEGG4 (Kanehisa et al., 2002) and the WIT database5
(Overbeek et al., 2000), which pertain not only to E. coli, but to several other
organisms, mostly microorganisms and pathogenic bacteria. Although at-
tempts are under way to catalogue similar information for higher, eukary-
otic organisms, such as Homo sapiens6 (Karp et al., 2002b), comprehensive
information for these is not available yet. However, in a recent comparison
of the small moleculemetabolism, using the KEGGdatabase, it was shown
that 48 pathways, or a core of 271 enzymes have been conserved between
E. coli and Saccharomyces cerevisiae (Jardine et al., 2002). Consequently, more
than half of all proteins involved in small molecule metabolism appear to
have remained conserved, since the separation of prokaryotes and eukary-
otes, and carry out common reactions. In contrast, in the part of the small
molecule metabolism that varies, very different extensions to it have been
made in the two organisms.
1.3 General characteristics of the small molecule
metabolic pathways
A remarkable molecular plasticity (i.e. the same biochemical reactions be-
ing catalyzed by different enzymes) and functional versatility (i.e. the as-
sociation of enzymes with distinct biochemical reactions and pathways)
(Ouzounis and Karp, 2000) exist in some pathways, even as central as the
glycolysis pathway (Huynen et al., 1999). These features can not only be
observed in between organisms, but also within a single species (Dan-
dekar et al., 1999; Tsoka and Ouzounis, 2001). Alternative routes of sub-
4http://gpath.ym.edu.tw:8090/kegg/kegg2.html
5http://wit.mcs.anl.gov/WIT/
6http://metacyc.org/
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strate flux and multiple functions of (iso)enzymes within the same or-
ganism, as well as varying enzyme patterns in different organisms can
be found more frequently than expected. These features imply that some
pathways are more stable and relatively immune to failures that could re-
sult from malfunctioning of some of the enzymes.
Almost half of the E. coli proteins involved in small molecule meta-
bolism are composed of a single protein domain (Teichmann et al., 2001a),
which, following the convention in the SCOP database7 and 3Dee data-
base8, is the basic structural and evolutionary unit of the protein. Insights
into the overall organization of the small molecule metabolic pathways
were gained by studying the distribution of proteins, classified into evo-
lutionarily related protein-(super)families, according to their amino acid
sequence similarity and/or structural homology, in the small molecule
metabolism (Teichmann et al., 2001b). A relatively small repertoire of
213 protein-domain families constitute 90% of the enzymes in the small
molecule metabolism (Teichmann et al., 2001a). Interestingly, it was found
that E. coli enzymes belonging to the same protein-family are widely dis-
tributed among different pathways. Protein homologues were also ob-
served to be twice as likely to be found in different pathways than in
the same pathway (Teichmann et al., 2001b). In contrast, homology be-
tween enzymes within the same small molecule metabolic pathway was
generally rare. However, if observed, homologous proteins tend to con-
serve their chemical reaction/catalytic mechanism and/or cofactor bind-
ing rather than similar substrate recognition (Teichmann et al., 2001b). An-
other strong correlation appears to exist between the pathway distance, as
defined by the number of steps by which two enzymes are separated in
metabolism, and the gene interval (Rison et al., 2002). Genes, which were
found to be localized closer to each other on the E. coli chromosome, tend
to encode enzymes catalyzing biochemical reactions that are separated by
a smaller number of steps in metabolism. Several blocks of co-regulated
7http://scop.mrc-lmb.cam.ac.uk/scop/
8http://www.compbio.dundee.ac.uk/3Dee/
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genes, similar to operons, of enzymes with a small pathway distance were
observed. These enzymes also seem to have a higher likelihood of being
functionally, but not necessarily evolutionarily related (Rison et al., 2002).
1.4 Evolution of the small molecule metabolic
pathways
E. coli is a representative of the descendants of the metabolically compe-
tent last common ancestor. The universal presence of many proteins of
the primary metabolism in the cell suggests that much of the basic pro-
tein repertoire was developed in organisms very much simpler than any
known at present. Apart from the ab initio invention of a set of different
domains, which most likely occurred at an early stage of the development
in life, the mechanisms that generate the protein repertoire in metabolism
are dominated by gene duplication, divergence, and recombination (Bab-
bitt and Gerlt, 2000; Chothia et al., 2003). In the context of pathway evo-
lution, the recruitment of proteins [or domains] across pathways is a very
common phenomenon and explains the absence of regularity in the pat-
tern of proteins, found in metabolic pathways (Teichmann et al., 2001b).
New enzymes are more likely to have evolved from enzymes belonging
to the same enzyme family or class, than from the same pathway. This
implies that an evolutionary mechanism, known as patchwork approach,
predominates, where enzymes are widely recruited from different path-
ways with no particular order or bias in respect to their position in the
metabolic network (Copley, 2000). Several examples of homology within
the metabolic neighbourhood however indicate that most likely this is not
the only mechanism, and that retrograde evolutionary mechanisms are
also active. The patchwork mechanism proposed by Jensen (Jensen, 1976),
implies chemistry-driven evolution, whereas Horowitz theory of retro-
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gade evolution mechanism (Horowitz, 1945), in which enzymes within
a pathway are related to each other, would seem to be substrate-driven.
Overall, it appears that both pathway evolution mechanisms occur in con-
cert (see Alves et al., 2002), although enzymes seem to be mainly selected
for their mechanism and function.
2 Pantothenate and Coenzyme A
biosynthesis
2.1 Pantothenate biosynthesis
Pantothenate is a central and vital metabolic compound in all organisms
(reviewed by Tahiliani and Beinlich (1991)). It constitutes the invariant
presursor of 4’-phosphopantetheine, the moiety of coenzyme A and the
acyl carrier protein. However, pantothenate is synthesized in bacteria,
fungi, and plants only; animals have lost the corresponding biosynthetic
pathway. As such, pantothenate is classified as a vitamin (vitamin B5).
Consequently, enzymes of the pathway are considered attractive targets
for the development of selectively toxic antimicrobial, fungicidal, and her-
bicidal drugs.
The pantothenate pathway is an anabolic, primary, small molecule
metabolic pathway. It is reasonable to assume that the pantothenate path-
way evolved rather early in the development of life on Earth, and exper-
iments support the notion that pantothenate may have existed in the pre-
biotic soup (Keefe et al., 1995). Whereas the biochemical steps in E. coli
and Salmonella typhimurium in the biosynthesis of pantothenate have es-
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sentially been known for a longer time (Maas, 1952a), only more recently
have detailed characterization and investigation of the enzymes been pur-
sued.
In E. coli the pantothenate pathway comprises four enzymatic steps (Fi-
gure 2.1). R-pantothenate is synthesised from α-ketoisovalerate (α-kiva)
and L-aspartate in a converging four-step process (Brown andWilliamson,
1982). The transfer of the C11 group of N5,N10-methylene tetrahy-
drofolate (5,10-meTHF) on to α-kiva to form ketopantoate (4-hydroxy-
3,3,-dimethyl-2-oxobutanoate), by ketopantoate hydroxymethyltransfer-
ase (EC 2.1.2.11, KPHMT), is traditionally referred to as the first commit-
ted reaction (Teller et al., 1976). α-kiva itself is predominantly supplied as
an intermediate of pyruvate-dependent L-valine and L-leucine biosynthe-
sis (Figure 2.1). However, in E. coli only a comparatively small fraction of
∼10% of the total flux of α-kiva through this pathway is consumed by con-
version into ketopantoate (Cronan et al., 1982). Subsequent to the first step,
ketopantoate reductase (EC 1.1.1.169, KPR) reduces ketopantoate to pan-
toate, using NADPH as a cofactor (Elischewski et al., 1999; Frodyma and
Downs, 1998a,b; King et al., 1974; Wilken et al., 1975; Zheng and Blanchard,
2000a,b, 2003). In addition, another gene product has been implicatedwith
ketopantoate processing. The primary reaction of acetohydroxy acid iso-
meroreductase (Biou et al., 1997) (see Figure 2.1), encoded by the ilvC gene,
is the reduction of α-acetolactate and α-aceto-α-hydroybutyrate to α,β-
dihydroxyisovalerate and α,β-dihydroxy-β-methylvalerate, respectively
in the above mentioned biosyntheses of L-valine and L-leucine. This en-
zyme was shown to rescue KPR auxotrophs with low, but significant,
KPR activity (Primerano and Burns, 1983). Concomitant with the reduc-
tion of ketopantoate, in a separate branch of the pathway, L-aspartate-α-
decarboxylase (EC 4.1.1.11, ADC) converts L-aspartate to β-alanine (Cro-
nan, 1980). β-alanine production uses less than 2% of the total amount of
cellular L-aspartate in E. coli (Cronan et al., 1982). In the final step of the
pantothenate pathway, β-alanine is coupled to the ATP activated C1 of L-
pantoate with an amide bond by pantothenate synthetase (EC 6.3.2.1, PS)
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yielding R-pantothenate (Figure 2.1) (Maas, 1952b; Miyatake et al., 1976,
1978, 1979; Zheng and Blanchard, 2001).
The cellular synthesis of β-alanine appears to be the limiting factor in
pantothenate production in E. coli, implying the accumulation of free pan-
toate (Cronan, 1980; Dusch et al., 1999). Nevertheless, in S. typhimurium a
mutation in the promoter gene sequence for panB resulted in overexpres-
sion of KPHMT and led to an increase of the pantothenate level (Rubio
and Downs, 2002). However, both E. coli and Bacillus subtilis overproduce
and excrete significant amounts of pantothenate (Baigori et al., 1991; Cro-
nan et al., 1982; Jackowski and Rock, 1981). The excess, which in E. coli can
even reach fifteen-fold requirement levels, is exported efficiently (Cronan
et al., 1982; Jackowski and Rock, 1981).
The abundance of pantothenate in these organisms indicates that the
pathway is not particularly tightly regulated or controlled. A possible ex-
planation for this could be that the metabolic cost of regulating the path-
way could exceed the cost of overproduction. In this respect, it is interest-
ing that extracellular uptake of pantothenate also occurs. In E. coli this
was shown to be facilitated by pantothenate permease, an inner mem-
brane protein encoded by the panF gene (Jackowski and Alix, 1990; Vallari
and Rock, 1985). This pantothenate carrier concentrates the vitamin by
a sodium co-transport mechanism, and overexpression of the panF gene
resulted in elevated intracellular levels of pantothenate. A pantothenate
transporter importing extracellular pantothenate was also identified in S.
cerevisiae (Stolz and Sauer, 1999) and appears to exist in animals (Barbarat
and Podevin, 1986; Lopaschuk et al., 1987; Wang et al., 1999). A different
H+-coupled pantothenate transport was identified in the malaria parasite
Plasmodium falciparum (Saliba and Kirk, 2001).
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Figure 2.1 Schematic representation of pantothenate and coenzyme A biosynthesis. The
names of the enzymes and gene designation are shown in italic font; substrates, prod-
ucts, and cofactors and their turnover are shown in normal font. Dashed arrows in A
indicate several enzymatic steps. (A) α-kiva as an intermediate of L-valine and L-leucine
biosynthesis. (B) The biosynthesis of pantothenate (colour, red). (C) The conversion of
pantothenate into coenzyme A.
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2.1.1 Organization, characteristics, and occurrence of the
pan genes
As mentioned in Section 2.1, the pantothenate pathway is not present in
animals, and, consequently, H. sapiens. However, enzymatic activities or
relevant genes have been found in eubacteria as well as eukaryotes, such
as fungi and plants.
The genes, and their organization, are characterized best in E. coli and
S. typhimurium (Jackowski, 1996) of which the nomenclature panB, panC,
panD, and panE, corresponding to KPHMT, PS, ADC, and KPR, respec-
tively has been derived. In E. coli the panB, panD, and panC genes were
shown to be co-localised (Cronan, 1980), in this clockwise order (Cronan
et al., 1982; Merkel and Nichols, 1996). The organization in the genome
suggests a, possibly ancestral, operon, which has been shown to be located
at 3 min on the genetic map. In B. subtilis and Corynebacterium glutamicum
an identical panBC gene cluster exists (Sahm and Eggeling, 1999; Sorokin
et al., 1996), and in the former panD is also co-localised with this cluster.
The panD gene of Corynebacterium glutamicum has also been cloned, but
was not observed to be localised close to the other pan genes (Dusch et al.,
1999). Cloning of the panD gene from Ralstonia eutropha has also been re-
ported (Hoppensack et al., 1999). panE was identified, cloned and charac-
terized rather late, compared with panB, panC, and panD, possibly because
of the existence of ilvC (Section 2.1) and confusing reports about the en-
zymatic function of apbA in S. typhimurium. The latter gene eventually
turned out to be identical to panE (Frodyma and Downs, 1998b). It maps
at 10 min at both the E. coli and S. typhimurium genome (Frodyma and
Downs, 1998a). The panE gene product has furthermore been purified and
partially characterized from Pseudomonas maltophilia 845 (Shimizu et al.,
1988) and Nocardia asteriodes (Kataoka et al., 1992). In C. glutamicum the
ilvC gene product alone appears to account for ketopantoate reductase ac-
tivity (Merkamm et al., 2003). However, in general, the key residues of the
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sequences of the pan genes seem to be well conserved among bacteria (see
amino acid sequence alignments in Section 11.3 and Section 13.3).
Pantothenate auxotrophs of Aspergillus nidulans were first observed by
Kaefer (1958). The corresponding mutants were then identified and ge-
netically localized as panB (Rever, 1965) and panC (Bal et al., 1977). More
recently, panB has been cloned and overexpressed fromA. nidulans by Kur-
tov et al. (1999). Further known fungal genes include panB and panC from
S. cerevisiae and Schizosaccharomyces pombe as well as panB from Emericella
nidulans. In addition, the panE product was reported to have been purified
and partially characterized from S. cerevisiae (King et al., 1974; King and
Wilken, 1972).
Evidence for the pathway in plants was provided by Jones et al. (1994)
and subsequently the panB and panC genes from Arabidopsis thaliana were
cloned and characterized (Jones et al., 1993; Ottenhof et al., 2004). In ad-
dition, the panC gene has been cloned and the gene product characterized
from both Lotus japonicus and Oryza sativum (Genschel et al., 1999). Indica-
tions for the existence of enzymatic activities in the pantothenate pathway
are also known from Datura innoxia (Savage et al., 1979) and Pisum sativum
(Jones et al., 1994). However, the identification of panE from plants has
remained elusive so far, despite extensive database searches of fully se-
quenced genomes (Ottenhof et al., 2004).
Similarly, so far, no evidence for a panD gene in cells of eukaryotic or-
ganisms has been found. This may not that surprising, since it is known
that there are two known alternative ways of supplying β-alanine (Camp-
bell, 1957; Canellakis, 1956; Fink et al., 1953; Rendina and Coon, 1957). It
is well established that in fungi and plants β-alanine can be physiologi-
cally derived in cells by the reductive degradation of pyrimidines, such as
uracil (Slotnick, 1956). Although evidence remains inconclusive, current
knowledge (Ottenhof et al., 2004) suggests that the panD gene probably is
completely absent from eukaryotes.
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2.2 Coenzyme A biosynthesis
Coenzyme A is invariably bio-synthesized from pantothenate, constitutes
the principal and universal carrier of acyl groups (Stryer, 1995), central to
anabolic (e.g. fatty acid synthesis) and catabolic (e.g. glycolysis) meta-
bolism. It features a terminal thiol group (Figure 2.1) that readily forms
labile, and consequently reactive, thioester bonds with a variety of acyl
groups, such as acetyl or malonyl, thereby activating these for biological
Claisen reactions. Coenzyme A is critical to cell growth and function. In
particular, the 4’-phosphopantetheine group of coenyzme A is important
in fatty acid biosynthesis and degradation, in the biosynthesis of polyke-
tides as well as in nonribosomal peptide biosynthesis (Kleinkauf and von
Dohren, 1995; Kleinkauf and Von Dohren, 1996). 4’-phosphopantetheine
itself constitutes an essential prosthetic group in a number of enzyme sys-
tems including acyl carrier protein components of bacterial and eukaryotic
fatty acid synthases. Metabolically, coenzyme A is designated as a cofac-
tor. In general, it is estimated that ∼4% of all enzymes use coenzyme A
or 4’-phosphopantetheine-containing compounds as cofactors in their re-
actions (Webb, 1992).
As first shown by Brown (1959) and Abiko (1975), coenzyme A is bio-
chemically synthesized in five enzymatic steps from pantothenate (Fi-
gure 2.1). In contrast to the biosynthesis of the latter, the biosynthetic steps
from pantothenate to coenzyme A do exist in higher eukaryotic organisms
and animals, such as H. sapiens. Based on this fact, the whole biosynthe-
sis of coenzyme A in bacteria can therefore schematically be divided into
two phases (Figure 2.1), the synthesis of pantothentate and its subsequent
conversion into coenzyme A (reviewed by Begley et al. (2001) and Jack-
owski (1996)). However, the coenzyme A pathway appears to be highly
conserved throughout all taxons.
The continuation of the pantothenate pathway into the coenzyme A
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pathway in E. coli begins with the phosphorylation of the hydroxyl group
of pantothenate by pantothenate kinase resulting in the formation of 4’-
phosphopantothenate (Figure 2.1) (Calder et al., 1999; Rock et al., 2000;
Song and Jackowski, 1992a,b, 1994; Yun et al., 2000). Subsequently, 4’-
phosphopantothenate is ligated to L-cysteine by phosphopantothenate
cysteine synthetase to produce 4’-phosphopantothenoylcysteine (Kupke,
2002; Strauss et al., 2001), the cysteinemoiety of which becomes decarboxy-
lated by phosphopantothenoylcysteine decarboxylase (EC 4.1.1.36) to 4’-
phosphopantetheine (Kupke, 2001; Kupke et al., 2001; Strauss and Begley,
2001). In E. coli, the enzymatic acitivities of the latter two proteins are lo-
cated in one bi-functional enzyme, theN-terminal domain carrying out the
decarboxylation (Kupke et al., 2000; Spitzer et al., 1988) and the C-terminal
domain the ligation to the cysteine. In the penultimate step of coenzyme
A biosynthesis, phosphopantetheine adenylyltransferase catalyzes the re-
versible transfer of an adenylyl group fromATP to 4’-phosphopantetheine
forming dephospho-coenzyme A (Geerlof et al., 1999; Izard and Blackwell,
2000; Izard and Geerlof, 1999). Finally, the ribose 3’-hydroxyl group of
dephospho-coenzymeA is phosphorylated by dephospho-coenzymeA ki-
nase (Figure 2.1) to form coenzyme A (Mishra et al., 2001; O’Toole et al.,
2003).
A genetic footprinting study by Gerdes et al. (2002) confirmed the in-
dispensable importance of the coenzyme A biosynthesis pathway for me-
tabolism. Genes encoding the enzymes for the five catalytic steps in the
coenzyme A pathway have been identified and characterized in E. coli
(Kupke et al., 2001), H. sapiens (Aghajanian and Worrall, 2002; Daugherty
et al., 2002; Zhyvoloup et al., 2002), andA. thaliana (Kupke, 2002). However,
these and other studies observed significant differences, both in the gene
sequence and in the organization of the gene products of the enzymes in
the coenzyme A pathway between prokaryotic and eukaryotic organisms.
Cloning and analysis of the A. nidulans (Calder et al., 1999) and two Mus
musculus (Rock et al., 2000) pantothenate kinases showed that neither en-
zyme bore significant resemblance in primary sequence to the prokaryotic
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enzyme. Phosphopantothenate cysteine ligase and phosphopantothenoyl-
cysteine decarboxylase are two separate enzymes in eukaryotes that have
little sequence similarity to the respective enzymes in bacteria (Manoj et al.,
2003). Whereas in bacteria, such as E. coli and Corynebacterium ammonia-
genes (Martin and Drueckhammer, 1993), separate enzymes exist for the
last two biosynthetic steps in coenzyme A synthesis, in higher eukaryotic
organisms, such as mammals and flies, both phosphopantetheine adeny-
lyltransferase and dephospho-coenzyme A kinase reactions are catalyzed
by a single bi-functional enzyme. This enzyme is designated coenzyme A
synthase (Aghajanian and Worrall, 2002; Daugherty et al., 2002; Hoagland
and Novelli, 1954; Suzuki et al., 1967; Worrall et al., 1985; Worrall and
Tubbs, 1983; Zhyvoloup et al., 2003). In S. cerevisiae, coenzyme A syn-
thase is part of a multi-enzyme complex (Bucovaz et al., 1997). As implied
above, in general, sequence similarity between the orthologous enzymes
in eukaryotes and prokaryotes of the coenzyme A pathway is low.
All of the E. coli enzymes catalyzing reactions in coenzyme A biosyn-
thesis have been functionally characterized. Correlation of these results
with structural information, although not exclusively from E. coli nor from
any single organism, is also possible for these enzymes. Crystal structures
have been determined for E. coli pantothenate kinase (Yun et al., 2000),
phosphopantothenate cysteine ligase from H. sapiens (Manoj et al., 2003),
phosphopantothenoylcysteine decarboxylase fromA. thaliana (Albert et al.,
2000), phosphopantetheine adenylyltransferase from E. coli (Izard, 2003;
Izard and Blackwell, 2000; Izard and Geerlof, 1999), and dephospho-
coenzyme A kinase from both E. coli (O’Toole et al., 2003) and Haemophilus
influenzae (Obmolova et al., 2001).
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2.2.1 Regulation of coenzyme A biosynthesis
In contrast to the pantothenate pathway, which does not appear to be par-
ticularly regulated, regulation of the coenzyme A biosynthesis is more
tightly controlled.
Metabolic experiments in E. coli (Jackowski and Rock, 1981) and of my-
ocytes of Rattus norvegicus (Robishaw et al., 1982; Robishaw and Neely,
1984, 1985) showed that the utilization rather than the supply of pantothe-
nate controls the rate of coenzyme A biosynthesis. Enhanced expression of
pantothenate kinase in M. musculus cells eliminated the intracellular pan-
tothenate pool and triggered a thirteen-fold increase in intra-cellular coen-
zyme A content (Rock et al., 2000). This is consistent with reports about
the positive correlation of elevated tissue levels of pantothenate kinase
and increased coenzyme A concentration (Fisher et al., 1985; Halvorsen,
1983; Skrede and Halvorsen, 1979). Overexpression of the pantothenate
kinase gene also lead to increased pantothenate uptake (Rock et al., 2000).
These and other experiments (Jackowski, 1996; Robishaw et al., 1982; Ro-
bishaw and Neely, 1985; Rock et al., 2003) have shown that the catalysis by
pantothenate kinase is the most important regulatory step, controlling the
flux through the coenzyme A biosynthesis pathway in both bacteria and
animals. Thereby, non-esterified as well as esterified coenzyme A are act-
ing as a feedback inhibitor of pantothenate kinase by competitive binding
to the ATP binding site (Song and Jackowski, 1994; Vallari et al., 1987; Yun
et al., 2000). However, bacteria appear far less sensitive to inhibition by
acetyl-coenzyme A than to coenzyme A (Rock et al., 2000). In contrast, in
eukaryotic pantothenate kinases, acetyl-coenzymeA is themore potent in-
hibitor (Fisher et al., 1985; Halvorsen and Skrede, 1982) and non-esterified
coenzyme A even seems to be able to stimulate pantothenate kinase ac-
tivity (Calder et al., 1999), although earlier studies reported inhibition by
coenzyme A (Falk and Guerra, 1993; Fisher et al., 1985; Karasawa et al.,
1972; Kirschbaum et al., 1990; Robishaw and Neely, 1985). The contradic-
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tory reports may be due to the existence of several different pantothenate
kinase isoforms and different expression patterns in different tissues.
A potential second, although far less significant, regulation step, consti-
tutes the catalysis by phosphopantetheine adenylyltransferase. This was
indicated by the accumulation of 4’-phosphopantetheine (Jackowski and
Rock, 1984). Regulatory control at this step may also involve the reuti-
lization of 4’-phosphopantetheine, which can arise by the turnover of 4’-
phosphopantetheine of the acyl carrier protein or the cleavage of coen-
zyme A (Jackowski and Rock, 1984; Vallari and Jackowski, 1988). How-
ever, Cronan et al. (1982) and Frodyma et al. (2000) showed that the level
of coenzyme A could be significantly, but not proportionally, elevated in
pantothenate auxotrophs of E. coli by supplementation of pantothenate
in the growth medium. Supplementation with β-alanine in the former
study and also by Jackowski and Rock (1981) resulted in a similar increase
of the intracellular coenzyme A level, whereas supplementation with ei-
ther pantoate or ketopantoate was less effective. Somewhat contrasting
this, results from (Rubio and Downs, 2002) indicated that elevated levels
of ketopantoate hydroxymethyltransferase lead to physiologically signi-
ficant increased coenzyme A concentration in S. typhimurium. Similarly,
Lopaschuk et al. (1986) showed that increasing the exogenous pantothe-
nate supply to heart tissue elevated cellular coenzyme A content.
Older studies reported that mitochondria can transport coenzyme A
into the matrix, implying that all coenzyme A biosynthetic enzymes are
cytosolic (Neuburger et al., 1984; Tahiliani, 1989, 1991; Tahiliani and Bein-
lich, 1991; Tahiliani and Neely, 1987). However, because mitochondria
and peroxisomes contain the highest concentration of coenzyme A and
its thioesters in eukaryotes (Van Broekhoven et al., 1981), it has been pro-
posed that the last two enzymatic activities in the pathway are located
inside these compartments (Skrede and Halvorsen, 1983). More recently,
this has been convincingly demonstrated for mitochondria. Coenzyme
A synthase from H. sapiens is indeed located at the mitochondrial outer
2.2 Coenzyme A biosynthesis 20
membrane, but not on peroxisomes, and the enzyme is regulated by phos-
pholipids (Zhyvoloup et al., 2003). 4’-phosphopantotheine arising from
coenzyme A degradation may be expelled from these compartments into
the cytosol, where it cannot be further metabolized. One isoform of pan-
tothenate kinase is a cytosolic enzyme (Halvorsen and Skrede, 1982; Ro-
bishaw et al., 1982), whereas another localizes to the mitochondria (Hort-
nagel et al., 2003). The latter results could suggest that mitochondria do
have the entire complement of coenzyme A biosynthetic enzymes. How-
ever, for the former isoform the biochemical regulators (i.e. Coenzyme A
and its thioesters) are largely sequestered frompantothenate kinase, which
renders the enzymes incapable of sensing a significant proportion of the
total coenzyme A pool directly. In general, the compartmentalization of
the coenzyme A biosynthetic pathway and its regulatory effects on the
various isoforms of pantothenate kinase are not very well understood fea-
tures in eukaryotes. The regulation of the coenzyme A content is complex,
and likely governed by the interplay between coenzyme A biosynthesis,
transport throughmembranes, and degradation (Ramaswamy et al., 2003).
The metabolic state of the organism or the cell (Kondrup and Grunnet,
1973; Smith et al., 1978; Smith and Savage, 1980), pathological states such
as diabetes (Reibel et al., 1981b) as well as drugs (Voltti et al., 1979), can all
significantly alter the cellular level of coenzyme A, and these fluctuations
are reflected by concomitant changes in the level of tissue pantothenate
kinase activity (Halvorsen, 1983). Cells can modulate pantothenate kinase
expression to modify the coenzyme A levels in tissue in response to diet
and disease. Pantothenate kinase activity in heart cells decreased in re-
sponse to glucose, pyruvate, fatty acids, or insulin, and hepatic concentra-
tions of coenzyme A increased in response to glucagon, starvation, high-
fat diet, or diabetes (Kondrup and Grunnet, 1973; Reibel et al., 1981a,b;
Smith and Savage, 1980; Tahiliani and Beinlich, 1991; Voltti et al., 1979).
However, to date these regulatory effects are not fully understood.
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2.2.2 Pathogenic syndromes of disturbed pantothenate
metabolism
Recently, pantothenate kinase was linked to both the neurodegenerative
Hallervorden-Spatz syndrome in H. sapiens, an autosomal recessive dis-
order (Cossu et al., 2002; Hayflick, 2003a,b; Hayflick et al., 2003), and to
HARP syndrome (Ching et al., 2002). Mutations in the gene for the H.
sapiens pantothenate kinase isoform, which is located in the mitochon-
dria, create a metabolic imbalance leading to Hallervorden-Spatz syn-
drome. This is characterized by iron accumulation in the basal ganglia
of the brain. Inactivation of the enzyme is the causative agent of progres-
sive childhood Hallervorden-Spatz syndrome and thus the disease was
very recently renamed pantothenate kinase-associated neurodegeneration
(Zhou et al., 2001). Both pantothenate kinase-associated neurodegener-
ation and HARP disease indicate that defective expression or sequence
alteration of a single pantothenate kinase isoform can selectively impact
the function of specific tissues. Pantothenate kinase-associated neurode-
generation bears all the hallmarks of a mitochondrial disorder and could
serve as a model for other complex neurodegenerative diseases, such as
Alzheimers and Parkinson, since all exhibit pathologic accumulation of
iron in the brain (Zhou et al., 2001). Consequently, perturbed pantothenate
metabolism could be a general feature of neurodegenerative diseases.
Additionally, mutation in the gene for pantothenate kinase was also as-
sociated with aberrant mitosis and meiosis in flies (Afshar et al., 2001).
2.3 Outlook
In order to manipulate, create, or destroy certain functions in metabolism,
an understanding of the general organization of metabolism as well as of
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the particular biochemical reactions catalyzed by the individual enzymes
is necessary. Consequently, one of the most important long term goals of
genome sequencing initiatives, proteomics, and structural genomics, is to
gain an understanding how the cell works and how it changes and adapts.
This should enable a description of molecular function in the global con-
text of the cell and at the whole organism level.
However, whereas large scale initiatives, such as proteomics and (struc-
tural) genomics, will be essential for the growing understanding of the
metabolic universe, they will never suffice to substitute detailed investi-
gation of individual pathways and their enzymes. Both things are, and
will remain complementary. Since a limited set of biochemical reaction
appears to exist (see Section 1.3), the results of detailed characterizations
of biochemical reactions for individual enzymes always have the poten-
tial to be applicable to functionally and/or structurally-related, but yet
uncharacterized, enzymes.
With respect to the pantothenate pathway, considerable interest from
industry exists in manipulating the pathway to overproduce pantothe-
nate (Dusch et al., 1999). Processed food, animal feed, pharmaceuticals
and cosmetics are often supplemented with extra vitamins, which are pro-
duced either by chemical synthesis or by fermentation. At least 4 000
000 kg of pantothenate are industrially produced annually (Vandamme,
1992). In order to improve production strains, knowledge of the complete
biosynthetic pantothenate pathway is a prerequisite (see Elischewski et al.,
1999). Overproduction of pantothenate by engineering overexpression of
some of the enzymes in the pantothenate pathway has already been ac-
complished by Sahm and Eggeling (1999).
Secondly, the pantothenate pathway constitutes a viable target for an-
timicrobial drugs. The majority of the existing antibiotics utilize a limited
number of core chemical structures and target only a few cellular functions
as potential targets, such as cell wall synthesis, DNA replication, tran-
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scription, and translation. A growing number of antibiotic-resistant mi-
crobial pathogens present serious challenges to modern medicine. In the
last decade, the emergence of both vancomycin- and methicillin-resistant
bacteria has led to an urgent search for novel classes of antibiotics and
new anti-microbial targets (Zhao et al., 2003). Investigation into the po-
tential of the enzymes of the pantothenate and coenzyme A biosynthesis
pathway as antibacterial targets is now an active area of research. Results
from Gerdes et al. (2002) and Zhao et al. (2003) indicate the value structural
information of the enzymes involved in coenzyme A synthesis can have
for the development of inhibitors.
The genes in the coenzyme A pathway appear to be significantly dif-
ferent between eukaryotes and prokaryotes, and thus the enzymes poten-
tially can be exploited for the development of drugs. However, the com-
plete absence of the pantothenate pathway in animals may make it more
straightforward to identify potent inhibitors for the bacterial enzymes. In
the following, I will introduce to the two E. coli enzymes of the pantothe-
nate pathway, KPHMT and ADC, that are the focus of study of this thesis.
3 Ketopantoate
hydroxymethyltransferase
3.1 Background
Kuhn and Wieland (1942) were the first to describe the synthesis of ke-
topantoate from α-kiva. Evidence that E. coli cells can synthesize ketopan-
toate from α-kiva, whereas certain pantoate-requiring mutants could not,
suggested that α-kiva is the precursor for ketopantoate (Maas and Vo-
gel, 1953). Shortly afterwards, McIntosh et al. (1957) reported the partial
purification of an enzyme catalyzing this reaction, which required free
formaldehyde as a substrate. However, since the Michaelis-Menten Km
values for formaldehyde and α-kiva were rather high, the physiological
relevance seemed questionable. Powers and Snell (1976) and Teller et al.
(1976) re-investigated the reaction and described the purification and bio-
chemical characterization of a different 5,10-meTHF dependent enzyme,
which they designated KPHMT, from E. coli. The transferase activity was
found to be absent in a ketopantoate auxotroph, which together with rea-
sonable Michaelis-Menten constants of <1 mM for its substrates, led them
to conclude that this is the enzyme involved in pantothenate biosynthesis.
Subsequently, the panB gene was cloned and the gene product character-
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ized from E. coli (Jones et al., 1993),A. nidulans (Kurtov et al., 1999), andMy-
cobacterium tuberculosis (Sugantino et al., 2003), and respective panB clones
were overexpressed in E. coli. The gene has also been characterized in S.
typhimurium (Downs and Roth, 1991; Rubio and Downs, 2002), and Ara-
bidopsis thaliana (Ottenhof et al., 2004). In the latter organism two genes,
both encoding functional KPHMT isoenzymes, were found.
3.2 The transferase reaction of KPHMT
In chemical terms, the reaction catalyzed by KPHMT is a common crossed
aldol addition reaction, where a general base deprotonates the carbon ad-
jacent to the ketogroup, followed by the nucleophilic attack of the resulting
double bond on a carbonyl group and C-C bond formation. The pKa value
of the α-hydrogen atom in aldehydes and ketones is usually between 19
and 21 (Vollhardt and Schore, 1995), which is far lower than that of usual
C-bonded hydrogens. The relatively acidic character of aldehydes and ke-
tones has two reasons, one is the electron-drawing effect of the positively-
polarized carbon atom in the aldehyde or ketogroup. The second, and
more important, is the resonance or conjugation effect after deprotonation.
During deprotonation the σ-orbital of the C-H bond assumes pi-orbital
character and stands perpendicular to the plane of the sp2-orbital. This
way it can undergo pi-orbital conjugation with the pi-system of the adja-
cent carbonyl group. In the case of α-kiva the resulting negative charge of
the deprotonation is further dispersed over the carboxylate group, which
also provides two electronegative oxygen atoms (Figure 3.1).
The classical aldol addition proceeds with nucleophilic attack of the α-
carbon on the pi-antibonding orbital of a carbonyl bond. This is followed
by C-C bond formation and protonation of the generated negative oxygen
atom, which stands in the β-position to the carbonyl of the nucleophile
(Figure 3.1). The electrophilic carbonyl carbon can be replaced by other
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Figure 3.1 Illustration of the deprotonatation of the ketoacidα-kiva. The pi-atomic orbitals
are indicated to illustrate the pi-conjugated system after deprotonation. Two of the most
likely resonance states are shown at the top.
electrophiles, which in the case of KPHMT is the 5,10-methylene carbon
of 5,10-meTHF. Kallen and Jencks (1966) reported that the reactive compo-
nent of 5,10-meTHF is the iminium intermediate (Figure 3.2). With regard
to the steric course of the KPHMT reaction, the addition of the carbon
from 5,10-meTHF proceeds with retention of configuration, as indicated
by isotopic labelling experiments (Aberhart and Russell, 1984).
In biological aldol reactions, increased stabilization of the arising neg-
ative charge is accomplished by dispersing it even further into a cationic
electron sink at the active site of the enzyme (Figure 3.2). Based on the
mechanism, two classes of aldolases may be distinguished (Morse and
Horecker, 1968). In class I aldolases a Schiff base or imine is formed with
an essential -amino group of a catalytic lysine residue in the enzyme. In
contrast, class II aldolases use a divalent metal ion, such as Mg2+, as an
electron sink. The imine, formed in class I aldolases, can be reduced by
borohydride, which results in irreversible inactivation of the enzyme. In
KPHMT no such inactivation could be observed and, thus, it was function-
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Figure 3.2 Illustration of the chemistry of the aldol reaction catalyzed by KPHMT. (A)
The nucleophilic attack on the C11 atom of 5,10-meTHF. (B) The postulated iminium in-
termediate of 5,10-meTHF. (C) The polyglutamate tail of 5,10-meTHF.
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ally assigned to the class II aldolase group (Powers and Snell, 1976). Class
I aldolases are mainly found in higher order organisms whereas class II
aldolases predominate in bacteria and fungi (Schurmann and Sprenger,
2001). The two classes of enzymes are considered to be evolutionarily un-
related (Flechner et al., 1999).
3.3 Catalytic properties of KPHMT
E. coli KPHMT is inhibited by pantoate and pantothenate at concentra-
tions greater than 50 µM and 500 µM, respectively. In both cases the Vmax
is decreased, the KM is increased and the cooperativity for ketopantoate
was greatly increased, whereas the enhancement of cooperativity for pan-
toate seemed to be less pronounced. Coenzyme A also appeared to be
inhibitory above 1 mM. The data indicated feedback inhibition and pos-
sible communication between the subunits during inhibition and also ca-
talysis. Therefore, KPHMT bears characteristics of an enzyme with mul-
tiple allosteric binding sites. KPHMT requires Mg2+ for activity, whereas
Mn2+, Co2+, Ni2+, and Zn2+ were found to be progressively less activating
(Powers and Snell, 1976). Similar results have also been obtained for M.
tuberculosis KPHMT by Sugantino et al. (2003).
Powers and Snell (1976) report that α-keto-β-methylvalerate, α-
ketobutyrate, and α-ketovalerate can all replace α-kiva as substrate,
whereas pyruvate, isovalerate, and valine proved to be inhibitors (Fi-
gure 3.3). This implies that the substitution on the C3 is essential, but can
vary. Isovalerate, 3-methyl-2-butanone, as well as D-and L-valine inhibit,
and indicate the importance of the α-keto and the carboxyl group. How-
ever, substitution at the C3 does apparently not impair the enolization re-
action— i.e. abstraction of the proton— of the substrate, as demonstrated
by Sugantino et al. (2003).
3.3 Catalytic properties of KPHMT 29
Figure 3.3 Illustration of substrate-analogues of α-kiva and inhibitors of KPHMT.
E. coli KPHMT requires 5,10-meTHF as a cofactor for the transferase re-
action. Tetrahydrofolate (THF) itself is the principal one-carbon-group car-
rier in metabolism, capable of carrying one carbon units at the oxidation
level of methanol, formaldehyde, and formate (Stover and Schirch, 1992).
Only the S-isomer of 5,10-meTHF appears to be utilized as a cofactor by
KPHMT, although the R-isomer did not inhibit the enzyme (Powers and
Snell, 1976). THF derivatives in vivo differ in the number of glutamate
residues that are attached to the para-aminobenzoic ring. The most com-
mon naturally occurring forms have between two and seven glutamate
residues. The predominant natural conjugates found in extracts of E. coli
cells were THF with five glutamate residues, followed by four, three, or
six (Powers and Snell, 1976). All of them were effective, but 5,10-meTHF
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with four or five glutamates exhibited the lowest KMs and thus strongest
affinity for binding to the enzyme. In eukaryotes, the glutamate residues
are γ-linked, connected together by their γ-carboxyl groups. In contrast, in
E. coli, in general, only the first three glutamate residues are γ-linked and
subsequent ones are α-linked (Figure 3.2) (Scarsdale et al., 2000; Schirch
and Strong, 1989).
3.4 Structural features of KPHMT
Based on native polyacrylamide gel electrophoresis (PAGE) and gel-
filtration, Powers and Snell (1976) reported a decameric organization of E.
coliKPHMTwith a subunit molecular weight of between 25 700 and 27 000
Da. Analytical sedimentation equilibrium ultracentrifugation confirmed
the decameric quaternary macromolecular assembly (von Delft, 2000),
which eventually was helpful in solving the crystal structure. The recom-
binant protein used for this had 264 amino acid residues, corresponding
to a subunit molecular weight of 28 237 Da. The crystal structure of the
enzyme with the product ketopantoate (PDB-ID: 1M3U) was solved to a
nominal resolution of 1.8 A˚ (von Delft et al., 2003).
Experimental phases for structure solution were derived by multi-
ple wavelength-anomalous dispersion of the selenomethionine deriva-
tized protein. Since two decamers were located in the asymmetric unit,
this meant that ∼560 kDa of protein had to be phased. 160 of the
possible 180 selenomethionine-sites were located, making it the largest
selenomethionine-substructure solved to date.
The protomeric tertiary structure of the subunits is a classical (βα)8- or
triosephosphate isomerase- (TIM)-like barrel fold (Figure 3.4) with some
minor, but important variations. A helix, usually found between β-strands
7 and 8, is here replaced by a loop, and an additional N-terminal α-helix, α-
1’, preceding the usual first β-strand in the sequence is located at the base
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Figure 3.4 Cartoon representation of the KPHMT subunit with the active site (von Delft
et al., 2003). (A) View down into the β-barrel and the active site. The Mg2+ is shown in
blue, coordinated by Asp45, Asp84, two water molecules, and the product ketopantoate.
For this and all following figures, unless otherwise stated, the colour scheme for ball
and stick representation of atoms is as follows: carbon (protein): yellow; carbon (ligand):
orange; hydrogen: white; nitrogen: blue; oxygen: red; sulfur: green. (B) Illustration of
a close up view of the active site of KPHMT, with important active site residues shown
and numbered.
of the β-barrel (see Figure 3.5). The quaternary assembly of the protein is
shown in Figure 3.6. Based on the analysis of both the hydrophobic and
polar interactions, and the buried surface area of the subunits (von Delft
et al., 2003), KPHMT is best described as a pentamer of dimers.
The subunits are arranged such that the vertical axis of the (βα)8-barrel
is perpendicular to the internal five-fold axis of the decamer (Figure 3.6).
The extensive interface can explain the high temperature resistance of the
protein (Powers and Snell, 1976). The active site of KPHMT could be reli-
ably identified, because it contained the prosthetic Mg2+ with the product
ketopantoate bound to it (von Delft et al., 2003). The active site of KPHMT
is located in a large cavity at the C-termini of the β-strands with dimen-
sions of 20 A˚ in length, 10 A˚ in width, and 15 A˚ in depth. It is inaccessible
from the bottom edge of the (βα)8-barrel.
The co-crystallized Mg2+ is bound in a distorted octahedral geometry,
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Figure 3.5 Schematic secondary structure topology representation of the KPHMT fold.
For this and the following schematic figure of secondary structures the colour scheme
for secondary structural elements is the same as in Figure 3.6, with the exception of 310
helices which are coloured brown, instead. Residues from the E. coli KPHMT amino
acid sequence bordering the respective secondary structural elements are shown with
numbered labels. The scheme for this figure was adapted and modified from von Delft
et al. (2003).
where residues Asp45 and Asp84 occupy axial and equatorial positions,
respectively, while Glu114 coordinates through a water molecule that oc-
cupies an equatorial position (Figure 3.4). The keto- and carboxyl-groups
of ketopantoate assume axial and equatorial positions to the Mg2+, respec-
tively and the remaining equatorial positions are occupied by two water
molecules (see Figure 3.4 and Section 11.5).
More recently, crystal structures for the M. tuberculosis (PDB-ID: 1OY0)
(Chaudhuri et al., 2003) and Neisseria meningitidis KPHMT (no reference
available; PDB-ID: 1O66) have also been reported. For the latter a cry-
stal structure in complex with substrate α-kiva has also been determined
(PDB-ID: 1O68).
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Figure 3.6 Cartoon representation of the KPHMT decamer (von Delft et al., 2003). For
this, and the following figures, the colour scheme is as follows, unless otherwise stated:
α-helices: red; β-strands: blue; loops and coils: grey. (A) The KPHMT decamer viewed
down the internal five-fold symmetry axis. For the subunits in the background the sec-
ondary structural elements are shown in lighter colours. (B) The KPHMT decamer ro-
tated by ∼90◦ from the view in A. These and all following cartoon figures of proteins
were prepared with MOLSCRIPT (Kraulis, 1991) and rendered in RASTER3D (Merritt and
Bacon, 1997), unless stated otherwise.
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3.5 Motives for studying KPHMT
Reasons for studying the pantothenate pathway in general have already
been given in Section 2.3. KPHMT catalyzes the first committed reactions
in this pathway and is absent in animals. As such it is a particularly at-
tractive target for the development of pantothenate pathway inhibitors.
With the crystal structure available, the mechanistic issues can now be
addressed, which are to identify the cofactor binding site, characterize key
catalytic residues, and carry out a detailed comparative structural analy-
sis. Relatively little is known about the binding of the cofactor 5,10-meTHF
to enzyme in general, and about the mode of transfer of groups from
THF from a structural point of view. High resolution crystal structures
of KPHMT bound to 5,10-meTHF analogues could provide insight into
the catalysis. In order to rationally design inhibitors against the enzyme a
thorough understanding of the mechanism is required.
The potential of aldolases in synthetic organic chemistry is widely rec-
ognized as they are carrying out specific C-C bond condensations with
exquisite control of stereochemistry. Their utilization has already proven
useful in the synthesis of compounds for the pharmaceutical industry
(Cooper et al., 1996), and directed evolution has successfully been em-
ployed to engineer new activities onto existing scaffolds (Wymer et al.,
2001). The (βα)8-barrel fold is particularly well-suited for this strategy,
because the functional and structural features are well separated in the
enzyme. The substrate specificity and the catalytic step, itself could be
changed by directed evolution (Gerlt and Babbitt, 2001).
KPHMT is certainly a complex and interesting enzyme, its research
reaching beyond the application-oriented aims towards an understand-
ing of this crucial enzyme in vitamin B5 biosynthesis from a structural and
mechanistic point of view.
4 L-aspartate-α-decarboxylase
4.1 Background
Virtanen and Laine (1937) discovered that β-alanine is formed in the fer-
mentation mash of the microorganism Rhizobium triolii, presumably from
the L-aspartate in the culture medium. Williamson and Brown (1979) were
subsequently the first to demonstrate the biosynthesis of β-alanine from L-
aspartate by ADC in E. coli. They also described the purification and some
biochemical properties of the enzyme. Independently, Cronan (1980) dis-
covered the enzyme in extracts of E. coli and showed that the catalysis by
L-aspartate-α-decarboxylase provides for the main route of β-alanine pro-
duction in E. coli. β-alanine auxotrophs were deficient in ADC activity and
the lesion could be mapped to the panD gene locus. The panD gene was
subsequently cloned and the enzymatic properties characterized in more
detail by both Smith (1988) and Ramjee et al. (1997). The gene has also
been cloned from both Helicobacter pylori (Kwon et al., 2002) and M. tuber-
culosis (Chopra et al., 2002), and in the latter the gene product has been
biochemically characterized.
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4.2 Posttranslational intramolecular self-
processing
4.2.1 Self-catalytic pyruvoyl formation
ADC is a particularly interesting enzyme in that it is capable of forming its
own cofactor, prior to carrying out the actual catalysis. In common with a
small, but widely distributed, group of mechanistically related pyruvoyl-
dependent enzymes, ADC is translated as an inactive pro-enzyme, the
subunit of which is also designated pi-chain. This self-processes at a spe-
cific cleavage site to create a covalently bound prosthetic group, a pyru-
voyl cofactor (Figure 4.1).
The latter is formed by intramolecular, non-hydrolytic serinolysis in
which the side-chain oxygen of Ser25 atttacks the carbonyl carbon of
Gly24. This process does not require any external auxiliary effectors. The
initial step of the reaction, which is also known as an N→O acyl shift, re-
sults in the formation of an ester in processing (Figure 4.1), which was
first demonstrated by isotope labelling experiments with O18 by Recsei
et al. (1983a). Direct evidence for the ester intermediate in the reaction has
also been provided by the crystal structures of processed, active ADC (Al-
bert et al., 1998), and human S-adenosylmethionine decarboxylase (Ado-
metDC) His243→Ala mutant (Ekstrom et al., 2001). β-elimination of the
ester intermediate produces dehydroalanine, which hydrolyses to form
the pyruvoyl group (Figure 4.1). In E. coli ADC this process yields a larger
α-chain of 11 kDa with the pyruvoyl group at the amino-terminus and a
smaller β-chain of 2.8 kDa with Gly24 at the carboxyl-terminus, as shown
by PAGE, electrospray mass spectrometry (Ramjee et al., 1997), and the
ADC crystal structure (Albert et al., 1998). However, both subunits remain
non-covalently attached to each other to form the active, functional sub-
unit of the enzyme.
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Interestingly, purified, tetrameric E. coli ADC was observed to be only
partially processed and SDS-PAGE showed the presence of significant am-
ounts of the pi-chain (see Section 12.2). Mass-spectrometry experiments by
Ramjee et al. (1997) indicated the presence of three processed subunits per
tetramer and one subunit with an N-terminal Ser residue at the α-chain.
The initial crystal structure (Albert et al., 1998) partly confirmed this by
finding three processed subunits and an ester intermediate in one of the
subunits. In general, self-processing in E. coliADC appears to be consider-
ably slower than in other self-processing enzymes and was observed to be
faster in vivo than in vitro, which could indicate the existence of an external
processing factor or a specific pH-dependence. Self-processing of the last
subunit was slow enough to survive purification, crystallization, and X-
ray data collection (Albert et al., 1998). More recent studies on tetrameric
M. tuberculosis ADC by Chopra et al. (2002) confirmed the finding of E.
coli ADC that protein self-processing in ADC is very slow. The M. tuber-
culosis enzyme essentially shows biochemical properties and characteris-
tics similar to E. coli ADC. The E. coli and M. tuberculosis enzymes exhibit
45% amino acid sequence identity, with the key residues being identical
(see amino acid sequence alignment in Section 13.3).
The overall molecular mechanism of self-processing and the forma-
tion of the pyruvoyl group is assumed to be essentially the same as in
other pyruvoyl-dependent enzymes (reviewed by van Poelje and Snell,
1990). Pyruvoyl formation is known from AdometDC, arginine decarbo-
xylase (ArgDC), histidine decarboxylase (HisDC) of Gram-positive bac-
teria, phosphatidylserine decarboxylase, and from glycine-, proline-, and
sarcosine reductases.
Lactobacillus 30a HisDC was the first enzyme extensively studied be-
cause of the formation of the pyruvoyl cofactor (Gallagher et al., 1989;
Huynh et al., 1984a; Huynh and Snell, 1986a,b; Huynh et al., 1984b; Rec-
sei et al., 1983a; Recsei and Snell, 1970, 1973, 1982; Snell and Huynh, 1986;
Vanderslice et al., 1988) and served as a model for the study of the others.
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The same enzyme has also been characterized from Clostridium perfringens
and Lactobacillus buchneri (Huynh and Snell, 1985a,b; Recsei et al., 1983b;
Recsei and Snell, 1985). Moreover, research has been carried out on Ado-
metDC from H. sapiens (Stanley and Pegg, 1991; Stanley et al., 1989, 1994;
Xiong and Pegg, 1999; Xiong et al., 1999), Methanococcus jannaschii (Kim
et al., 2000a), Acanthamoeba castellani (Hugo and Byers, 1993), Sulfolobus sol-
fataricus (Porcelli et al., 1993), Catharanthus roseus (Schroder and Schroder,
1995) and S. cerevisiae (Kashiwagi et al., 1990). AdometDC is a critical reg-
ulatory enzyme in the polyamine (spermidine and spermine) biosynthetic
pathway. Both processing and enzyme activity in theH. sapiens and S. cere-
visiae forms were shown to be enhanced by putrescine (Pegg et al., 1998).
Pyruvoyl-dependent phosphatidylserine decarboxylase has been charac-
terized from E. coli (Li and Dowhan, 1988, 1990) and S. cerevisiae (Trotter
et al., 1995; Voelker, 1997), and glycine- proline-reductases from Clostrid-
ium sticklandii (Bednarski et al., 2001; Kabisch et al., 1999; Seto, 1978).
In addition to the crystal structure of ADC (Albert et al., 1998), the pro-
cessed crystal structures of three pyruvoyl-dependent enzymes have been
reported, namely, Lactobacillus 30a HisDC (Gallagher et al., 1993), H. sapi-
ensAdometDC (Ekstrom et al., 1999) andM. jannaschii arginine decarboxy-
lase (ArgDC) (Tolbert et al., 2003a). Although all these enzymes have their
cleavage site located in a loop region between two β-strands, only ArgDC
and HisDC are homologous to each other. The absence of similarity in
sequence and structure between the pyruvoyl-dependent enzymes points
towards convergent evolution for the molecular mechanism of cleavage.
4.2.2 Related forms of self-processing
In self-catalyzed protein processing the initial biochemical step, common
to all self-processing enzymes, is the formation of an ester or thioester (Fi-
gure 4.1). In an open system, the thermodynamic equilibrium for this step
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would be expected to be on the side of the amide bond, and consequently
the reaction would be unfavourable. However, chemical model systems
have shown that the equilibrium in N→O is on the side of the ester, when
the amine can be protonated (Iwai and Ando, 1967).
The ester formation may be additionally driven by relief of strain
present in the loop region preceding the self-cleavage site. In HisDC me-
chanical strain appeared to be built into the Ser81-Ser82 cleavage site,
which was indicated by the relatively large distance of 6 A˚ between the
cleaved N-and C-terminal ends of the cleaved chain (Gallagher et al.,
1993). Likewise, unusual peptide conformations were observed by Xu
et al. (1999) in the crystal structure of an unprocessed glycosylasparagi-
nase mutant, another self-processing enzyme. Relaxation of this strain by
the N-O acyl rearrangements was proposed to shift the amide-ester equi-
librium in favour of the ester intermediate. In general, the biochemical
rationale for the formation of the ester intermediate presumably lies in its
greater reactivity compared with amides, making them intermediates that
are more suitable for the subsequent biochemical steps in self-catalyzed
reactions. In recent years, self-processing has emerged as an important
post-translational modification for protein maturation that is observed in
a growing number of, often evolutionary and structurally unrelated, pro-
teins. The molecular mechanism is assumed to have strong parallels in all
self-processing systems. Consequently, self-processing in ADC is thought
to bear the general characteristics of intramolecular, self-catalyzed back-
bone rearrangements.
As already indicated above, whereas the inital N→O or N→S shift is
chemically the same in all self-processing systems, the subsequent reac-
tion, which invariably leads to cleavage of the rearranged peptide bond,
can proceed in different ways. Based on the fate of the ester intermedi-
ate, these enzymes can be mechanistically classified into four main sys-
tems (reviewed by Paulus, 2000): hedgehog proteins, inteins, N-terminal
nucleophilic aminohydrolases (Ntn hydrolases) and pyruvoyl-dependent
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Figure 4.1 Schematic overview of the chemistry of the various forms of intramolecular
protein self-processing. (A) The initial N→O or N→S acyl shift common to all forms of
protein self-processing. (B) Pyruvoyl group formation, as in ADC, coloured in red. (C)
Hydrolysis of the ester as in N-teminal nucleophile hydrolases. (D) Intermolecular attack
of the ester by cholesterol as in the case of the hedgehog proteins. (E) Intramolecular
transesterification as in inteins.
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enzymes. An initial N→S or N→O acyl shift with invariably a Cys, Ser or
Thr nucleophile, resulting in a thioester or ester intermediate, respectively,
is common to all four groups. The following steps differ, but always result
in breakdown of the activated (thio)ester (Figure 4.1).
In Ntn hydrolases the (thio)ester is simply hydrolyzed generating a
prosthetic N-terminal Cys, Ser, or Thr at the cleaved C-terminal part,
which then becomes crucial to the actual catalysis of the enzyme (Fi-
gure 4.1) (Artymiuk, 1995). One of the most prominent examples for
an Ntn hydrolase is the β-subunit of the proteasome, the principal pro-
tease responsible for non-lysosomal protein degradation in most eukary-
otic cells. Upon self-processing, the much smaller N-terminal part appears
to act as molecular chaperone (Chen and Hochstrasser, 1996) whereas the
resulting new N-terminal residue at the C-terminal part is central in car-
rying out the nucleophilic attack for peptide bond hydrolysis of the sub-
strates (Chen and Hochstrasser, 1996; Groll et al., 1999; Seemuller et al.,
1996). Other known and characterized Ntn hydrolases include glycosylas-
paraginase (Guan et al., 1996, 1998; Ikonen et al., 1991; Liu et al., 1998; Riiko-
nen et al., 1995; Saarela et al., 1998, 2004; Tikkanen et al., 1996), glutamine
phosphoribosylpyrophosphate amidotranferase (Li et al., 1999a), glutaryl
7-aminocephalosporanic acid acylase (Lee et al., 2000; Lee and Park, 1998),
L-aminopeptidase D-Ala-esterase (Bompard-Gilles et al., 2000), penicillin
acylases (Martin et al., 1991; Slade et al., 1991), and cephalosporin acylases
(Li et al., 1999b).
The Ntn glycosylasparaginase is one of the most detailed studied Ntn
hydrolases to date. Site-directed mutagenesis and structural studies have
revealed several important aspects of self-processing. A wide spectrum
of different disease-causing mutations are known in the human gene of
glycosylasparaginase, several of which impair self-processing (Tikkanen
et al., 1996). A resulting deficiency of enzyme activity causes the lysosomal
accumulation disease aspartylglycosaminuria in H. sapiens, which results
in mental retardation (Mononen et al., 1993).
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Penicillin and cephalosporin acylases are industrially very important
enzymes, used to hydrolyze penicillin or cephalosporin, respectively to
give the β-lactam nucleus of many semi-synthetic drugs (Valle et al., 1991).
Although there is hardly any sequence similarity among most of the
Ntn hydrolase enzymes, all enzymes share a common, specific fold. Con-
sequently, they appear to be evolutionary related (Artymiuk, 1995; Bran-
nigan et al., 1995), and have been classified into one superfamily in SCOP
(Murzin et al., 1995). The fold has been the subject of a detailed compar-
ison by Oinonen and Rouvinen (2000). The SCOP classification enabled
the crystal structure of the conserved protein MTH 1020 fromMethanobac-
terium thermoautotrophicum to be assigned to this superfamily (Saridakis
et al., 2002). Based on sequence comparison the proteins of the peptidase
family U34, of unknown function, could also be classified into the Ntn
superfamily (Pei and Grishin, 2003).
In hedgehog proteins an intermolecular attack of the 3β hydroxyl group
of cholesterol on the thioester occurs, resulting in covalent linkage of
cholesterol to the C-terminus of the smaller N-terminal signalling domain
and release of the larger C-terminal domain (Beachy et al., 1997; Ham-
merschmidt et al., 1997) (Figure 4.1). Members of the hedgehog fam-
ily of secreted signalling proteins are among the primary signals gener-
ated by certain embryonic patterning centers, and are consequently cen-
tral in developmental biology of both invertebrates and vertebrates. Se-
creted signalling proteins encoded by the hedgehog gene family induce
specific patterns of differentiation in a variety of tissues (Lee et al., 1994;
Porter et al., 1996, 1995). The N-terminal domain of the cleaved hedge-
hog protein, accounting for local and long-range signalling activity, re-
mains tightly cell surface-associated, whereas the C-terminal domain dif-
fuses freely upon secretion in embryos. The cholesterol modification of
the N-terminal domain was demonstrated to be crucial for its association
with the cell surface-membrane, and is essential for proper signaling func-
tion (Gallet et al., 2003). Self-processing in hedgehog proteins appears to
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be concentration-independent (Porter et al., 1995). Genes that are simi-
lar in sequence to the self-processing domain in hedgehog proteins have
been identified in several nematode genes of unknown function (Hall et al.,
1997).
Protein splicing in inteins was first described by Kane et al. (1990). In-
teins are internal polypeptide sequences, between 100 and 600 amino acids
in size, that are posttranslationally excised from a protein precursor (Per-
ler et al., 1997). In inteins the (thio)ester is intramolecularly attacked by a
nucleophile from a spatially different region, which splices the intein, the
central part of the protein, and ligates the two flanking N- and C-terminal
polypeptides, termed exteins, together to form the mature and active ex-
ternal protein (Figure 4.1) (reviewed by Gogarten et al., 2002; Liu, 2000;
Noren et al., 2000; Paulus, 2000). Protein splicing is distantly reminiscent
of self-splicing in the ribozyme, self-cleaving RNAs that are synthesized
as one polynucleotide and catalyze cleavage via an internal phosphoester
transfer (Doherty and Doudna, 2000). The catalytic power rests within the
intein and catalysis only requires one additional Cys, Ser, or Thr residue
of the extein at the C-terminal splice junction.
To date, no apparent cellular function has been established for inteins.
It is assumed that inteins are parasitic genetic elements which can persist,
because they do not impair the function of the enzyme as they are being
spliced. Most of the inteins contain a homing endonuclease activity which
allows them to insert the intein gene into other genomes. This guarantees
their mobility and also enables them to spread by horizontal gene transfer.
Homing endonucleases are a class of sequence-specific double-stranded
endonucleases that recognize and cleave DNA at or near the intein in-
sertion site in homologous genes lacking the intein element (Belfort and
Perlman, 1995; Belfort and Roberts, 1997). Intein endonucleases cleave the
intein-minus copy of the intein gene at or near the intein-encoding site and
the intein-plus copy is then used as a template to repair the intein-minus
gene, converting it into an intein-containing allele. More than 130 inteins
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have been identified in members of all three phylogenetic kingdoms of life
and are listed in the Intein database1 (Perler, 2002). They have been found
inserted in a variety of archaeal, bacterial, and chloroplast proteins as well
as vacuolar ATPases from S. cerevisiae (Noren et al., 2000). The majority
of these mature proteins are nucleotide triphosphate-utilizing enzymes,
such as DNA and RNA polymerases, gyrases, and helicases (Liu, 2000;
Pietrokovski, 1994).
Significant sequence similarity exists between the C-terminal part of
hedgehog proteins and inteins and the C-terminal self-processing domain
of hedgehog and inteins bear strong structural similarity. The conserved
fold was termed HINT (HedgehogIntein) module (Dalgaard et al., 1997;
Hall et al., 1997). In addition, a conserved Thr-X-X-His (where X is any
amino acid) sequence motif in both hedgehog proteins and inteins, that
is spacially close to the cleavage site, could be identified (Lee et al., 1994).
Together, these data indicate a common evolutionary origin of inteins and
hedgehog proteins, with hedgehog proteins likely having evolved from
inteins (Dalgaard et al., 1997).
Structural information for the processed forms of self-processing en-
zymes is available for the hedgehog protein (Hall et al., 1995, 1997), in-
teins (Ding et al., 2003; Duan et al., 1997), the proteasome (Lowe et al.,
1995), and for several other Ntn hydrolases, such as cephalosporin acy-
lase (Kim et al., 2000b), glycosylasparaginase (Guo et al., 1998; Oinonen
et al., 1995), from glucosamine 6-phosphate synthase (Isupov et al., 1996),
glutamine phosphoribosylpyrophosphate (Smith et al., 1994), glutaryl 7-
aminocephalosporanic acid acylase (Kim et al., 2003), L-aminopeptidase
D-Ala-esterase (Bompard-Gilles et al., 2000), penicillin acylase (Duggleby
et al., 1995), penicillin G acylase (McDonough et al., 1999), and penicillin V
acylase (Suresh et al., 1999).
1http://www.neb.com/neb/inteins.html
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4.3 Catalytic properties of ADC
One efficient biochemical way to decarboxylate an amino acid is to attach
it to a molecule with an ”electron sink” in order to facilitate bond cleavage
of the α-carboxylate group. A large number of enzymes typically accom-
plishes this task by providing a pyridoxal 5-phosphate cofactor, invariably
bound to the -amino group of a catalytic lysine residue (reviewed by John,
1995). The amino group of the amino acids then covalently binds to the
cofactor through its aldehyde group. An alternative route, with respect to
the cofactor that is used by pyruvoyl-dependent enzymes, is to covalently
attach the substrate to a pyruvate-like moiety of the enzyme, the pyru-
voyl group. A comparative computational investigation of the effect of
the pyridine ring for amino acid decarboxylations and the pyruvoyl group
came to the conclusion that the additional stabilization effect of the pyri-
dine ring is only minor (Toney, 2001). Consequently, pyruvoyl-dependent
enzymes appear to capture the major part of the catalytic power that pyri-
doxal 5-phosphate offers, are identical in stereospecificity, and appear to
be similar in catalytic efficiency (Toney, 2001; van Poelje and Snell, 1990).
HisDC is the only amino acid decarboxylase for which both types of co-
factors have been observed: pyridoxal 5-phosphate dependent HisDC in
Gram-negative bacteria (Tanase et al., 1985) and animals (Watanabe et al.,
1979); pyruvoyl-dependent HisDC in Gram-positive bacteria, which show
no relatedness in amino acid sequence. The general utility of both the
pyruvoyl group and pyridoxal 5-phosphate stems from their ability to sta-
bilize carbanions formed adjacent to the Schiff-base through delocalization
into the extended pi-bonded system. However, compared with pyridoxal
5-phosphate-dependent catalysis, pyruvoyl-dependent catalysis may be a
more primitive mechanism that does not require exogeneous cofactors.
ADC uses a pyruvoyl-group as a cofactor to covalently bind L-aspartate.
The nucleophilic attack of the amino-group of L-aspartate on to the car-
bonyl carbon of the pyruvoyl group results in formation of a Schiff-base
(Figure 4.2) and creates a pi-conjugated system between the bound sub-
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strate and the adjacent amide bond. The created Schiff-base can easily be
trapped by reduction with cyanoborohydride (Ramjee et al., 1997), which
was also shown for other pyruvoyl-dependent decarboxylases such as
AdometDC (Markham et al., 1982), HisDC (Recsei and Snell, 1970), and
phosphatidylserine decarboxylase (Satre and Kennedy, 1978).
Upon decarboxylation of the α-carboxyl group, which dissociates as car-
bon dioxide, the negative charge on the α-carbon can be dispersed over the
pi-conjugated system, and even further into amino acid residues that H-
bond to it, which could provide a ”pull-effect” for the reaction. The pres-
ence of a ”pull” and ”push” effect appears to be required to facilitate decar-
boxylation (von Delft, 2000), because of the strength of the carbon-carbon
bond. The decarboxylation results in formation a planar carbanionic in-
termediate. A ”push” effect driving the negative charge from the carboxyl
into the electron sink and towards the neutral carbon dioxide species could
be provided by the hydrophobic environment at the active site. Based on
the crystallographic analysis of enzyme-ligand complexes (see Section 4.4)
von Delft (2000) proposed a detailed four-step catalytic mechanism for the
decarboxylation reaction, which was, in part, supported by deuterium la-
beling experiments by Saldanha et al. (2001).
β-substituted D-amino acid analogues (i.e. with the opposite stereo-
chemistry), such as β-fluoro/chloro-D-alanine, were demonstrated to be
inhibitory for E. coli ADC (Smith, 1988), probably as a result of elimina-
tion of the β-substituted group and subsequent attack of a basic group
of the enzyme on the vinyl group to cause irreversible inhibition (Smith,
1988; von Delft, 2000; Williamson and Brown, 1979). Of the tested com-
pounds, mostly D-amino acids, i.e. with the opposite configuration of
substrate, showed inhibition, although L-glutamate and L-serine also in-
hibited the enzyme. However, significant feedback inhibition by later
pathway products, such as β-alanine, acetyl coenzyme A, coenzyme A,
or pantothenate could not be observed (Williamson and Brown, 1979). All
known pyruvoyl-dependent enzymes can be irreversibly inactivated by
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Figure 4.2 Schematic of the chemistry of the decarboxylation reaction catalyzed by ADC.
(A) The first step involves formation of a Schiff-base or imine.(B) Decarboxylation of
bound substrate. Atomic orbitals are drawn to highlight the pi-conjugated system. (C)
pi-conjugation that stabilizes the negative charge after decarboxylation (D) In the final
step, protonation and hydrolysis of the decarboxylated substrate results in formation of
β-alanine and regeneration of the pyruvoyl cofactor.
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a substrate mediated transamination in which they undergo an incorrect
protonation during the enzymatic reaction, as was demonstrated for Ado-
metDC (Diaz and Anton, 1991; Xiong et al., 1999). The protonation occurs
on the pyruvate instead of the α-carbon leading to conversion of the pyru-
voyl group to an alanyl group. This can also explain why L-aspartate was
observed to inhibit to some extent (Smith, 1988).
4.4 Structural features of ADC
The crystal structure of E. coli ADC (PDB-ID: 1AW8) was solved by
multiple-isomorphous replacement (Albert et al., 1998) to 2.2 A˚ maximum
resolution, using a recombinant 126 amino acid protein with a molecular
subunit weight of 13.8 kDa. The enzyme had been shown to be homote-
trameric by electro-spray mass spectrometry (Ramjee et al., 1997) and this
was confirmed by the crystal structure (Figure 4.3 A, Figure 4.5). How-
ever, because of the crystallographic hexagonal symmetry, P6122, only one
dimer is located in the asymmetric unit and the tetramer is created by
the crystallographic two-fold axis. The latter coincides with the internal
pseudo-four-fold rotational symmetry of the tetramer. Apart from two
small helices and one 310 helix, the protein is completely β-stranded. Six
β-strands form a β-barrel, which forms the core of the mushroom-shaped
oligomer. The upper part of the protein (viewed in a side-orientation of the
protein; Figure 4.5) adopts a rare tertiary structural arrangement, termed
a ”double-ψ” fold (Castillo et al., 1999). This fold is formed by two inter-
locked motifs each of which comprise a loop and a sheet, that together
resemble the Greek letter ψ (Figure 4.4).
E. coli ADC does not share significant sequence similarity with any
other, non-ADC enzyme and, consequently, comparison based on se-
quence alone was unrewarding. However, the double-ψ fold (Figure 4.3)
of ADC has been the subject of a detailed comparative structural analysis
by Castillo et al. (1999). This suggested a common homodimeric ancestor
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Figure 4.3 (A) Cartoon representation of one ADC subunit (Albert et al., 1998). (B) View at
the active site of ADCwith the product β-alanine covalently bound to the pyruvoyl group
(Pvl-group) (von Delft, unpublished results). Carbon atoms from an adjacent subunit are
coloured in cyan. Figure Bwas prepared with PYMOL (DeLano, 2002).
Figure 4.4 Schematic secondary structure topology representation of the ADC fold. Note
the two crossovers that form the double-ψ arrangement. The location of the self-cleavage
site is indicated with a yellow bar. Residues for the E. coli ADC amino acid sequence that
border the respective secondary structural elements, are indicated with numbered labels.
The scheme for this figure was adapted and modified from Castillo et al. (1999).
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to ADC, barwin (Ludvigsen and Poulsen, 1992), dimethylsulfoxide reduc-
tase (Schindelin et al., 1996), endonuclease V (Davies et al., 1993), and for-
mate dehydrogenase B (Boyington et al., 1997). Although the enzymes do
not exhibit significant sequence similarity, several common interactions
including hydrophobic contacts and sidechain-mainchain H-bonds, that
seem to be important for stabilizing the fold were identified. Residues at
the ψ-turn (Ile28, Ala79) are hydrophobic and conserved among proteins
of the fold, presumably for stabilising the β-barrel. Castillo et al. (1999)
also identified a common functional role in these enzymes for the ψ-loop
as a good place to position the catalytic or cofactor binding site, since in
all these structures central active site residues are located in the ψ-loop
between strands β1 and β2 (β1’ and β2 in ADC), indicating a common
structural role for it (Figure 4.4).
Importantly, the ADC crystal structure revealed a fully processed cleav-
age site in one subunit, and a superposition of the ester intermediate and
the fully processed cleavage site in the other subunit. Based on this ob-
servation the active site could be reliably identified (Figure 4.3). However,
the interpretation of the electron density for the ester intermediate was
not entirely straightforward but was eventually convincing because of a
better data fit of the structural model with the modeled ester intermediate
and more optimal sterochemistry (Albert et al., 1998). The structure pro-
vided the first direct evidence for the existence of an ester intermediate in
self-processing.
The self-cleavage site is located at the interface of two subunits. It was
suggested that processing occurs after tetramer assembly and that it is a
cyclical, co-operative process, more rapid for the first subunits of the pro-
enzyme, but progressively slowing down as successive subunits cleave,
because of subtle conformational change. The unexpected stability of the
fourth ester may be explained by the fact that the residues likely to be
involved in its further processing are then too far away for ester cleavage
(Albert et al., 1998).
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Figure 4.5 Cartoon representation of the ADC tetramer (Albert et al., 1998). (A) View of
the ADC tetramer with the internal four-fold symmetry axis in the plane of the paper.
The pyruvoyl group (Pvl-group) and Gly24 of one subunit are shown in ball-and-stick
representation. For this and all following figures of ADC the carbon atoms of the two
self-cleavage residues 24 and 25 in ADC will be coloured in grey. (B) Rotated view of A,
down the internal four-fold symmetry axis.
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Based on the ADC crystal structure, it was also proposed that the nucle-
ophilicity of the Ser25 may be enhanced by relaying the hydroxyl proton
through a network involving a triad of conserved residues of Lys9, His11,
from an adjacent subunit, and Tyr58 from the same subunit as the cleavage
site (Figure 4.3). Increasing the nucleophilicity has been anticipated to be
necessary for the self-processing reaction. Additionally, mechanical strain
in the loop region, including residues His21, Tyr22, and Glu23 preceding
the self-cleavage site (Figure 4.3), was suggested to play a role for ester
formation (see Section 4.2).
In addition to the apo-enzyme crystal structure of ADC, several crystal
structures of ADC in complex with various ligands have been determined
by von Delft (2000). The enzyme was co-crystallized with substrate L-
aspartate, product β-alanine (Figure 4.3), reduced product, and α-methyl
aspartate as well as 3-amino-4-methyl-pentanoate. The crystallographic
analysis enabled the authors to propose a catalytic mechanism for decar-
boxylation (see Section 4.3).
Crystallization and preliminary crystallographic analysis for H. pylori
ADC have been described (Kwon et al., 2002), but, to date, no other ADC
structure has been reported.
4.5 Motives for studying ADC
Until recently, it has generally been assumed that the conversion of all in-
active protein precursors to biologically active proteins ismediated by spe-
cific processing enzymes. Within the last two decades, self-catalyzed back-
bone rearrangements have been observed, described, and characterized in
a number of physiologically highly important eukaryotic and prokaryotic
enzymes. N→O and N→S acyl rearrangements represent common meth-
ods of activation and protein maturation of self-processing in diverse bi-
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ological processes. Although first considered unrelated, it emerged in re-
cent years that the molecular basis for this initial step in the mechanism
for the four types of self-processing (Figure 4.1), is indeed closely related.
Although a number of processed structures of self-processing systems
have been determined, structural information about unprocessed precur-
sors of self-processing enzymes is relatively sparse. Because processing
is generally a very rapid process in almost all self-processing systems,
investigation of the unprocessed precursor enzyme is usually very diffi-
cult. Most investigators chose to circumvent this problem by mutating
the nucleophile to a non- or less-nucleophilic residue (e.g. Ser→Ala mu-
tants) and pursue structure solution for these precursor mutants. The nu-
cleophile was then computationally modeled to deduce the native cleav-
age site conformation. Structure solution of a native precursor has so
far proved impossible and no unprocessed cleavage site, from a self-
processing enzyme that has not been mutated, has been reported. Con-
sequently, it is not known to what extent the cleavage site structures of
mutants that had their nucleophilic Cys, Ser, or Thr substituted resem-
ble that of the native, unprocessed cleavage site. Therefore, the validity
of the approach to computationally model the nucleophile in place of the
mutated residue remains unproven. Dissecting the underlying molecular
mechanism and the exciting (bio)chemistry in more detail will clearly re-
quire more structural data of self-processing enzymes in a pre-processed
state.
In E. coli ADC, in contrast to other systems, self-processing is compara-
tively slow, which suggests that ADC is a particularly suitable model sys-
tem for structural studies of the molecular mechanism of self-processing.
Critical issues for the cleavage reaction in general and for pyruvoyl forma-
tion in ADC in particular are the steric relationship of the nucleophile to
the carbonyl, the orientation of the leaving group (the amino nitrogen of
the scissile peptide bond), identification of assisting catalytic residues in
the protein, and perhaps most importantly, the energetic driving force be-
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hind the isomerization event during self-processing. Addressing these is-
sues should assist in coming towards a more comprehensive understand-
ing of self-processing.
Insights into the molecular basis of the mechanism can potentially aid in
producing drugs to prevent protein maturation and may be helpful in de-
veloping novel engineering tools. Intein splicing can already successfully
generated multiple protein engineering applications, such as the IMPACT
(intein-mediated purification with an affinity chitin-binding tag) (Chong
et al., 1997), EPL (expressed protein ligation) (Muir et al., 1998), and IPL
(intein-mediated protein ligation) (Evans et al., 1999) techniques. Further-
more, since intein-containing precursors are inactive, chemical reagents
that block splicing would have significant pharmacological value. Con-
trollable inteins inserted into foreign contexts would provide a method
for activating an enzyme on command, allowing biosynthesis of cyto-
toxic proteins or controllable gene knockouts. Vincent et al. (2003) sub-
stituted the N-terminal hedgehog domain with different proteins and by
this means managed to target proteins to the cell membrane.
ADC presumably catalyzes the rate-limiting step in pantothenate
biosynthesis and as such is a suitable target for the development of drugs.
Preventing the protein maturation event in ADC, for instance by small
molecule inhibitors, could render the protein inactive.
5 Scope of this thesis
Research on the four enzymes of pantothenate biosynthesis in Cambridge
was initiated in the two laboratories of Prof. Chris Abell, in the Cambridge
University Chemical Laboratory, and Dr Alison Smith, in the Plant Science
Department, University of Cambridge. Consequently, the pan enzymes
have all been cloned in their laboratories, and initial overexpression and
purification of the enzymes has been developed there. In addition, much
of the biochemical characterization has been carried out in their groups.
The aim of the scientific investigation is to gain an in-depth understanding
of the function and mechanism of the four enzymes in the pantothenate
pathway.
The laboratory of Prof. Tom Blundell became involved in the research
about seven years ago. Since then, crystal structures for KPHMT (von
Delft et al., 2003), KPR (Matak-Vinkovic et al., 2001), ADC (Albert et al.,
1998), and PS (von Delft et al., 2001), all from E. coli, have been determined
in the colloboration with Prof. Chris Abell and Dr Alison Smith. With
these structures at hand more detailed functional studies by crystallog-
raphy of site-directed mutants, and complexes with ligands can now be
pursued.
The aim of the research, described in this thesis, was to cocrystallize
KPHMTwith cofactor analogues, obtain crystals suitable for X-ray diffrac-
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tion data collection, and solve the crystal structure. Furthermore, with the
KPHMT crystal structure just solved, it was imperative to carry out a de-
tailed comparative analysis of the structure, in order to possibly derive
functional aspects from other enzymes.
For ADC, a series of site-directed mutants had been constructed to in-
vestigate the details of the self-processing mechanism. The aim was to
develop a fast and reliable purification system, and to crystallize several
of the ADCmutants. Furthermore, by solving their structure, and analysis
of the latter, it was hoped to identify key residues involved in the self-
processing reaction.
The following parts and chapters of this thesis are structured as follows:
In Part II the relevant materials, and biochemical, crystallographic, and
computational methods, used in this study, will be described.
In Part III the results will be presented and discussed. This starts with
Chapter 10, which will elaborate on the cocrystallization of KPHMT with
two cofactor analogues; attempts to collect X-ray diffraction data; the en-
countered problems that were hampering successful data collection and
structure solution; and a proposal for how to proceed for structure solu-
tion.
Chapter 11 discusses the detailed structural analysis of the KPHMT
fold, which enabled the structure to be assigned to the phosphoenolpyru-
vate/pyruvate superfamily in the SCOP database; and interesting similar-
ities in the active sites of enzymes in this superfamily.
Chapter 12 describes the establishment of a reliable purification system
for ADC mutants, crystallization of several of them, and X-ray diffraction
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data collection. Furthermore, the structure solution process (structure so-
lution, refinement, and model building) of the first native precursor of a
self-processing enzyme and three site-directed mutants of ADC, one of the
latter at near atomic resolution, will be presented.
Chapter 13 encompasses the comparative analysis of seven ADC mu-
tant structures with the native precursor ADC structure. It will be shown
that conformational constraints apparently account for the loss of self-
processing activity in certain mutants. A detailed possible reactionmecha-
nism for the self-processing reaction will be suggested. Structural compar-
ison carried out with other self-processing systems will show remarkable
similarity, particularly with the enzyme glycosylasparaginase. Based on
the investigation, several general features of the self-processing biochem-
istry appear to emerge.
In Part V the reader will find a description of the crystallization of mor-
phine dehydrogenase in the presence of NADP+. This research is however
unrelated to the main focus of this study.
Part II
Materials and methods
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6 Materials
6.1 Chemical compounds
All chemical compounds that were used for the biochemical procedures
were purchased from Sigma-Aldrich or Fluka, unless stated otherwise in
parentheses in the text. Sterile, de-ionized water was supplied by the
MilliQ system (Millipore) in the laboratory.
E. coli growth media composition
All bacterial growth media were autoclaved (Astell Hearson, 2000 series)
for one hour, and left to cool down to room-temperature, before usage.
2xYT medium (Difco Laboratories) 1.6% (w/v)
bactotryptone,
1% (w/v) yeast extract,
86 mM NaCl.
LB medium (Difco Laboratories) 1% (w/v) bactotryptone,
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0.5% (w/v) yeast extract,
0.17 M NaCl.
SOC medium (Invitrogen) 0.5% (w/v) yeast extract,
2.0% (w/v) tryptone,
10 mM NaCl,
2.5 mM KCl,
10 mMMgCl2,
20 mMMgSO4,
20 mM glucose.
LB agarose plates 20 g ultra-pure
agarose (GibcoBRL),
dissolved in 1 l of
MilliQ H2O, supplemented
with LB medium;
after autocla-
ving and cooling to
below 60◦C, 100 mg of
ampicillin was added.
Components for SDS-PAGE
Buffer I 1.5 M Tris-HCl, pH 8.8.
Buffer II 0.5 M Tris-HCl, pH 6.8.
30% (w/v) acrylamide (Severn Biotech) 29.2% (w/v) acrylamide,
0.8% (w/v) bis-acrylamide.
Running buffer 25 mM Tris, 0.192 M glycine,
0.1% (w/v) SDS.
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2x-sample buffer 0.35 M Tris-HC,
20% (v/v) glycerol,
4% (w/v) SDS,
2% (v/v) β-mercaptoethanol,
0.02% (w/v) bromphenol blue.
Coomassie blue stain solution 0.5% (w/v) Coomassie blue,
45% (v/v) methanol,
18% (v/v) acetic acid.
Destain solution 60% (v/v) MilliQ, 30% (v/v)
methanol, 10% (v/v) acetic acid.
TEMED (BioRad)
APS
Table 6.1Gel composition for two SDS-PAGE stacking gels with 1.5 mm spacers (BioRad)
Upon mixture of these components 10 µl of TEMED was added to start the polymeriza-
tion
Component 30% (w/v) acrylamide Buffer II MilliQ 10% (w/v) SDS 10% (w/v) APS
Volume 0.5 ml 1.0 ml 2.4 ml 40 µl 40 µl
Table 6.2 Gel composition for two 12% (w/v) acrylamide SDS-PAGE separating gel with
1.5 mm spacers (BioRad) Upon mixture of these components 10 µl of TEMED was added
to start the polymerization
Component 30% (w/v) acrylamide Buffer I MilliQ 10% (w/v) SDS 10% (w/v) APS
Volume 4.0 ml 2.5 ml 3.3 ml 100 µl 80 µl
Components for tricine-PAGE
Buffer I: 3 M Tris, 0.3% (w/v) SDS, pH 8.45
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5x Bottom electrode buffer 1 M Tris, pH 8.9
Top electrode buffer 0.1 M Tris, 0.1 M Tricine,
0.1% (w/v) SDS, pH 8.2
Fixative solution for gel development 25 mM Tris, 40 mM glycine,
50% (v/v) methanol,
5% (v/v) acetic acid
TEMED
APS
Table 6.3 Gel composition for one 8% (w/v) acrylamide tricine-PAGE stacking gel with
1.0 mm spacers (BioRad) Upon mixture of these components 3 µl of TEMED was added
to start the polymerization
Component 30% (w/v) acrylamide Buffer I MilliQ 10% (w/v) APS
Volume 0.47 ml 0.73 ml 1.75 ml 36 µl
Table 6.4 Gel composition for one 10% (w/v) acrylamide tricine-PAGE spacer gel with
1.0 mm spacers (BioRad) Upon mixture of these components 2 µl of TEMED was added
to start the polymerization
Component 30% (w/v) acrylamide Buffer I MilliQ 10% (w/v) APS
Volume 0.40 ml 0.66 ml 0.92 ml 10 µl
Table 6.5 Gel composition for one 16.5% (w/v) tricine-PAGE separating gel with 1.0 mm
spacers (BioRad) Upon mixture of these components 2.6 µl of TEMED was added to start
the polymerization
Component 30% (w/v) acrylamide Buffer I MilliQ 80% (w/v) Glycerol 10% (w/v) APS
Volume 2.72 ml 2.72 ml 1.59 ml 1.06 ml 40 µl
Tricine-PAGE is a modification of the original SDS-PAGE as devel-
oped by Laemmli (1970). The method was developed by Schagger and
Von Jagow (1987) and allows separation of small molecular weight pep-
tides, especially in the range of 2-20 kDa. Instead of a trailing glycine ion,
tricine is used. Alternatively to self-prepared tricine-gels, 10-20% (w/v)
acrylamide gradient tricine-gels (NovexInvitrogen) were used.
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6.2 Chromatographic hardware
Fast performance liquid chromatography (FPLC) hardware (Pharmacia)
was exclusively used for protein purification. For purification at room
temperature and at 4◦C the A¨kta Explorer and the A¨kta Prime system,
respectively, were used.
7 Biochemical procedures
7.1 Transformation of plasmids into E. coli cells
Overexpression of recombinant proteins is today a routine-procedure in
biochemistry and has the advantage of obtaining large quantities of the
protein of interest, which are naturally often present only in relatively
small quantities in the cell. Quantities of several milligrams of pure pro-
tein have, so far, been a prerequisite to successfully obtain protein crystals.
For overexpression of many proteins, the protein production machinery of
E. coli can be used. Because of the ease of use of this organism, it is often
the first choice as host for overexpression. In order to insert a specific gene
into bacteria, transformation of a plasmid through the cell membrane into
E. coli cells is carried out. This procedure makes use of the fact that the cell
wall and membrane of E. coli can be made permeable by treatment and
partial destruction with chemicals, such as RbCl2 and detergents, mak-
ing the cells ”competent” for transformation. During transformation, the
sample is heated up in order to increase the mobility of the lipids in the
membrane, thus allowing the plasmid to diffuse into the cell. The subse-
quent cold-shock procedure decreases the permeability of the membrane
again, ensuring that the plasmid is kept inside the cells.
Plasmids containing the panDmutants, and the panB genes for the over-
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expression of recombinant ADC mutants and for KPHMT respectively,
were provided from the collaboration with the groups headed by Prof.
Chris Abell and Dr Alison Smith. Competent cells were available from
the respective laboratories and from members of the laboratory of Prof.
Tom Blundell. In general, standard transformation protocols for insert-
ing the plasmid into the expression host as described by Sambrook et al.
(1989) were followed. The plasmids and E.coli expression strains that were
used for the overexpression of ADC mutants and KPHMT are shown in
Table 7.1.
Table 7.1 Plasmids and E. coli strains used for the transformation.
Protein Gene Plasmid Antibiotic resistance E. coli expression strain
ADC panD pRSETA Ampicillin BL21 C41
KPHMT panB pUC Ampicillin BL21 C41
The pUC plasmid (Vieira and Messing, 1991) contains a lac promoter
upstream of both the gene of interest and the lacI gene, to which the lac
repressor binds. Upon addition of IPTG (Melford Laboratories) the lac
repressor is inactivated allowing the polymerase gene and the gene of in-
terest to be expressed. The pRSETA plasmid (Invitrogen) is a small (2.9
kbases), high-copy number plasmid with a coding site for an N-terminal
hexa-histidine tag and a thrombin protease cleavage site. Expression of the
gene of interest is dependent on the T7 promoter (Hyvonen and Saraste,
1997), which relies on the fast and specific RNA polymerase of the T7 bac-
teriophage. Similarly to the pUC plamid, overexpression of the gene of
interest is induced upon addition of IPTG.
The transformation protocol was as follows:
1. Transformation-competent E. coli cells, which were pre-treated with
calcium and stored at −80◦C were thawed on ice.
2. 1 µl of plasmid (∼20 ng/µl) was added to 50 µl of C41 BL21 E. coli
cells.
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3. The sample was incubated on ice for 20-30 min.
4. Subsequently, the mixture was heat-shocked for 1-2 min at 42◦C on a
water bath.
5. The mixture was kept on ice for another 2 min.
6. 1 ml of LB medium for ADC mutants or SOC medium for KPHMT
medium, respectively was added.
7. The mixture was kept at 37◦C in the incubator shaking for one hour.
8. The culture was centrifuged at 6500 r.p.m. for 5 min.
9. The cells were spread onto sterile, solid LB agarose plates, which
were supplemented with ampicillin (Melford Laboratories) (final
concentration: 100 µg/ml) with a sterilized, bent glass rod.
10. The plates were incubated at 37◦C overnight and stored at 4◦C in the
coldroom or the fridge for subsequent picking of the colonies.
7.2 Protein overexpression in E. coli
Overexpression uses the cell machinery of the host to specifically produce
a protein of interest in high quantities. Overexpression of the protein of
interest in E. coli often relies on a specific RNApolymerase (predominantly
the bacteriophage T7 polymerase), the gene for which has been inserted
into the genome of the host cell. This RNA polymerase strongly interacts
with a recognition site (T7 promoter) prior to the gene of interest on the
plasmid, enabling production of large amounts of RNA transcripts and
consequently overexpression of the protein. The plasmid then typically
has a site for a gene that produces a repressor (such as the lacI repressor)
that inhibits the transcription of the genomic RNA polymerase by binding
to a specific DNA binding site (such as the lac operator site) prior to the
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location of the RNA polymerase gene. Some plasmids, such as pRSETA
used in this study, also have the same DNA binding site to which the lac
repressor can bind located after the T7 promoter site.
Addition of a specific molecule (such as IPTG) that binds to the repres-
sor, prevents the latter from binding to the operator site of the RNA poly-
merase allowing transcription of RNA polymerase. In this manner, over-
expression can be controlled and selectively induced. Generally, overex-
pression is induced when the cells reach a late logarithmic phase, where a
large amount of cells in conjunction with a high potential of them to pro-
duce the protein of interest exists. The RNA polymerase can then act on
the promoter on the plasmid and transcribe the gene of interest. In order
to prevent the cells from ejecting the plasmid, a gene for a protein (gener-
ally β-lactamase) is located and transcribed, independently of the gene of
interest, on the plasmid. This enzyme can inactivate the antibiotic, that is
added to the cell culture medium, such that cells containing the plasmid
will survive.
In this study, after the plasmid was successfully transformed, overex-
pression of the gene to obtain sufficient amounts of protein was pursued.
This was usually carried out as soon as possible after the transformation.
The overexpression protocol was as follows:
• A single colony of the transformed cells was picked from the agar
plate with a sterilized pipette tip.
• The tip was then put into a sterile tube (Millipore) with 5 or 10 ml of
autoclaved LB or 2xYT medium, to which ampicillin (usually stored
as stock solutions at −20◦C; alternatively it was prepared freshly)
was added to reach a final concentration of 100 µg/ml.
• Thus obtained miniculture was then incubated in an orbital shaker,
shaking at 200 r.p.m. at 37◦C overnight, for ∼14 h.
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• The next day the miniculture was added to 1 l in a 2 l Erlenmeyer
flask with autoclaved LB medium, containing ampicillin (final con-
centration: 100 mg/ml).
• The flask with the culture was left shaking and the OD600 was spec-
trometrically controlled (Pharmacia, Novaspec II) in half hours steps.
• At an OD600 of 0.3-0.4, which usually took ∼ 3-4 h to reach, expres-
sion of the protein was induced by addition of IPTG (final concen-
tration: 1 mM).
• Incubation at 37◦C was maintained for a further 4 h (for ADC) and
for up to 16 h (for KPHMT).
• The cells were centrifuged for 40 min at 4◦C at 4300 r.p.m. with a
Beckmann 1059G centrifuge.
The use of the pRSETA plasmid in conjunction with the BL21 C41 cells
proved to be successful and up to 80mg of protein per litre of culture could
be routinely produced for the ADCmutants, as judged by the approximate
absorbance at 280 nm of the lysate, using the theoretical extinction coeffi-
cient of the protein (see Subsection 7.3.1)
Likewise to ADC, overexpression of KPHMT from the pUC plasmid
yielded amounts of up to 100 mg protein per litre of E. coli culture. How-
ever, following a suggestion by Dr Adrian Saldanha, induction with IPTG
was kept for a longer period than for the overexpression of ADC. In gen-
eral, it took a longer time for these cells to reach the equivalent optical den-
sity as for the cells overexpressing ADC. Once successfully overexpressed,
a small amount of cells was flash frozen in liquid N2 in an Eppendorf tube
in the presence of glycerol at a final concentration of 20% (v/v). These
stocks were then kept at −80◦C. For further usage a pipette tip of cells
was plated on an agarose plate, which produced colonies that were subse-
quently used for further overexpression.
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7.3 Protein purification
Protein purification is a necessary step to obtain a pure and homogeneous
protein sample. The term pure does not only refer to the lack of other
contaminating macromolecules, but often also to the existence of a sin-
gle molecular species of the macromolecule of interest, ideally identical in
length, conformation, and charge. Because a crystal predominantly con-
sist of an assembly of the same molecule interacting with each other, con-
tamination with other proteins often prevents crystal formation or crystal
growth. As a rule of thumb, a high purity of the protein can be indicated
by a single band on SDS-PAGE, or, more so, by a monodisperse distribu-
tion of a single molecule species in dynamic light scattering experiments.
Liquid chromatography, such as affinity, hydrophobic interaction, ion-
exchange, or size exclusion chromatography, is the most widely-used sep-
aration method for macromolecules. In general, it is based on the different
interactions of the different macromolecular species, in the sample, with
an immobilized solid phase (the resin), resulting in differing degrees of
retardation, and therefore separation.
In this study, the following chromatographic techniques were used to
purify protein:
• Affinity chromatography with Ni2+ and histidine-tagged protein
This technique relies on the highly-specific interactions between the
histidine residues and the Ni2+.
• Anion-exchange chromatography
The cationic group (CH2-N+(CH3)3) is immobilised on a cross-linked
agarose hydrophilic bead similar to the one used for the gelfiltration
(pre-packed Hiprep 16/10 SP XL, MonoQ HR 5/5 and Resource Q,
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6ml columns). Anionic groups of the proteins will interact with the
the cationic group of the resin, thus resulting in retardation.
• Hydroxyapatite chromatography
Hydroxyapatite (Ca5(PO4)3OH)2 is a specific form of calcium phos-
phate that can be used for the separation of proteins (BioRad-gel hy-
droxyapatite, BioRad). Whereas the cationic groups of the protein
can interact with the phosphate groups, the anionic groups interact
with calcium sites of the resin.
• Size exclusion or gel-filtration chromatography
A cross-linked matrix of agarose covalently attached to dextran (Se-
phadex resin) was used (pre-packed Superdex 75 10/30, Superdex
200 10/30, and Superdex 26/60 columns, Pharmacia). This ma-
trix combines the gel filtration properties of cross-linked dextran
with the high physical and chemical stability of highly cross-linked
agarose. The matrix allows high resolution separation of macro-
molecules with relatively high flow-rates, at high pressure, and low,
non-specific interaction of the matrix enables high recovery of pro-
tein.
7.3.1 Purification of ADC mutants
Purification of S25T and R54KADCmutants overexpressed from pBlue-
script KS plasmid
After I started to work on the project, attempts were made to purify non-
histidine tagged R54K and S25T ADC mutants. The purification protocol
for these was similar to that for the wild-type ADC by Ramjee et al. (1997)
and the whole procedure usually required seven working days. How-
ever, the purification was not successful to produce sufficient amounts of
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pure protein for crystallization and was therefore not pursued further. It
will however be mentioned briefly. The protein purified by this method
yielded only very small crystals, unsuitable for X-ray diffraction studies.
At the same time as I attempted to purify S25T and R54K ADCmutants by
this method, Dr Brent Nabbs subcloned a number of ADC mutants from
the pBluescript KS plasmid into pRSETA plasmid with a coding sequence
for an N-terminal hexa-histidine tag.
Clones for the ADC mutants had been previously constructed by Dr
MikeWitty, who also supplied them and introduced me to the purification
protocol (Dr Michael Witty, personal communication). ADCmutants S25T
and R54Kwere overexpressed from a pBluescript KS (Stratagene) plasmid,
which was transformed into E. coli SJ16 cells according to a protocol sim-
ilar to the one described in Section 7.1. SJ16 cells (Jackowski and Rock,
1981) are β-alanine auxotrophs, defective in ADC activity. The mutation
in the panD gene encodes for an ADC version, that is identical to wild-type
ADC with the difference of an additional eleven C-terminal residues.
A purification procedure similar to the purification of wild-type ADC,
as described by Ramjee et al. (1997), was followed with small modifi-
cations. Harvested cells were resuspended in 10 mM Tris/HCl, 1 mM
EDTA buffer pH 8.0. After disrupting the cell membranes with two passes
through a French pressure cell press (SLM Aminco, SLM Instruments), at
20-40 000 psi, a 30-79% (w/v) (NH4)2SO4 precipitation was carried out.
This was potentially helpful to separate the protein from DNA or RNA
that could influence the efficiency of the subsequent ion-exchange steps.
The cell pellet was redissolved and dialyzed against 10 mM Tris/HCl, 1
mM EDTA, pH 8.0. Therafter, the protein sample was loaded on a Q-
Sepharose column (Pharmacia), after which the protein was eluted with
10 mM Tris/HCl buffer, pH 6.8, with a 0.0-1.0 M KCl gradient. The eluted
protein fractions were analyzed with tricine-PAGE and those containing
ADC were concentrated to ∼10 ml volume using Centriprep 10 (Amicon)
concentrators. Until this stage no problems were observed.
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The next step involved purification with hydroxyapatite chromatogra-
phy and at this stage large amounts of protein were lost. For the pu-
rification, hydroxyapatite (BioRad Laboratories; Bio-gel hydroxyapatite)
packed into an Econo-column (BioRad) was used. The protein was at-
tempted to be eluted with a 50-300 mM gradient of K2HPO4/KH2PO4
buffer pH 7.0, as recommended for acidic proteins (wildtype ADC has a
theoretical pI of 5.75 as calculated with the Protparam online utility1). Dr
Mike Witty had reported successful elution with this purification protocol
for native ADC from hydroxyapatite resin before (personal communica-
tion). However, in the attempt to purify S25T and R54K ADC mutants
the protein eluted between 0.2-0.3 M K2HPO4/KH2PO4 and no separation
from contaminating proteins was achieved. Consequently, the eluted pro-
tein proved to be rather impure and the purity could not be improved
by the following gel-filtration with Superdex 200 16/60 nor by anion-
exchange chromatography on MonoQ resin (Pharmacia).
After this, Dr Mike Witty made another purification attempt, with a hy-
droxyapatite chromatography and changed the pH of the elution buffer
for the hydroxyapatite step to pH 4.0. The column was equilibrated with
10 mM succinate buffer pH 4.0 and elution was then carried out with a
50-500 mM K2HPO4/KH2PO4 gradient. However, this attempt did not
overcome the problem encountered before and also failed to yield suffi-
ciently pure protein. Since by that time, histidine-tagged ADC mutants
had been constructed, no further attempts to manipulate the purification
protocol were pursued.
7.3.2 Purification of histidine-tagged ADC mutants
The centrifuged cell pellet obtained as described in Section 7.2 was left
shaking in the incubator at 37◦C overnight. This was done to allow for the
1http://ca.expasy.org/tools/protparam.html
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fact that self-processing had previously been observed to be faster in vivo
than in vitro (Dr Mike Witty, personal communication). On the following
day, the purification protocol was started:
• Cell lysis
Harvested cells were redissolved in ∼40 ml of lysis buffer (see Ta-
ble 7.2) with one or two EDTA-free protease inhibitor tablets (Boehr-
ingerMannheim) that were added immediately prior to the cell lysis.
Table 7.2 Component composition for the lysis buffer for the purification of ADC mu-
tants. The pH was adjusted to 8.0 with NaOH.
Buffer component NaH2PO4 NaCl Imidazole
Concentration 50 mM 300 mM 10 mM
Cells were then disrupted by sonication, on ice. For this, a 50 ml
beaker with the lysis solution was kept in another 500 ml plastic
beaker, filled with a water/ice mixture to prevent the solution from
heating. A sonication protocol of 10 minutes total processing time,
at medium intensity (5-7 on a 1-10 scale), with 3-5 seconds pulse ex-
posure and 10-15 seconds recovery time was chosen using a sonica-
tor (Misonix). Special care was taken that the sample did not heat
up too much, by manually checking the temperature of the beaker
with the lysis solution. Subsequently, cell debris was removed by
centrifugation at 19 000 r.p.m. (33 902 g) for 45 mins at 4◦C with a
Sigma centrifuge and a 19776 rotor type. Apart from one ADC mu-
tant, K9A, overexpressed protein from all ADC mutants could be
predominantly found in the soluble fractions of the lysate, and pu-
rification could proceed immediately.
• Affinity chromatography on Ni2+-NTA resin
A 25 ml Econocolumn (BioRad) was packed with Ni2+-NTA resin
(Qiagen) and equilibrated with several column volumes of equili-
bration buffer (see Table 7.3).
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Table 7.3Component composition for the column equilibration buffer for the purification
of ADC mutants The pH was adjusted to pH 8.0 with NaOH
Buffer component NaH2PO4 NaCl Imidazole
Concentration 50 mM 300 mM 20 mM
Before loading the protein sample on the column, the supernatant
was filtered through a 0.22 µm syringe filter (Millipore). The filtered
protein sample was loaded onto the affinity chromatography col-
umn, at ∼25◦C or room-temperature, and the column was washed
with 5 column volumes of equilibration buffer to elute non-bound
protein. Elution from the column was carried out by gravity-flow.
This was followed by 5-8 column volumes of wash buffer I (see Ta-
ble 7.4) and 5 column volumes of wash buffer II (see Table 7.5).
Table 7.4 Component composition for the wash buffer I for the purification of ADC mu-
tants The pH was adjusted to pH 8.0 with NaOH
Buffer component NaH2PO4 NaCl Imidazole
Concentration 50 mM 300 mM 50 mM
Table 7.5 Component composition for the wash buffer II for purification of ADCmutants
The pH was adjusted to pH 8.0 with NaOH
Buffer component NaH2PO4 NaCl Imidazole
Concentration 50 mM 300 mM 100 mM
The histidine-tagged protein of interest was eluted with elution
buffer (Table 7.6), and collected in 4 ml fractions.
The NTA resin was generally re-used up to four times. The clean-
ing was carried out with 5 column volumes of 0.1 M NaOH, 5 col-
umn volumes of 0.1% (w/v) SDS, 5 column volumes of 50 mM
EDTA, 10 column volumes of MilliQ H2O and 5 column volumes of
70% ethanol. The column was then recharged with Ni2+ by adding
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Table 7.6 Component composition for the elution buffer for the purification of ADC mu-
tants The pH was adjusted to pH 8.0 with NaOH
Buffer component NaH2PO4 NaCl Imidazole
Concentration 50 mM 300 mM 250 mM
2 column volumes of 100 mM NiSO4. The column was stored in
20% (v/v) ethanol at 4◦C.
• Gel-filtration on Superdex 200 resin
Protein fractions were analyzed by tricine-PAGE and those fractions
containing the ADC enzyme were combined and concentrated to 1-3
ml with a Vivaspin 20ml concentrator (Vivascience) using a 5 kDa
molecular weight cut-off membrane by centrifugation at 7500 r.p.m.
at 4◦C with a Sigma centrifuge and a 12150 rotor type. A Pharmacia
Superdex 200-HR 30/2 (Pharmacia) size exclusion chromatography
columnwas equilibrated with 2-4 column volumes of 25 mMHEPES
(Melford Laboratories or Sigma) buffer, pH 7.4. The concentrated
protein was then loaded on this column with a syringe (Vivasience),
which was connected to the purification system at room tempera-
ture.
The protein was eluted with 25 mM HEPES buffer pH 7.4, collecting
2 ml fractions. All ADC mutants eluted after 12-15 ml, with a flow
rate of 0.5-1.2 ml/min (see Section 12.2). During elution the optical
absorbance at 230, 260, and 280 nm was monitored. Protein samples
were analyzed by tricine-PAGE and the pure fractions containing the
desired protein combined and concentrated in a procedure similar to
that described above.
The protein was concentrated to a final concentration between 30
and 40 mg/ml as judged by its theoretical absorbance at 280 nm
(280 = 15 340 M-1 cm-1 or 0.974 ml mg-1 cm-1) with a Vivaspin 20
concentrator (Vivascience) with a 5 kDa molecular weight cut-off
membrane. All absorption coefficients were calculated with the
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Protparam utility2 (Gill and von Hippel, 1989) from the Swissprot-
Expasy internet server. The absorbance was measured using a spec-
trophotometer (BioSpec-1601E, Shimadzu). The protein solutionwas
concentrated to 10-15 mg/ml and then stored at 4◦C for further us-
age.
7.3.3 Purification of KPHMT
The purification protocol for KPHMT comprised the following steps:
• Cell lysis
Centrifuged cells were resuspended in ∼30 ml of lysis buffer (see
Table 7.7) in which 1-2 EDTA-free protease inhibitors tablets were
dissolved.
Table 7.7 Component composition for the lysis buffer for the purification of KPHMT The
pH was adjusted to pH 6.8 with NaOH. 10 protease inhibitor tablets per l of buffer were
added
Buffer component NaH2PO4 EDTA DTT
Concentration 50 mM 1 mM 5 mM
The cells were broken by passing them 2-4 times through an Emulsi-
flex C-5 homogenisor (Avestin). The apparatus was cooled with cold
water during the procedure, which took ∼10-15 min. Subsequently,
cell debris were removed by centrifugation at 19 000 r.p.m. (33 902 g)
for 45 minutes at 4◦Cwith a Sigma centrifuge and a 19776 rotor type.
The overexpressed KPHMT protein could be predominantly found
in the soluble fractions of the lysate.
• (NH4)2SO4 precipitation
2http://ca.expasy.org/tools/protparam.html
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Prior to the chromatographic separation techniques, a (NH4)2SO4
precipitationwas carried out. The supernatant was poured into a 250
ml Erlenmeyer beaker and the beaker put in a 500 ml plastic beaker
filled with a water/ice mixture. While the supernatant was left stir-
ring at 4◦C , over a time-period of 20-25 min, (NH4)2SO4 was slowly
added to a final concentration of 15% (w/v) with a small metal spa-
tula. The solution was kept stirring for 25 min and precipitated pro-
tein were removed by centrifugation at 19 000 r.p.m. (33 902 g) for 35
minutes at 4◦C.
The step above was then repeated almost identically. An additional
25% (NH4)2SO4 was added to the supernatant. The precipitated
protein pellet was dissolved in ∼20-30 ml extraction buffer (see Ta-
ble 7.8).
Table 7.8Component composition for the extraction buffer for the purification of KPHMT
The pH was adjusted to pH 6.8 with NaOH. 10 protease inhibitor tablets per l of buffer
were added
Buffer component NaH2PO4 EDTA DTT KCl
Concentration 50 mM 1 mM 5 mM 100 mM
In order to ensure smooth dissolving, the buffer was added to the
pellet in the centrifuge tubes and the tubes were placed in the incu-
bator, shaking at 200 r.p.m. and at a temperature below 10◦C. Once
the whole pellet had dissolved, the solution was poured into a dialy-
sis tubing (Spectra/Por) with a molecular weight cut-off membrane
of 13-18 kDa. The sample was then dialyzed overnight in 2 l of ex-
traction buffer at 4◦C.
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• First anion-exchange chromatography step
The dialyzed protein was loaded on an anion-exchange column (Hi-
prep Q XL, Pharmacia) equilibrated with extraction buffer, at room
temperature or at 4◦C. The column was eluted at a flow-rate of 2.5
ml/min with extraction buffer and a KCl gradient from 0.2 to 1.0 M
over 200 ml total elution volume, collecting 5 ml fractions. Two KCl
gradient plateaus were kept, one at 0.4MKCl for 40ml and one at 0.5
M KCl for 25 ml. Protein fractions were analyzed with SDS-PAGE.
KPHMT was eluted close the to 0.5 M KCl plateau (see Section 10.2).
The combined fractions containing KPHMT, were poured into a dial-
ysis tubing (Spectra/Por, Sprectrum) with amolecular weight cut-off
membrane of 12-14 or 15 kDa and dialyzed overnight against 2 l of
purification buffer I (see Table 7.9).
Table 7.9 Component composition for the purification buffer I for the purification of
KPHMT The pH was adjusted to pH 6.8 with NaOH. 10 protease inhibitor tablets per
l of buffer were added
Buffer component NaH2PO4 EDTA DTT KCl
Concentration 50 mM 1 mM 5 mM 200 mM
• Second anion-exchange chromatography step
The last purification step, described above, was repeated essentially
identically, using a higher resolution column (ResourceQ 6 ml, Phar-
macia), equilibrated with purification buffer I. After dialysis, frac-
tions were concentrated to 2-5 ml with a Vivaspin 20 concentrator
(Vivascience) with a 10 kDa molecular weight cut-off membrane by
centrifugation at 7500 r.p.m. at 4◦C with a Sigma centrifuge and a
12150 rotor type.
• Gelfiltration on Superdex 200 resin
The concentrated protein sample was loaded onto a size exclusion
column (Superdex 200 26/60), equilibrated with purification buffer
II (see Table 7.10) at 4◦C.
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Table 7.10 Component composition for the purification buffer II for the purification of
KPHMT The pH was adjusted to pH 6.8 with NaOH 10 protease inhibitor tablets per l of
buffer were added
Buffer component NaH2PO4 EDTA DTT KCl
Concentration 50 mM 1 mM 5 mM 1000 mM
A flow-rate of 1.3 ml/min was chosen and 4 ml fractions were col-
lected. The protein eluted after ∼125 ml.
• Dialysis
Protein samples containing pure KPHMT were combined and
poured into the dialysis tubing with a molecular weight cut-off
membrane of 12-14 kDa and dialyzed twice against 2 l of 25 mM
HEPES, pH 7.0 at 4◦C. After dialysis, the protein was concentrated
to a final concentration of 40-45 mg/ml as calculated with its theo-
retical absorption coefficient at 280 nm (280 = 16 050M-1 cm-1 or 0.568
mlmg-1 cm-1) with a Vivaspin 20ml concentrator (Vivascience) with a
10 kDa molecular weight cut-off membrane. The protein was stored
at this concentration at 4◦C for further usage.
7.4 Assessment of the quality of the purified
protein samples
7.4.1 Gel electrophoresis
The purity of the protein samples were assessed either SDS-PAGE
by tricine-PAGE. PAGE predominantly separates proteins based on
their molecular mass, after they have been denatured by SDS. For
ADC tricine-PAGE with three zones, containing different acrylamide
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concentrations (6.1) was chosen and for KPHMT 12% SDS-PAGE was car-
ried out (see 6.1). The gels were prepared by using a gel pouring sys-
tem (BioRad). Protein samples were mixed with an equal amount of 2×-
sample buffer and heated for 10 min at 100◦C to denature the protein. The
samples were then loaded into the wells with a Hamilton syringe. Mark12
(Invitrogen), for ADC mutants, and Dalton 7 (Sigma), for KPHMT, were
used as molecular weight markers. The gels were normally run at 75-100
mA and 100-150 V with a Powerpac 300 (BioRad) instrument. Both SDS
and tricine gel were then stained with Coomassie blue stain solution for
10-15 min. The process of staining was accelerated by microwaving the
solution with the gel for 1 min. tricine-gels were put into fixative solution
first and then into Coomassie blue stain. After staining, the gels were put
into the destain solution (6.1) for several hours. The gels were then dried
between two cellophane sheets (BioRad gel drying apparatus).
7.4.2 Mass spectrometry
Mass-spectrometry is a accurate technique to acquire information of the
purity of a protein sample, particularly to determine possible minor size
differences of different protein species of the protein sample. What is mea-
sured is the mass/charge ratio. Proteins, in general can accommodate
several different charges, leading to a series of peaks observed for each
protein charge species, from which the mass can be deduced.
After purification, ADC protein samples were given to the Protein and
Nucleic Acid Chemistry facility (Department of Biochemistry, Univer-
sity of Cambridge) for matrix-assisted-laser-desorption-ionization time-
of-flight mass spectrometry analysis. These analytical steps were carried
out by the personnel of the facility. For mass-spectrometry the protein was
typically diluted to a concentration of ∼10 µm in a low salt buffer, such as
5 mM Hepes. Dialysis was carried out by repeated dilution and concen-
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tration with Ultrafree (0.5 ml, Millipore) concentrators with a molecular
weight membrane cut-off of 5 kDa, at 4◦C.
KPHMT protein samples were analyzed by the mass spectrometry facil-
ity of the Chemical Laboratory (Cambridge University) with a nano elec-
trospray ionization on an Abi Qstar spectrometer. The protein was diluted
to a concentration of ∼5-10 pmol/µl, in 10 mM NH4CH3CO2, pH 6.0.
7.4.3 Amino-terminal sequencing
After purification, KPHMT samples were submitted for N-terminal se-
quencing to the Protein and Nucleic Acid Chemistry facility to determine
the N-terminal sequence of the protein.
7.4.4 Dynamic light scattering
Dynamic light scattering (see Carter and Sweet, 1997a, p.157) relies on the
scattering of monochromatic light by aggregates or particles moving in
solution. Because the diffusivity of the particles is a function of their size,
measurement of diffusion coefficients can be transformed into hydrody-
namic radii and a distribution of the sizes of the molecular species can be
calculated.
Dynamic light scattering is an excellent technique to assess how
monodisperse a protein sample is. Consequently, it is a very good indica-
tor for the crystallizability of the protein. Dynamic light scattering with a
PD2000DLS instrument (Precision Detectors) was attempted several times,
but failed to give reproducable results. Even though the machine was re-
paired, this problem was not solved, and the technique could thus not be
used, reliably.
8 Protein crystallography
Crystallography today is the most wide-spread and, probably, most di-
rect technique to obtain atomic representations of macromolecules. As-
pects of protein crystallography are covered in numerous books, such as
by Blow (2002), Blundell and Johnson (1976), Carter and Sweet (1997a),
and Carter and Sweet (1997b). More recently, a comprehensive coverage
of macromolecular crystallography and structural biology was also pub-
lished by Rossmann et al. (2001). An overview of the various stages of
protein crystallography is given in Figure 8.1 and the individual steps will
be discussed in more detail in the next sections.
8.1 Protein crystallization
Protein crystals are an absolute prerequisite to obtain discrete X-ray
diffraction patterns of protein molecules extending to a reciprocal spac-
ing, which corresponds to real space atomic resolution. Crystals present
matter in a highly ordered and condensed form. In an ideal crystal, the
protein molecules assemble in a regular way in three dimensions, so that
every molecule is interacting identically with the neighbouring molecule.
This crystalline array, with usually 1015 molecules (Blow, 2002), is neces-
sary to obtain a sufficiently strong signal of the scattered X-rays. However,
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Figure 8.1 Schematic of the crystallographic process from protein crystallization to the
final model for the crystal structure. Data information, whose acquisition is generally
considered to be limiting for the process, is indicated in yellow colour.
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protein crystals, in general, contain a relatively high amount of solvent (30-
70% v/v). Also, the number of interactions, between the macromolecules
in a crystal is small compared with the total number of atoms within each
macromolecule. This often limit the possible achievable maximal resolu-
tion to which crystals of macromolecules, such as proteins, diffract.
In order to grow a protein crystal, the protein has to be brought into a su-
persaturated, thermodynamically unstable state, from which a crystalline
phase may develop as it returns to thermodynamic equilibrium. Super-
saturation can be achieved by slow evaporation of the solvent, such as by
the vapour diffusion technique. Techniques, mechanisms, and practical
aspects of protein crystallization are extensively covered by McPherson
(1999).
In this study, protein crystallization trials were generally carried out at a
constant temperature of 19◦C or 4◦C in temperature-controlled incubators
(Sanyo). The hanging drop technique, with vapour diffusion, was used to
screen for suitable conditions and also later to optimize crystal quality. For
this technique, a reservoir was filled with 500 µl of an aqueous precipitant
solution. The same solution was mixed with the protein solution, of a cer-
tain concentration, in different µl-proportions on a small, siliconised cover
slip (Hampton Research). Normally, for screening, a 1µl:1µl ratio of pre-
cipitant solution to protein solution was chosen. After mixing, the cover
slip was turned over to seal the reservoir, so that vapour diffusion could
take place between the reservoir and the drop, leading to a volume vari-
ation of the drop until an equilibrium was reached between the reservoir
solution and the drop. 24-well Linbro plates (Hampton Research, Molec-
ular Dimensions) were used as reservoirs. Commercial screens with pre-
prepared precipitant solutions (Hampton Research, Jena Bioscience, and
Molecular Dimensions) were used for screening. Assessment of the crys-
tallization trials and crystal growth were monitored with a microscope
(Leica MZ12 and Olympus SZPT).
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8.1.1 Choice of cocrystallization compounds for KPHMT
In solution, the natural cofactor of KPHMT, 5,10-meTHF, is unstable in the
presence of air. A 1 mM solution reportedly degrades by 5% within 60
min (Schircks Laboratories)1. Therefore cofactor analogues were used for
the cocrystallisation trials. (6S)-5-methyl-5,6,7,8-tetrahydrofolic acid ((6S)-
5-meTHF) and (6S)-5-formyl-5,6,7,8-tetrahydrofolic acid ((6S)-5-foTHF)
were identified as the most promising cofactor analogues. Both com-
pounds share a high similarity with the actual substrate (see Figure 8.2)
and carry a substitution at the N5, so that the molecular structure could
resemble the iminium form of 5,10-meTHF (see Section 3.2).
(6S)-5-meTHF calcium salt (Schircks Laboratories) is reported to be sol-
uble in water up to a concentration of 10 mM (5g/l) at 25◦C, whereas
(6S)-5-foTHF calcium salt is soluble in water up to a concentration of 20
mM (10g/l) at 25◦C. Both compounds are relatively stable when used
within hours. However, 6(S)-5-meTHF calcium salt at 1 mM reportedly
degrades by 4% within four hours (Schircks Laboratories), whereas the
same concentration of (6S)-5-foTHF calcium salt degrades to that extent
within fifteen days (Schircks Laboratories). Folic acid was also purchased,
but proved very difficult to solubilize (reported solubility of 3 mM, or 1.6
mg in 1 l, at 25◦C).
While for initial crystallization trials a racemic mixture of (6R)-5-foTHF
and (6S)-5-foTHF was used, for the later trials, only the S-isomer was used
which is known to be the biochemically relevant form for the enzyme
(Powers and Snell, 1976). The solutions were always prepared freshly,
immediately prior to the crystallization trials, either at 4◦C or room tem-
perature. After the solution had been made up, it was centrifuged at 9000
r.p.m. for 10 min to remove residual compound that did not solubilize.
1http://www.schircks.com/prices/sys/pteridines_frame21.htm
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Figure 8.2 Illustration of the cofactor analogues of 5,10-meTHF used for cocrystallization
with KPHMT in this study.
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Dihydro-4,4-dimethyl-2,3-furandione (Aldrich) was used as the chemi-
cal compound for the product. The furan ring is known to be readily at-
tacked by water to form ketopantoate in solution. A similar procedure to
form ketopantoate was also used by Zheng and Blanchard (2003). Because
the same compound could be cocrystallized and was shown to result in
the product bound to the protein (von Delft et al., 2003), it was also used
for the crystallization trials pursued in this study. 3-methyl-2-oxobutanoic
acid (α-kiva) sodium salt (ACROS Organics), was used for cocrystalliza-
tion trials with the substrate. All compounds were kept at -20◦C for stor-
age.
8.2 Cryoprotection and crystal mounting
Cryocrystallography, reviewed by Garman and Schneider (1997), is used
to minimize X-ray induced secondary radiation damage to the macro-
molecules in the crystal, by cooling down the crystal to a very low tem-
perature. The absorbed energy of the X-rays produces heat and free radi-
cals that damage the macromolecules in the crystal. Whereas the primary
damage, caused by the incident X-rays, is independent of the temperature,
the secondary damage caused by propagating radicals can be reduced by
lowering the temperature. For X-ray diffraction data collection, this en-
ables longer collection times on the same crystal. In this study, N2 was
used to flash-freeze the crystal specimens to a temperature of −173◦C.
However, this can in general not be done without carrying out a pro-
cedure known as cryoprotection of the crystals, in which a low-molecular
weight compound, such as glycerol or ethyleneglycol, is added to the cry-
stal, or cocrystallized with the protein. Addition of such a compound
(cryoprotectant) in sufficient concentration causes the aqueous solution
surrounding the crystal to freeze as an amorphous glass, rather than in
a crystalline form. Water in a crystalline form produces characteristic ice-
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rings, which can impair X-ray diffraction data indexing (Section 8.3). The
vitrified water will not produce X-ray diffraction patterns that could in-
terfere with the X-ray diffraction of the crystallized protein. In addition,
the use of cryo-loops (Teng, 1990) also obviates the need to mount the cry-
stal in capillaries. As a consequence, during data collection, background
X-ray scattering from the excess mother liquor and the capillary material
is avoided.
In order to determine the concentration of the cryoprotectant, necessary
to avoid ice-formation, a cryo-loop was dipped into different solutions
of the mother-liquor, with varying concentrations of the cryoprotectant.
The loop was then mounted on the in-house X-ray data collection facility
into a stream of N2 and an X-ray diffraction image (see Section 8.3) was
collected. The lowest concentration of the cryoprotectant in the mother
liquor solution, which did not result in significant ice-rings in the X-ray
diffraction pattern was subsequently chosen for cryoprotection.
Cryocrystallography was used for all crystals in this study for mount-
ing the crystals. For cryo-protection the coverslip was inverted, and the
mother liquor containing the cryoprotectant was added to the drop with
the crystal. Generally, the concentration of the cryoprotectant was in-
creased stepwise, in order to minimize concentration gradients. The cry-
stal was soaked in the cryoprotection solution for 1-10 min, during which
the coverslip was covered with an inverted well, that had been removed
from a 24 Linbro plate, to prevent evaporation. After the crystals had
been cryo-protected in this way, they were collected in cryo-loops of ap-
propriate size (CrystalCap system; Hampton Research) with cryo-tongs
(Hampton research) under the microscope. The crystals were then quickly
plunged into liquid N2 and stored in crystal vials (Hampton research).
These were kept on racks in larger storage dewars, which can maintain
the temperature of below −173◦C for several months, until further usage.
Alternatively, crystals were directly put in a flow of N2 gas, produced by
a cooling device (Oxford Cryosystems), on the in-house X-ray equipment
for screening in the home laboratory.
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For each protein a different cryoprotection protocol had to be devised
and parameters, such as the time period of the crystal in cryoprotectant
solutions, cryoprotectant concentration and speed of transfer in the liquid
N2 had to be optimized. Glycerol, ethyleneglycol, and sodium malonate
were used as cryoprotectants in this study.
8.3 X-ray diffraction data collection and data
processing
X-rays are electromagnetic waves (or photons) with a wavelength in the
range of ∼0.05-0.35 nm. This coincides with the spacing between cova-
lently attached atoms, polar interactions, and H-bonds, as existent in pro-
teins. In general, X-rays can be generated in two physically different ways.
Firstly, they can be generated after an electron in an atom has been el-
evated from its ground state atomic orbital to a higher energy atomic or-
bital. On its transition back from the latter to a higher energy orbital than
it has been initially in, the energy difference is emitted in the form of heat
and an X-ray photon of a specific wavelength. The impulse for exciting
an electron from its ground state can for instance come from another elec-
tron colliding with the atom. The rotating anode is an example where this
effect is taken advantage of in order to produce X-rays. It consists of a fila-
ment, which constitutes the cathode, that emits electrons. The cathode has
a potential difference of several kilovolts from an anode, which is usually
made of Cu. The electrons that are released from the cathode hit the an-
ode and X-rays are emitted (p.125 in Rossmann et al., 2001). Because the
heat development limits the intensity of the generated X-rays, the anode
is cooled by water and rotated, to dissipate heat.
The second way to produce X-rays is to force electrons, whose speed
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is close to the velocity of light, in an orbit by a magnetic field. Because
the electrons are deviated from their linear path and undergo a path alter-
ation, they are decelerated. During the deceleration they emit photons of
a wider energy spectrum, some of which fall into the range of X-rays. This
method is used at synchrotrons (see Lindley, 1999). Electromagnetic in-
struments such as bending magnets, undulators, and wigglers change the
path of the electrons and produce the X-rays which can then be used at
stations or beamlines around the storage ring. Synchrotron radiation has
the advantage to be far more intense, of higher brilliance and collimation
than radiation from a rotating anode. This often enables data collection of
protein crystals to a higher resolution, better overall data quality, and in a
shorter period of time.
Si, coated with materials such as Rb, is used for mirrors at both X-ray
sources, rotating anodes and synchrotrons, to focus the beam. In addi-
tion, monochromators and slits are are used at the synchrotron to enable a
monochromatic and collimated X-ray beam.
X-rays are predominantly scattered by the electrons in an atom. When
an X-ray photon hits an electron, it can be absorbed and, if so, sets the
electron into a vibration at the X-ray frequency. The excited electron can
then emit an X-ray photon of the original energy and wavelength, in all
directions. Coherent X-ray scattering from repetitive points, as in a crystal,
can be understood in terms of Bragg’s law (Equation 8.1).
2d sin θ = nλ (8.1)
In the Bragg equation, d is the separation between two planes of atoms,
θ denotes the angle of diffraction, n is an integer, defining the order, and
λ is the wavelength of the X-ray radiation. This formula provides an ex-
planation why X-ray diffraction maxima will only be observed at certain
angles, at which the path difference between the waves, corresponding to
the spacing between the atoms, equals an integer number of the wave-
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length. A geometrical way to visualize the Bragg equation is the Ewald
sphere, a sphere of radius 1/λ with the crystal at the centre (Figure 8.3).
This schematic representation of diffraction is also useful to understand
the relation of real-space and the imaginary, reciprocal space (see Ross-
mann et al., 2001, p.58). The reciprocal lattice consists of points (withMiller
indices hkl) that are the endpoints of reciprocal lattice vectors. The length
of these vectors (1/d) is proportional to the inverse of the real-space spac-
ing between two planes in the crystal, separated by distance d.
Figure 8.3 Schematic illustration of X-ray diffraction data collection in oscillation mode.
The axis of rotation of the crystal, relative to the incident beam (yellow) is indicated.
The circle, with radius 1/λ, illustrates the Ewald sphere. A small set of reciprocal lattice
points (small circles) are shown. Only reciprocal lattice points that are located on the
surface of the Ewald sphere will give rise to a diffracted beam along the line joining the
centre of the sphere to the reciprocal lattice-point on the surface of the sphere. Diffracted
beams can then be recorded on the detector (black circle). Note that the relative size of
the components of the illustration, in particular the Ewald sphere, the reciprocal lattice,
and the detector, are not to scale.
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X-rays, which are diffracted from the macromolecules in a crystal, are
detected by X-ray detectors. These respond to the energy of the diffracted
beam, or to the intensity, which is proportional to the number of photons
per unit of time that are delivered. The X-ray diffraction detector mea-
sures the position of the diffracted X-rays (reflections), relative to the other
diffracted X-rays, and its intensity. Two types of two-dimensional detec-
tors were used in this study, image plates and charge-coupled devices.
Image plates store the diffraction image in a temporary form in which
atoms are promoted to an excited state, by the X-ray photons, in which
they remain trapped. The image plate can then be scanned by a laser
beam that measures the intensity of the fluorescence. In general, image
plates are storage phosphors made from BaFBr:Eu coated on a suitable
backing. The energy of the trapped state can be released as blue fluo-
rescence upon photostimulation by a red laser and the photostimulated
emission can be recorded by a photomultiplier. After the diffraction pat-
tern has been recorded the image plate is erased by exposing it to visible
light. Many image plate instruments, such as the one used in this study,
contain two plates, so that while one is being read out, another image can
be collected in the meantime.
In contrast to image plates, charge-coupled devices (Phillips et al., 2002)
convert X-ray photons directly into electric current. Charge-coupled de-
vices allow faster read out time (seconds), but are limited in size and in
their dynamic range.
After the crystal has been mounted on the goniostat in a more or less
arbitrary orientation (the ”American method” (see Rossmann et al., 2001,
p.209)), X-ray diffraction data with a monochromatic X-ray source can be
collected in several different ways (see Dauter, 1999; Evans, 1999, for pos-
sible data collection strategies). Among other considerations, optimal data
collection strategy has to take into account the wavelength of the X-rays
used for the data collection, the orientation of the crystal with respect to
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the image plate and the X-ray beam, the position of the beamstop, the ex-
posure time to the X-rays, the crystal-to-detector distance, the oscillation
angle (rotation angle increment), the rotation start and the symmetry of
the crystal lattice for the overall angle collected. These considerations af-
fect later computational data calculations strongly.
During the X-ray diffraction data collection experiment, indexing of the
X-ray diffraction images (see Subsection 8.3.3) is begun in order to moni-
tor the X-ray data collection experiment. X-ray diffraction data processing
of the whole dataset then becomes a short iterative process, in which the
experimenter attempts to optimize the quality of the collected data, by
manipulating parameters in the indexing software, such as spot radius,
and/or by discarding images which are deemed of not high enough qual-
ity. The overall quality of the X-ray diffraction dataset can then be assessed
by the following parameters:
• the low and high-resolution limits of the X-ray diffraction data;
• the mosaicity, a measure of long-range order of the unit cells within
a crystal, which essentially defines the angular increment, by which
a diffraction image can be rotated and still record the identical reflec-
tions as in the state before rotation;
• the completeness of the data as a percentage of the theoretical num-
ber of possible reflections;
• the intensities with its standard uncertainties 〈I〉/σ〈I〉;
• the Rsym (Equation 8.2) a measure for the agreement of the data
Rsym =
∑
h
∑
i ||Ihi| − |Ih||∑
h
∑
i |Ihi|
(8.2)
where, Ihi are symmetry-related intensities and Ih is the mean inten-
sity of the reflection with unique index h;
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• the redundancy or multiplicity of the dataset, which indicates how
often a reflection has been measured on average.
8.3.1 X-ray diffraction data collection facilities
The in-house facility was generally used to screen crystals for diffraction.
In the laboratory, in which the research for this study was carried out, X-
rays were generated with a Cu-rotating anode (Rigaku MSC), at 50 mA
and 100 kV, with a wavelength of 1.541 A˚ of the Cu Kα radiation. The
radiation was collimated using Osmic confocal mirrors. For recording the
X-ray data a RAXIS IV image plate (Rigaku MSC) was used.
Synchrotron radiation at Daresbury stations 9.6, 14.1, and 14.2 was then
used for X-ray diffraction data collection. The wavelength used at the
three stations was 0.870, 1.488, and 0.978 A˚, respectively. A Quantum
4R ADSC (ADSC) or MAR 150 mm (MAR) digital charge-coupled device
were used for recording of the X-ray diffraction data. Collimation of the
X-rays at Daresbury synchrotron is carried out using slits and Rh-coated
Si-mirrors.
8.3.2 X-ray diffraction data collection
All X-ray diffraction data were collected using the oscillation method
(Arndt and Wonacott, 1977; Otwinowski, 1991), where the crystal is ro-
tated about an axis perpendicular to the incident X-ray beam and a static
two-dimensional X-ray detector. For the X-ray diffraction data collection
in this study, the plane of the X-ray detector was kept perpendicular to
the incident beam. Software packages used to control oscillation angle,
exposure time to X-rays, and the total data collection time, included CRYS-
TALCLEAR (RigakuMSC) for the in-house facility and PXGEN++ (Mar) and
ADX (ADSC) at Daresbury synchrotron.
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8.3.3 X-ray diffraction image processing
All computational calculations, described in the following, were carried
out on Unix software-operated Silicon graphics Origin 2000 server, a Sili-
con graphics O2 machine, or a Linux-based personal computer with Intel
Celeron processor.
Diffraction data were indexed and processed with DENZO V1.97.2 (Ot-
winowski, 1991). The program is used to produce accurate unit cell di-
mensions, and to assign both Miller indices and a value for the intensity
for all the recorded X-ray reflections of a dataset. The program carries out
a sequence of calculations and steps, as follows:
Peak search The first step constitutes an initial peak search on a single
image, by searching for intensity maxima on the X-ray diffraction image.
Each spot must meet certain criteria to be retained as a diffraction spot,
such as the signal-to-noise ratio and the size of the reflection.
Auto-indexing Auto-indexing is a required procedure if the crystals are
mounted in an arbitrary orientation, as was the case in this study. In order
to index and integrate the X-ray diffraction data it is necessary to know
the unit cell dimensions as well as the orientation of the unit cell axes,
relative to the X-ray beam, and the X-ray detector. To auto-index an im-
age, the only information the user has to supply is the crystal-to-detector
distance, the wavelength, the direct X-ray beam position and the image ro-
tation parameter that relates the raster grid orientation to the camera axes.
The auto-indexing procedure for DENZO has not been described in detail.
However, the algorithmmay be assumed to have significant similarities to
the one used in the indexing software of DPS and MOSFLM as described by
Steller et al. (1997).
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In these programs, a set of observed reflection positions, determined
by the peak searching procedure, is used to compute the corresponding
reciprocal-lattice vectors, assuming a stationary crystal. These vectors are
then projected onto a chosen orientation and the projections are subjected
to a one-dimensional fast Fourier transform. The program explores all
possible directions, separated by a small increment, and analyzes the fre-
quency distribution of the projected reciprocal-lattice vectors for each of
them. Exploration of such directions establishes the best potential basis
vectors of the real cell. The program then determines a reduced cell from
the obtained basis vectors, and calculates the best cells for all fourteen
Bravais lattices, including a distortion index. The experimenter then has
to choose a lattice, which in general will be the highest-symmetry lattice
with the lowest distortion index. However, the cell reduction routine can
not determine the lattice symmetry.
Diffraction geometry refinement After the unit cell parameters for the
first image have been determined, it can be used to predict the position
of reflections on other oscillation images and parameters can be refined,
so that predicted spots fit the measured reflection positions better. Sev-
eral parameters, such as the crystal and detector orientation, the unit cell
dimensions, the position of the direct beam, and the crystal to detector
distance, require refinement for each processed image. For this, a least-
squares method is used, which minimizes the deviation of the reflection
centroids from their predicted positions. An accurate prediction of the po-
sitions of the reflections is crucial to achieve a precise integration of the
intensities in the next step.
Integration of X-ray diffraction data intensity Data integration refers to
the process of obtaining estimates of diffracted intensities of the individ-
ual reflections and their standard deviations. In DENZO the intensity of
each reflection is estimated using a method known as profile fitting. In
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order to calculate the diffraction intensity, the detector background has to
be estimated and then subtracted from the reflection profile. Profile fit-
ting assumes that the actual spot shape or spot profile is known, and the
intensity is derived by finding the scale factor that, when applied to the
known profile, gives the best fit to the observed reflection profile. For this,
an averaged profile is first predicted based on the shape of the other reflec-
tions within a chosen radius. The predicted profile is an average of profiles
shifted by the predicted separation between the spots. If the predicted re-
flections are wrong, the profile will be broadened. In the second step, the
information from the actual profiles is combined with the predicted one,
and the intensity is given by the scale that has to applied to the profile
to best fit the reflection. The background is calculated using an average
detector signal in the immediate neighbourhood of a specific reflection.
The experimenter can influence the integration process by changing spot
radius and the size of the background.
Scaling and post-refinement Once the diffraction spots of all images
have been assigned an index, the integrated and indexed data have to be
placed on a common scale and multiple observations merged together.
For data scaling in this study, the intensities were scaled with SCALEPACK
V1.97.2 (Otwinowski, 1991). Scale factors are determined by comparison
of symmetry-related reflections, which should be equal in intensity. The
scale-factors are then adjusted to obtain the best internal consistency of
intensities, and applied to all recorded reflections. During the process re-
dundant measurements and symmetry-related measurements are merged
and outliers, reflections which do not meet certain criteria, are rejected.
In addition to the scaling procedure, the program refines crystal param-
eters (unit cell and orientation) for all images. This process of refining cry-
stal parameters, using the combined reflection intensity measurements, is
known as global or post refinement. It allows for separate refinement of
the orientation of each image, but with the same unit-cell value used for
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the whole dataset. The post refinement is also more precise than the pro-
cessing of a single image in the determination of crystal mosaicity and the
orientation of each image. At the end of the scaling and post-refinement
procedure the experimenter ends up with a file containing the precise unit
cell dimensions and scaled intensities. In order to convert the intensities
into structure factor amplitudes and to generate the intensity distribu-
tion of the reflections (Wilson plot), the program TRUNCATE (Collabora-
tive Computational Project Number 4, 1994) was used. In this program
the intensities are converted into amplitudes and the amplitudes are put
on an approximate scale using the scale factor from the Wilson plot.
8.4 Molecular replacement
Because no X-ray lenses exist to recombine the diffracted X-ray, to directly
form a visual representation of the diffracting model, indirect ways have
to be pursued to reconstruct a representation of it. Therefore, calculation
of a three-dimensional representation of the protein structure, always re-
quires a second piece of information, other than the Miller indices and the
intensities of the reflections, and that is the phase angle associated with
each reflection. Considering X-rays as waves, the phase angle refers to the
relative times the waves, which create the different reflections, arrive at
the detector. However, the direct phase information of the reflections is
lost, because it cannot be recorded on the two-dimensional X-ray diffrac-
tion detector. Several indirect ways have been deviced in order to acquire
the phase information.
Two proteins that are structurally related or identical will have some
similarities in the structure factors, even if they are located in different Bra-
vais lattice types, space groups or unit cells. If a protein model is already
known to be structurally similar to the protein, for which X-ray diffrac-
tion data has been collected, this model can be used to obtain phase angle
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estimates for the unknown protein structure. The technique is known as
molecular replacement (see Rossmann et al., 2001, p.263-278) and essen-
tially places the related model (thereafter referred to as the probe) in the
unit cell in place of the molecule, one is searching for (thereafter referred
to as the target). Then the phases from the known probe are used as first
estimates for the unknown protein structure.
Since the structures of both ADC and KPHMT were already available,
molecular replacement could be pursued for structure solution in this
study. In order to acquire information about the non-crystallographic
symmetry and to calculate internal Patterson correlations, the program
POLARRFN (Collaborative Computational Project Number 4, 1994), which
carries out a fast rotation function search (see below) in polar coordi-
nates, was used. The corresponding Patterson maps were displayed with
XPLOT84DRIVER (Collaborative Computational Project Number 4, 1994).
For molecular replacement, AMORE (Navaza, 2001) was used as the pro-
gram of choice to determine the molecular replacement solutions. Two
successive steps are carried out.
Rotation function search First, the program has to calculate a Patterson
vector map (see Rossmann et al., 2001, p.61) of the target, based on the
observed structure factor amplitudes, and of the probe, in a P1 cell. It
then tries to determine the angular orientation of the target to the probe
by rotating the probe around an origin point. The rotational position of
the Patterson map of the probe is changed in increments and correlation
with the Patterson map of the target is evaluated using a rotation function.
Overlap between the two Patterson maps will result in maxima or peaks
for the rotation function, which are then chosen by the experimenter for
the subsequent translation function search.
Translation function search If the crystal has symmetry other than the
lattice symmetry, a translational search has to be carried out, to determine
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the position of the crystal origin relative to the position of the rotation axis
relating symmetry-related molecules. The translation function evaluates
the overlap between the Patterson maps of the probe and the target. For
this the inter-molecular inter-atomic cross-vectors, of symmetry-related
molecules, far from the origin of the Patterson map are important. Sim-
ilarly, to the rotational search, the positional parameters of the probe in
the unit cell are varied on a grid. The correct orientation and position of
a search model in the crystal unit cell should lead to the maximal overlap
of both the self- and cross vectors throughout the entire unit cell. In ad-
dition to the peak height of the maxima, a correlation coefficient and the
crystallographic R-factor (see below) are calculated to evaluate the molec-
ular replacement solutions. The experimenter then, in general, chooses
the highest translation function peak(s) with the lowest R-factor and the
highest correlation coefficient(s).
In order to assess the validity of the molecular replacement solutions,
the orientation and position in the unit cell has to be examined, which was
carried out with MOLPACK (Wang et al., 1991). There should be no clashes
between the molecules in the unit cell. After the probe has been posi-
tioned, phases can be calculated from the probe, which, combined with
the observed structure factor amplitudes of the target, produce an initial
model for the target.
8.5 Protein structure model refinement
After an initial atomic model has been derived, the agreement between
the model and the experimental data has to be maximized. This is carried
out in an iterative process, alternating between structure refinement and
manual protein model rebuilding (Figure 8.1, Section 8.6). In macromolec-
ular refinement one searches for the conformation of the macromolecule
that fits the observed diffraction data best, while maintaining reasonable
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stereo-chemistry. Therefore, in general, the properties that are modified
during the process of refinement are the three-dimensional coordinates of
the atomic positions and the temperature-factor (known as the anisotropic
U or the isotropic B-factor) that characterizes the displacement from the
atom’s mean position. The latter value is often used as an indicator of the
local disorder.
Refinement is a particularly important process in structure solution of
proteins, because the number of observations is smaller than the number
of variables that can be refined (underdetermined system), unless very
high-resolution data are available. This does not allow refinement of the
atomic positions, independently from each other, and in turn requires the
input of additional, often chemical, knowledge to simplify the approach.
Addition of this information, such as restriction on bond angles, bond
length and peptide geometry, can then be used to restrain or even con-
strain certain variables. Consequently, this increases the observations-to-
variables ratio, making refinement of macromolecules feasible. In addition
to modelling the atomic positions of the atoms, the diffraction will not be
modelled accurately without accounting for the bulk solvent, because of
the large solvent volume. Bulk solvent, as represented by low-resolution
reflections, is generally modelled as a continuum of electron density with
a high atomic displacement parameter (see Rossmann et al., 2001, p.372
and 400).
Aspects of reciprocal space refinement and several program-approaches
are described by Rossmann et al. (2001)(p.369-414), and have been re-
viewed by Brunger et al. (1998). As for any optimization problem, the
aim in refinement is to find a global minimum of a defined target func-
tion. Both reciprocal space refinement-programs, used in this study, apply
a mathematical approach known as cross-validated maximum-likelihood
refinement (cross-validation will be discussed below), which has been de-
scribed by Murshudov et al. (1997) and Pannu and Read (1996). The ba-
sis for the maximum-likelihood approach is that the best model will be
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the one most consistent with the data. The consistency is measured sta-
tistically, by the probability that the observations would be made, given
the current model, which is known as likelihood. The probability of the
model given the data is then proportional to the likelihood multiplied by
the probability of the model, known without the data (Bayes’ theorem).
The probability of the model, known without the data, is reflected by
the prior knowledge, such as the stereochemical information about bond
lengths and bond angles. These parameters on bond angles and length are
in general based on the ones described by Engh and Huber (1991), which
were derived from small molecule crystallography. Changing the model
parameters so that the values of the observations become more probable,
increases the likelihood, which indicates a better model. The program at-
tempts to find the best model parameters by effectively maximizing the
likelihood (in fact it is minimizing the negative logarithmic likelihood).
Different mathematical optimization methods exist to optimize the
maximum-likelihood target function. The programs used for the classical
energy minimization in this study apply a combination of the steepest de-
scent and conjugate-gradient approach (first derivative of the target func-
tion) to find a minimum (Murshudov et al., 1999). This allows prediction
of which directional change will reduce the value of the target function.
An alternative approach to this method is optimization by simulated
annealing, as described by Adams et al. (1997) and Brunger in Rossmann
et al. (2001). Annealing is a physical process of heating up a solid phase
until its particles randomly arrange themselves in a viscous liquid phase.
This phase is then cooled slowly so that particles arrange themselves in
the lowest energy state. By setting the target energy to be equivalent to
the potential energy of the system, the process of annealing can be sim-
ulated. The objective function is then essentially sampled at a new point
in parameter space. If the value of the objective function at the new point
is less than that at the current point, the new point becomes the current
point. If the value is greater at the new point, the Boltzmann probability
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of the difference in the energy function is compared to a random num-
ber. If it is less than the random number the new point is accepted as the
current point. This process continues until a sufficiently deep minimum
is found that the sampling process never leaves that region of parameter
space. At this point the temperature for the Boltzmann term is reduced,
which lowers the probability that the current point will move out of the re-
gion. This produces a finer search of the local region. The cooling process
is continued until the solution has been restricted to a sufficiently small
region.
In contrast to the optimizationmethodsmentioned above, simulated an-
nealing allowsmotion against the gradient. The temperature of the system
can be altered, where the temperature has not its normal physical mean-
ing, but determines the probability of overcoming barriers or maxima of
the target function. The higher the temperature, the more likely it is to
cross these barriers. The optimal temperature, in general, has to be found
by trial and error. The simulated-annealing procedure requires a Boltz-
mann distribution to be calculated at a given temperature and an anneal-
ing schedule, which consists of a sequence of temperatures at which the
Boltzmann distribution is calculated. Simulated annealing procedures can
differ in the way a transition or move is generated from one set of param-
eters to another. In the program used for this study, molecular dynam-
ics simulation, which limits the search to physicochemically reasonable
moves is applied. Molecular dynamics, essentially, calculates a solution
for Newton’s second law. The initial velocities for this calculation are cho-
sen randomly and each different starting velocity will result in slightly dif-
ferent models. The best model, among the different ones generated by this
multi-start approach, can then be chosen by the experimenter. Simulated
annealing requires that the temperature is controlled during the molecu-
lar dynamics simulation, which is achieved by coupling the equations to
a heat bath through a friction term, known as temperature coupling (see
Rossmann et al., 2001, p.378).
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For the annealing schedule, in general, a linear slow-cooling protocol is
chosen which ensures that once a global minimum for a model is found
it will not be moved out of it. Molecular dynamics will result in small
changes of the model, some of which lower the energy term of the tar-
get, which increases the kinetic energy (i.e. temperature) of the system.
The temperature-coupling removes the excess of energy, and makes the
reverse motion and escape from a global minimum more unlikely. The
program also allows constraints on bond lengths and bond angles to be
used, such that, essentially, only the torsion angles are refined as variable
parameters (Rice and Brunger, 1994), in contrast to cartesian molecular
dynamics (flexible bond lengths and angles).
Simulated annealing as an optimization technique is particularly well-
suited to overcome the multiple minima problem, because it can cross bar-
riers between minima. Therefore it can explore a greater volume of the pa-
rameter space to find better models and has a large radius of convergence
compared with gradient minimization techniques.
The process of refinement, or the end result of each refinement cycle
run, has to be monitored, in order to find out whether it improves the
protein model. The main criterion used to measure the agreement is the
crystallographic R-factor. This residual measures the discrepancy between
the calculated and the observed data (Equation 8.3).
Rcryst =
∑
h ||F o| − |F c||∑
h |F o|
(8.3)
where |F o| refers to the observed structure factor amplitudes of index h
and |F c| to the calculated structure factor amplitudes of index h.
However, it was shown that the R-factor can be made very low by in-
creasing the number of parameters used to describe the model and that in-
correct models can be refined to acceptable R-factors (Branden and Jones,
1990). In order to overcome the model bias of the R-factor, Brunger (1992)
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introduced the use of a set of randomly selected reflections (generally 5-
10% of all reflections) that are put aside and are not used during the re-
finement. When a separate R-factor is calculated for this set of data, it
can provide an objective cross-validation of the R-factor. This R-factor is
known as Rfree.
Because every reflection contains information about the entire structure,
changes made to the model that do not improve the fit of the model to the
X-ray diffraction data, should not improve the fit of the test-set data to
the model. Consequently, the Rfree should remain constant or increase.
In contrast to the conventional Rcryst, the Rfree is highly correlated with
the accuracy of the model (Brunger, 1993; Kleywegt and Brunger, 1996;
Kleywegt and Jones, 1995). Thus, monitoring of the Rfree can avoid over-
interpretation of the data. If the model is correct the test set reflections
should have an R-factor close to that of the reflections used in the refine-
ment. The process of refinement is then normally considered to have con-
verged when the changes in Rfree are no longer significant.
In this study, the programs CNS V1.1 (Brunger et al., 1998) and REFMAC
V5.1.24 (Murshudov et al., 1997) were used to refine the protein models.
CNS V1.1 was used for the initial refinement, which consisted of cycles
of rigid-body refinement, to improve the overall position of the model,
followed by molecular dynamics simulated-annealing. This was partic-
ularly important to reduce the model bias, which is often significant in
models derived by molecular replacement. The settings for the simulated-
annealing procedure involved torsion-angle molecular dynamics and a
slow-cooling protocol. In general, 5-10 starting velocities were chosen
with a starting temperature of 1727◦C. Other than that, the default param-
eters, from the provided script-template were used. Subsequently, REF-
MAC was used for the conventional minimization refinement. The diago-
nal weighting term, representing the weight put on the restraints, was put
lower for the earlier stages of refinement to restrain the geometry. While
progressing in the refinement cycles this was then increased to relax the re-
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straints. A 5% test set of randomly-chosen reflections, using the program
UNIQUE (Collaborative Computational Project Number 4, 1994) was used
for calculation of the Rfree throughout the whole refinement process.
At high resolution it is sometimes possible to model the anisotropic dis-
placement of the atoms either in a full anisotropic refinement or by a single
tensor that describes translation, libration, and screw (TLS) for the corre-
lated motion of atoms in rigid groups. The latter may be an extremely
accurate way to model the behaviour of the molecules (Rossmann et al.,
2001, p.372), possibly even at medium resolution. TLS refinement has
been described for small molecule crystallography (Schomaker and True-
blood, 1998) and for macromolecular refinement (Howlin et al., 1989). TLS
refinement has more recently also been implemented into REFMAC. TLS
refinement (Winn et al., 2001) was applied in the last refinement cycles to
improve the data fit. The TLS groups were defined according to secondary
structural motifs, such as α-helices, β-strands, and loops. The number of
TLS groups was then varied, while monitoring the Rfree and Rcryst. The
TLS parameters were evaluated with the program TLSANL (Howlin et al.,
1993). For the TLS refinement, the initial B-factor was fixed to the mean
B-factor as derived from the Wilson plot.
In addition, electron density modifications, such as solvent flatten-
ing and non-crystallographic symmetry averaging with the program DM
(Cowtan and Zhang, 1999) were occasionally used in this study. Electron
density modification essentially adds real-space restraints or constraints
that potentially can improve the phase information and consequently the
electron density maps (see Carter and Sweet, 1997b, p.55). Solvent flat-
tening exploits the fact that the solvent region is flat at medium resolu-
tion owing to the disorder of the solvent. Non-crystallographic symmetry
averaging (see Carter and Sweet, 1997b, p.18-53) essentially increases the
signal-to-noise ratio by averaging equivalent parts in molecules, related
by non-crystallographic symmetry.
In order to add water molecules to the model, the automatic water-
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adding procedure from ARP/WARP (Perrakis et al., 1999) was used occa-
sionally. The overall refinement was continued until convergence of the
Rfree and until the model was deemed correct.
8.6 Protein structure model building
Alternating with refinement cycles, rebuilding of the model has to be car-
ried out. The electron density maps are derived by calculating the Fourier
transform of the structure factor amplitudes. During each refinement cy-
cle, adjustments in the position of the atoms in the protein model are
made, so that they fit the electron density map better. Furthermore, wa-
ter molecules and other hetero-groups such as ions and ligands are added
during the rebuilding process. Errors in models can generate peaks in the
Fourier maps that can be interpreted as solvent peaks. Therefore, adding
waters too early in the process may lead to model errors and should be
carried out at an intermediary stage of rebuilding and refinement. As a
rule of thumb one water molecule can be placed per amino acid residue in
a structural model with structure factors to 2 A˚ resolution.
The adjustments are facilitated by graphic programs, that allow move-
ment of the atoms on the screen. Changes of the atomic coordinates will
result in a new model, the phases of which, after refinement, will be com-
bined with the observed structure factor amplitudes to calculate a new
electron density map, which ideally will be improved and clearer to inter-
pret.
Practical advice for good rebuilding as well as refinement procedures
has been described by Kleywegt in Carter and Sweet (1997b). In order to
rebuild and interpret the models in this study, σA-weighted (Read, 1986)
difference electron density maps of the 2mFo-DFc and mFo-DFc type were
used. Fo-Fc electron density maps have ”positive” and ”negative” peaks,
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for parts of the protein model that have not been adequately represented
and parts that are not supported by the observed data, respectively. Man-
ual rebuilding cycles were performed in the programs O (Jones et al., 1991)
and XTALVIEW (McRee, 1999). The parameters for bond angles and lengths
for ligand molecules and inorganic small molecule compounds, which
were modelled into the electron density maps, were retrieved from the
Uppsala HIC-UP server2 (Kleywegt and Jones, 1998).
8.7 Assessment of protein structure model qual-
ity
At the end of the refinement and rebuilding procedure, as well as at in-
termediate model refinement and rebuilding stages, the protein structure
model should be examined for (in)correctness. In general, the accuracy of
a protein structure model and the level of detail it contains is a function
of the quality and quantity of the experimental data on which it is based,
and the care and protocols used during data processing and refinement.
The objective of validation of the data and the model is to give a realistic
estimate of the true accuracy of the model as well as an indicator of the
precision with which the model explains the data.
Owing to the limited observation-to-parameter ratio and poor phase in-
formation that are often encountered in macromolecular crystallography,
constructing and refining the protein structure model is not an exact scien-
tific process with a unique solution. Therefore, it is particularly important
to assess the confidence level the experimenter, as well as the users of the
model coordinates, should assign to the overall and individual parameters
of the final model. Moreover, the evaluation process can help detecting
problematic regions in a model structure, or identifying unusual atoms
2http://xray.bmc.uu.se/hicup/
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or residues, which may have a functional role. Protein structure model
assessment and its central role in crystallography has been reviewed by
Dodson et al. (1998), Dodson (1998), and Kleywegt (2000).
The major global quality indicator for validating protein crystal struc-
tures is the Rfree. In general, better and higher resolution X-ray data will
lead to a lower Rfree and better Rfree/Rcryst ratio (Kleywegt and Jones, 2002;
Tickle et al., 2000). Furthermore, it can be used to estimate the coordi-
nate error (Kleywegt and Brunger, 1996), a second important indicator.
Coordinate-error estimates from cross-validated σA (Read, 1986) give a re-
liable impression of the positional error of the model.
Global stereochemical statistics such as overall bond angles, bond
length and dihedral angles variability are often used as global statistical
indicators. The r.m.s.d. from the parameters, retrieved from small mole-
cule crystal structures by Engh and Huber (1991) are monitored. R.m.s.ds.
for specific residues can then also be used as a local indicators of model
quality. A particularly powerful structure validation tool is the distribu-
tion of the φ/ψ torsion-angles in the Ramachandran plot (Ramakrishnan
and Ramachandran, 1965). In contrast to the bond lengths and bond an-
gles which are essentially constrained during refinement by the same val-
ues with which they are compared at the evaluation stage, the φ/ψ are in
general not constrained during the refinement.
The Ramachandran plot is one of the most useful stereochemical statis-
tics. It essentially provides a map of angular dimensions, in which the
φ/ψ angles of all the residues of the protein model are placed. The side-
chains of the amino-acids clash at certain angles and such conformations
of amino-acids are energetically unfavourable. In general, this allows only
a range of combinations of φ/ψ. A global indicator of a model is the per-
centage of the residues in the allowed, generously allowed or forbidden
region of the Ramachandran plot. Most often, a protein model with a
good quality will only have a small number of outliers, which are residues
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in the forbidden part of the Ramachandran plot. The outliers in the Ra-
machandran plot can then be examined by the experimenter and as such
the Ramachandran plot is also an indicator for the local quality.
The average B-factor of a protein structure model can also be a good in-
dicator for its quality, but care should be taken when TLS refinement was
used. In this case the individual B-factors may only represent a fraction of
the real B-factor, unless TLSANL was applied to account for the contribu-
tion of the TLS group.
Local analysis tools for the protein structure model include H-bonding
analysis, such as for the correct orientation of His, Asn, and Gln side
chains, which can often not be inferred from electron density alone. An-
alysis of the H-bonding networks (Hooft et al., 1996b) can help here. Fur-
thermore, evaluation of the side-chain planarity, chiral volumes, that can
identify potential clashes, abnormally short interatomic distances, individ-
ual B-factors, and unusual rotamers. In general, the values for these pa-
rameters are compared to statistics derived from previously solvedmacro-
molecular and/or small molecule crystal structures.
All these assessment procedures can help to detect outliers, residues
with properties, that are unusual compared with the most commonly
known values. The difference of a true outlier, supported by the data, or an
error, has to determined by inspection of the local electron density map by
the experimenter. Outliers, such as residues with unusual mainchain φ/ψ
torsion-angle combinations, that do not have unequivocally clear electron
density are often errors.
After this validation has been carried out, it is good practice to sub-
mit the three-dimensional coordinates together with the observed struc-
ture factor amplitudes to the Protein Data Bank3 (Berman et al., 2000), an
online archive for experimentally determined protein structure models.
3http://www.rcsb.org/pdb/
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From this open database coordinates and observed structure factors can
be easily retrieved in a standard form by everyone.
Validation was used throughout the model building and refinement
process. The quality of the protein models was evaluated with RAMPAGE4
(Lovell et al., 2003). The program calculates φ/ψ angles and evaluates them
with respect to their position in the Ramachandran plot. Furthermore, val-
idation was pursued with WHATCHECK (Hooft et al., 1996b), which also
assesses the correct nomenclature of the atom assignment, and PROCHECK
(Laskowski et al., 1993). All models, together with the observed structure
factors, were deposited in the PDB through the online AUTODEP tool 5.
4http://www-cryst.bioc.cam.ac.uk/rampage
5http://deposit.pdb.org/adit/
9 Bioinformatical methods
A range of bioinformatical methods was used in this study to analyze the
protein structure models and examine similarities between them.
In order carry out comparative analysis of protein structure models, su-
perposition of the various models is often useful. Structural superposi-
tions of atomic coordinates and calculations of r.m.s.ds. between similar
protein models (such as different ADC mutants) were carried out with
LSQMAN (Kleywegt and Jones, 1994) and LSQKAB (Kabsch, 1976). Both
programs calculate a translation and rotation matrix for the superposition,
which can then be applied to one of the molecules to bring it into an equiv-
alent global position to the other. To apply the operator, XPAND (see Ross-
mann et al., 2001, p.353) was used. In order to calculate geometric residue
parameters, such as torsion angles, DANG from the KINEMAGE package by
Prof. Jane Richardson as described in Rossmann et al. (see 2001, p.729-731)
was used.
The objective of amino acid sequence-to-sequence, amino acid
sequence-to-structure, and structure-to-structure searches in this study
was to identify homologues, which in turn could help to establish func-
tional and structural relationships. In order to generate amino acid
sequence alignments BLAST and PSI-BLAST, basic local alignment tools
(Altschul et al., 1990), were used to automatically retrieve sequences.
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These tools essentially calculate a matrix of similarity scores, in which
identities have positive values and mismatches have negative values, for
all possible pairs of residues. The similarity score for a contiguous seg-
ment is then the sum of the similarity scores for each pair of aligned
residues. A maximal segment pair is defined in the algorithm, which is
the highest scoring pair of identical length segments chosen from two se-
quences. A segment pair is locally maximal if its score cannot be improved
by extending or shortening both segments. As a measure of local simi-
larity, BLAST calculates the score of each maximal segment pair and then
seeks all locally maximal segment pairs with scores above some cutoff.
The program BLAST first identifies similar segments between the query se-
quence and a database sequence, then evaluates the statistical significance
of any matches that were found, and finally reports only those matches
that satisfy a user-selectable threshold of significance. Amino acid se-
quences were retrieved from the Swiss-Prot protein sequence database1
(Bairoch and Boeckmann, 1991).
Subsequently, the retrieved protein sequences were aligned with
CLUSTALW (Thompson et al., 1994) to generate multiple-sequence align-
ment, and alignments were displayed in the CLUSTALX interface (Thomp-
son et al., 1997). CLUSTALW assigns individual weights to each sequence,
and amino acid substitution matrices are varied at different alignment
stages according to the divergence of the sequences to be aligned. Residue-
specific gap penalties encourage new gaps in potential loop regions rather
than regular secondary structure.
In order to find homologues, a more sensitive method to sequence-to-
sequence alignments constitute sequence-structure alignments. Amino-
acid sequence-to-structure searches and alignments were carried out by
using the fold recognition server 3D-PSSM (Kelley et al., 2000) and the ho-
mology recognition server FUGUE (Shi et al., 2001). Similar to CLUSTALW,
FUGUE initially generates a multiple-sequence alignment with the query
1http://ca.expasy.org/sprot/
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sequence. This sequence profile is then used to search structural pro-
files. The structural profiles are derived from homologous structural
alignments in the HOMSTRAD database (Mizuguchi et al., 1998b), us-
ing environment-specific substitution tables and structure-dependent gap
penalties.
When structural information is available for the search model, recog-
nition of distant homology between two proteins, is more probable than
with sequence-to-structure searches alone. The DALI software (Holm and
Sander, 1993), which carries out automatic structure-to-structure com-
parisons to all protein in the PDB. The coordinates of each protein are
used to calculate residue-residue Cα distance matrices. Amino acid se-
quence alignments taking into account structural information (structural
alignments) were generated with COMPARER (Sali and Blundell, 1990),
a structure-based alignment program. For visualization, the structural
alignments were formatted in JOY (Mizuguchi et al., 1998a). Essentially
the program annotates the one-dimensional information contained in se-
quence alignments with a code for several aspects of three-dimensional in-
formation, such as H-bonding, solvent accessibility, and secondary struc-
ture of residues. Structural superpositions, as generated by COMPARER,
for the visual inspection of the pairwise superposed three-dimensional co-
ordinates were produced with MNYFIT (Sutcliffe et al., 1987).
Catalytically-important residues were identified from their conserva-
tion in multiple sequence alignments and their relevance judged from vi-
sual inspection of the structures. Once homologues have been identified,
their classification in the SCOP database (Murzin et al., 1995), a database
that classifies homologous protein structures into families and superfami-
lies, was investigated. This was done to potentially determine both more
distant relationshipswith proteins classified in the same (super)family and
evolutionary aspects.
The DSSP algorithm (Kabsch and Sander, 1983), which assigns sec-
9. Bioinformatical methods 115
ondary structure based on pattern recognition of H-bonds and geometri-
cal features, was used to assign secondary structures to produce figures in
PYMOL (DeLano, 2002). MOLSCRIPT (Kraulis, 1991), and RASTER3D (Mer-
ritt and Bacon, 1997) for rendering, were also used for illustration of the
protein structure models. Schematic topology diagrams of the protein sec-
ondary structure were drawn following the representation developed by
Prof. Jane Richardson (see Wyckoff et al., 1985, p.351).
Part III
Results and discussion
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10 Crystallization of KPHMT
with cofactor analogues
10.1 Introduction
In order to understand the catalytic mechanism of KPHMT, a structure
model of the protein in complex with a cofactor analogue would certainly
be helpful. Identifying the binding residues for the cofactor, will also be
important for the development of THF-based enzyme inhibitors.
Several crystal structures of enzymes in complex with THF and/or THF
analogues have been solved. Among them are dihydrofolate reductase in
complex with folic acid (Sawaya and Kraut, 1997), dimethylglycine oxi-
dase in complex with 5-fo-THF (Leys et al., 2003), nitric oxide synthase in
complex with THF (Pant et al., 2002), ribonucleotide transformylase with
5-deazafolic acid (Almassy et al., 1992), serine hydroxymethyltransferase
with 5-fo-THF (Trivedi et al., 2002), formiminotransferase-cyclodeaminase
with 5-fo-THF (Kohls et al., 2000), and thymidylate synthase in complex
with 5-hydroxymethylene-6-hydrofolic acid (Perry et al., 1993). These cry-
stal structures proved that such THF cofactor analogues are, in principle,
amenable to cocrystallization with enzymes.
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Structural models for binding of 5,10-meTHF to KPHMT based on
the structure of THF-derivatives in serine hydroxymethyltransferase have
been constructed (Louise Birch, personal communication). However, the
reliability of such computationally-derived models is often limited and
can hardly substitute experimental results. Therefore, an experimental
model of the binding was clearly desirable.
10.2 Overexpression and purification of KPHMT
The purification protocol used in this study was an adaptation of the pro-
tocol described by von Delft (2000), which in turn was based on the pu-
rification protocol developed by Jones et al. (1993) and modified by Drs
Michael Witty and Adrian Saldanha.
KPHMT could be overexpressed in large quantities, following the pro-
tocol described in Section 7.2, as judged by the final amount of purified
protein of up to 80 mg of pure protein expressed per litre of E. coli culture.
Despite the high level of overexpression, the protein was predominantly
found in the soluble fraction of the crude lysate of the E. coli cells.
The (NH4)2SO4 precipitation (see Subsection 7.3.3) was carried out to
potentially separate the protein from polynucleotides (DNA and RNA)
which could have affected the efficiency of the subsequent anion-exchange
steps. However, given the amount of overexpressed protein, this step pre-
sumably could be omitted and one could possibly start the purification
with the first anion-exchange step. Furthermore, the first (NH4)2SO4 pre-
cipitation step did apparently hardly result in significant precipitation and
may consequently be a redundant separation step.
In order to minimize the risk of proteolytic cleavage of KPHMT during
the purification procedure, the buffers for the two anion-exchange steps
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contained protease-inhibitors. For the same reason, the purification steps
for KPHMT in this study were normally carried out at 4◦C. However,
depending on the availability of the purification facilities, the two anion-
exchange purification steps, described in Subsection 7.3.3, were also car-
ried out at 19◦C, without apparent effects on the quality of the expressed
protein sample. The previous purification procedure had involved a heat
step of 80◦C for 5 min (Jones et al., 1993), indicating that the protein is rel-
atively heat-resistant and stable. Therefore, the anion-exchange steps can
also be carried out at 19◦C or room temperature.
In terms of separation, the first anion-exchange step proved quite ef-
ficient (see Figure 10.1). The second anion-exchange step was repeated
identically to the first one but with a higher resolution column. The gel-
filtration stepwas necessary to remove further contaminants and to ensure
homogeneity and monodispersity of the sample. On one occasion, the last
two purification steps were exchanged in their time-order, but it did not
appear to have a major effect on the purity of the protein sample. The elu-
tion profile of the gel-filtration step indicated the possibility of two peaks
that were not well separated (Figure 10.1). Therefore, fractions 32, 33, 34,
and 35 and fractions 36, 37, and 38, respectively were combined. How-
ever, the two fractions did not show differences on 12% SDS-PAGE, and
the purified protein migrated as a single band (Figure 10.1), indicating a
pure sample. Mass-spectrometry analysis confirmed the high purity of the
protein sample, and N-terminal sequencing confirmed the correctness of
the first 10 N-terminal residues (data not shown).
The protein has before been observed to be stable on storage at
4◦C for several months without apparently influencing crystallizability
(Dr Adrian Saldanha, personal communication). Therefore, in this study
the protein was also stored at 4◦C, after being concentrated to ∼40-45
mg/ml.
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Figure 10.1 (A) 12% SDS-PAGE of the fractions containing KPHMT from the first anion-
exchange step. Molecular weight markers are shown on the left (Mw) and the molecular
weight is indicated in kDa. The relative position of KPHMT is indicated with a red bar.
On the right; the corresponding purification graph with the x-axis showing the elution
volume in ml, whereas the y-axis shows the optical absorbance for 280 nm, blue. The ab-
sorbance is not to realistic scale, because it was calibrated with the flow-through, which,
for the first step, is very high. Also monitored is the optical absorbance at 230 nm: red
and at 260 nm: maroon; the KCL concentration is shown in green. Fractions that were
pooled together for the next step are indicated as black numbers and shown on the SDS-
PAGE. (B) 12% SDS-PAGE of the fractions containg KPHMT and graph of the second
anionexchange step. Fractions that were pooled together are shown as black numbers.
(C) 12% SDS-PAGE and graph of the gelfiltration step. Fractions 32, 33, 34, and 35, and,
separately, fractions 36, 37, and 38 were combined respectively. The optical absorbance
at 280 nm was monitored
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10.3 Crystallization conditions for KPHMTwith
cofactor analogues
10.3.1 Background
From initial crystallization trials on KPHMT, carried out by Drs Venugopal
Dhanaraj and Galib Khan, three conditions could be identified, which pro-
duced crystals. However, only one of them resulted in stable crystals with
reasonably strong X-ray diffraction patterns, and this condition was fur-
ther optimized by Dr Frank von Delft (von Delft, 2000). The overall crys-
tallization protocol was rather complex, with difficulties in reproducing
crystals with a single precipitant condition and temperature.
The final crystallization conditions Dr Frank von Delft developed, in-
cluded PEG8000, NaCl, NaCH3CO2 with sodium citrate, pH 6.8 as a buffer
(von Delft, 2000). A series of six drops, varying in the concentration
of PEG8000 (9-11% (w/w)), and NaCl (in reverse order than PEG8000;
200-100 mM) was set up within a few minutes. Crystals were grown
at 4◦C with an intermediate temperature equilibration step at 19◦C in a
polystyrol box and further crystal growth at 4◦C. This was considered to
be necessary in order to obtain a sufficient nucleation rate, while still gain-
ing a reasonable size of the crystals.
The crystallization conditions resulted in two crystals forms of appar-
ently similar morphology, clusters of rhombic crystals with dimensions
of 100×100×100 µm3 or larger, plate-like rhombic crystals with dimen-
sions of 500×300×100 µm3 (von Delft, 2000). X-ray diffraction patterns
collected from these crystals showed that both crystals were monoclinic
in space group P21, with unit cell dimensions a=86 A˚, b=156 A˚, c=208 A˚,
β=98◦ (subsequently referred to as ”large unit cell” crystal form). These
crystals would diffract to a minimum Bragg spacing of 2.8 A˚ at a syn-
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chrotron X-ray source. However, on one X-ray diffraction data collec-
tion visit to the APS synchrotron in Chicago, unusually regular tear drop-
shaped crystals were found in a crystallization drop, prepared five month
before crystal mounting. X-ray diffraction data of one of these crystals,
could be collected up to a resolution of 1.8 A˚. Subsequent data indexing
showed that the crystals were in the same space group, but in contrast to
the large unit cell had unit cell dimensions of a=86, b=157, c=100 A˚ and
β=98◦ (subsequently referred to as ”small unit cell” crystal form). These
small unit cell crystals, however, could not be reproduced by von Delft
(2000). Whereas the large unit cell contained two KPHMT decamers, the
small unit cells contained only one decamer. Both crystal forms apparently
grew in the presence of α-kiva and ketopantoate, although no KPHMT
crystal structure with α-kiva was eventually solved.
After Dr Frank von Delft had left, Dr Tsuyoshi Inoue took over the
project temporarily. He encountered difficulties in reproducing the previ-
ous crystallization conditions and consequently started to screen for new
crystallization conditions. When I took over the project I started to explore
conditions where Dr Tsuyoshi Inoue had left the project. The protein used
for these initial crystallization trials was purified by Dr Adrian Saldanha.
10.3.2 Crystallization trials
Initial screening for crystallization conditions was carried out with
PEG4000 because with lowermolecular weight PEGs the response time for
crystallization is often shorter thanwith higher molecular weight PEGs. In
order to gain a faster nucleation rate, the temperature used for these tri-
als was 19◦C. A solution of 100 mM NaCl, 100 mM NaCH3CO2, 10 mM
Mg(CH3CO2)2, 50 mM Bis-tris buffer pH 6.0 with 6-13% (w/v) PEG4000
was initially used as precipitant solution. The final protein concentration
in the drop was varied between 23 and 38 mg/ml for different crystalliza-
tion trials.
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This condition was also pursued for cocrystallization with a cofactor-
analogue. A saturated solution (10 mM) of (6R,S)-5-foTHF calcium salt
was prepared freshly immediately before setting up the crystallization
drops. This solution was then diluted with the protein solution to a final
(6R,S)-5-foTHF concentration of ∼4-8 mM, which was well above the pro-
tein concentration of ∼1-1.34 mM. The protein—cofactor analogue solu-
tion was incubated on ice for 30 min, to allow diffusion of the cofactor ana-
logue into the protein and for binding, prior to setting up crystallization
trials. This early screening surprisingly yielded rather big crystals of up to
900 µm (Figure 10.2 A) in size in one dimension, with a precipitant com-
position of 100 mM NaCl, 100 mM NaCH3CO2, 10 mM Mg(CH3CO2)2, 50
mM Bis-tris buffer pH 6.0, 7.5% (w/v) PEG4000. However, these crystals
were very unstable in the X-ray beam and proved difficult to cryoprotect
with either ethyleneglycol or glycerol. The X-ray diffraction pattern col-
lected on the in-house X-ray data collection facility was very weak (data
not shown) and the crystals showed strong decay within a few minutes.
These crystals could not be reproduced, and the unusual growthmay have
resulted from temperature instability due to amalfunctioning temperature
control at that time in the crystallization room.
Because of the observed instability of the crystals, subsequent crystal-
lization trials were carried out at 4◦C in temperature-controlled incuba-
tors. The initial protein concentration was maintained between 23 and 30
mg/ml, but the pH and buffer component of the precipitant solutions was
varied. The tested buffers and the corresponding pH-values for the pre-
cipitant solutions were 50 mM sodium citrate pH 6.0, 50 mM Bis-tris pH
6.5, 50 mM imidazole pH 7.0, 100 mMHepes pH 7.4, and 50 mM Tris/HCl
pH 7.5 and 8.0, while keeping the other components that were mentioned
above relatively constant. Crystallization screening only around the neu-
tral pH range was pursued because all cofactor analogues are more stable
at neutral pH. Crystals would usually grow relatively quickly within 2-8
days.
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All these trials were carried out with product ketopantoate and, in sep-
arate drops, with α-kiva as well. The protein was mixed with a ketopan-
toate or α-kiva solution to obtain a final concentration of 30 mM of the
product or substrate, and the solutions were incubated on ice for 30 min,
prior to the crystallization trials. Apart from the last two conditions with
Tris/HCl pH 7.5 and 8.0, all conditions with the different buffers produced
crystals. Nucleation in the drop started quickly, as monitored under the
microscope and, therefore, care was taken that the trays were moved to
4◦Cwithin 5 min after the first drop of protein was mixed with precipitant
solution. This meant setting up only six wells out of a possible twenty four
wells from the Linbro plates.
The precipitant conditions with 50 mM citric acid pH 6.0 and 100 mM
Hepes pH 7.4 were found to be the most promising. A large amount of
small (maximal dimension 100 µm) rhombic crystals could be grown, sim-
ilar to the smaller of the two morphologically different crystal forms Dr
Frank von Delft had obtained. However, these conditions yielded many
small and often cross-linked crystals and thus required optimization to
enable screening for X-ray diffraction. First, a range of additives, such as
dioxane, ethanol, 2-methyl-2,4-pentanediol; and PEG400 in concentrations
up to 5% (v/v) added to the precipitant solution, were tested for their ef-
fect on the crystallization. However, none of these additives improved
the crystals. Almost all had a rather contrary effect, resulting in smaller
crystals or none at all.
For this reason, attempts to improve the crystal quality and size, focused
on refining the condition by changing protein and the PEG4000 concen-
tration. A concentration of 6-8% (w/v) of PEG4000 with a final protein
concentration of 28-30 mg/ml was found to be optimal for crystallising
KPHMT in the presence of ketopantoate. Crystals with 50 mM citric acid
as a buffer could be grown to a size of ∼100×100×50 µm3. The crystals
were cryoprotected with PEG400 in the following way: mother liquor so-
lutions containing PEG400 at concentrations of 5, 10, 15 and 20% (v/v)
were prepared; 0.4 µl of the 5% solution was then added to the drop with
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Figure 10.2 Morphology of the crystal forms obtained for KPHMT. (A) Crystals of
KPHMT incubated with (6R,S)-5-foTHF. (B) Small unit cell crystals of KPHMT incubated
with ketopantoate grown with the crystallization condition of Table 10.2. (C) Crystals
of KPHMT incubated with α-kiva and (6R,S)-5-meTHF. (D) Crystals of KPHMT incu-
bated with α-kiva (E) KPHMT crystals grown in the presence of α-kiva and (6S)-5-foTHF,
with Bis-tris buffer pH 6.0. (F) KPHMT crystals grown in the presence of α-kiva, (6S)-5-
meTHF, with Bis-tris buffer, pH 6.0. (G) KPHMT crystals grown in the presence of α-kiva,
(6S)-5-meTHF with Bis-tris buffer, pH 6.5. (H) KPHMT with α-kiva, (6S)-5-meTHF, Bis-
tris, pH 6.5.
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the crystals on a coverslip and left for 5 min. The inverted coverslip was
coveredwith a well from a crystallization plate to reduce evaporation. An-
other 0.5-1 µl of 5% solution was added to the drop and left for another
5 min. Then the crystal was successively transferred in 5 min intervals,
first into the 5% solution and then stepwise to the final 20% solution. The
crystals were then directly mounted at the in-house X-ray machine in a
flow of N2 and screened for X-ray diffraction.
Table 10.1 Crystallization condition A for KPHMT that was incubated with ketopantoate
obtained with sodium citrate as a buffer
Component PEG4000 NaCl NaCH3CO2 Mg(CH3CO2)2 Sodium Protein
citrate pH 6.0a
Concentration 6% (w/v) 100 mM 100 mM 10 mM 50 mM 24-30 mg/ml
a The pH was adjusted with NaOH
X-ray diffraction reflections were extended out to 2.8 A˚ resolution (see
Figure 10.3 A). Indexing showed that the crystal was of monoclinic space-
group with unit cell dimensions of 101×164×172 A˚3 and β=96.4◦. Al-
though the c-axis was 30 A˚ shorter than that of the large unit cell previ-
ously obtained by Dr Frank von Delft, there was no indication that these
crystals could be crystals with small unit cell type. However, it was the
crystals with the small unit cell that were expected to give higher resolu-
tion.
While further optimizing the crystallization conditions, regularly-
shaped crystals of KPHMT (Figure 10.2 B) incubated with ketopantoate
were also obtained with Hepes (Table 10.1). These crystals were cryopro-
tected similar to the crystals obtained with sodium citrate. While initial
diffraction indicated a high mosaicity (Figure 10.3 B), slower increase of
the cryoprotection solutions resulted in X-ray diffraction patterns extend-
ing to a maximum resolution of 4.0 A˚ using the in-house X-ray data col-
lection facility. However, strong lower-resolution reflections could be ob-
served (Figure 10.3 B,C,D). Crystals were monoclinic with unit cell dimen-
sions of 86×159×109 A˚3 and β=159◦.
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Table 10.2 Crystallization condition B for KPHMT that was incubated with ketopantoate
yielding crystals with small unit cell dimensions
Component PEG4000 NaCl NaCH3CO2 Mg(CH3CO2)2 Hepes pH 7.4a Protein
Concentration 7% (w/v) 100 mM 100 mM 10 mM 100 mM 24-30 mg/ml
a The pH was adjusted with NaOH
Importantly, these unit cell dimensions were close to the dimensions
of the crystals with small unit cell dimensions from Dr Frank von Delft.
This was somewhat promising in that a condition (Table 10.2) was found
that appeared to produce KPHMT crystals in the same space group as
before with small unit cell dimensions. However, further improvement
of the crystallization conditions was necessary to increase the maximum
resolution (Figure 10.3).
Once reliable crystallization conditions for the small unit cell crystals
had been found, they were then pursued for the potential to produce
crystals with cofactor analogues. Attempts were then made to soak these
crystals with (6R,S)-5-foTHF. The cofactor analogue was either added in
solid form with a spatula or in mother liquor solution. However, in both
cases the KPHMT crystals dissolved, and consequently soaking this cofac-
tor analogue into the crystals was not successful. Therefore the crystal-
lization conditions, using either Hepes pH 7.4 or sodium citrate pH 6.0 as
buffers, and α-kiva, were then pursued further including KPHMT incu-
bated with (6R,S)-5-foTHF in 4-8 molar excess. No crystals could be ob-
tainedwith sodium citrate. In contrast, using the crystallization conditions
from Table 10.2 to cocrystallize with the cofactor resulted in small crystals
(maxium dimension 60 µm) that took 5-9 days to grow (Figure 10.2 C).
Regularly, precipitate would form uponmixture of the protein-cofactor so-
lutions and the precipitant solution and after several days, crystals would
form within this precipitate. However, these crystals were too small to
mount and to screen them for X-ray diffraction on the in-house X-ray
diffraction facility. KPHMT incubated with cofactor analogue and ke-
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topantoate did not result in crystals and the solution only contained pre-
cipitate.
Subsequently, new protein samples were purified by the author and fur-
ther crystallization trials could be pursued, jointly with Dr Loı¨c Bertrand
who temporarily joined the project. The crystallization trials with the new
protein sample started with the conditions described in Table 10.2 with
6-12% (w/v) PEG3350 instead of PEG4000, at 4◦C. However, instead of
a racemic mixture of the cofactor analogue, the stereochemically S-pure
form, known to be used by the enzyme was used (Subsection 8.1.1). In
addition to (6S)-5-foTHF two other analogues, (6S)-5-meTHF calcium salt
and folic acid, were used.
α-kiva was added to the protein solution in five- and ten-fold excess
to the protein concentration. Crystals of KPHMT incubated with α-kiva
could readily be obtained (Figure 10.2 D) with the condition described in
Table 10.2. This indicated that the protein from this sample crystallized
under the same conditions as before. With respect to the concentration of
α-kiva, no marked effect on the crystallization of KPHMT (without cofac-
tor analogues), could be observed between using a five- or ten-fold excess.
Crystallization trials were then pursued further with KPHMT incubated
with both α-kiva and cofactor analogues. The cofactors were only added
in slight excess at a concentration of 1-2 mM, while initially using a protein
concentration between 28-31 mg/ml (0.9-1.1 mM) and an α-kiva concen-
tration of 5 or 10 mM. Crystals could be obtained with and without α-kiva
for all three cofactor analogues. The optimal PEG3350 concentration was
in the range of 6-8% (w/v). The crystallization drops in all cases were
covered by a high number of thin plate-like crystals. The maximum di-
mension of a single crystal was approximately 80 µm. However, crystals
would frequently grow attached to each other.
Although crystals with KPHMT and folic acid, both with and without
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α-kiva, were obtained, cocrystallization with this cofactor analogue was
then not pursued further because the other two analogues resulted inmore
regularly-shaped and bigger crystals. Additionally, the solubility of folic
acid was rather low (see Subsection 8.1.1) and it was difficult to solubilize
it.
Because of the high number of nucleation sites, the protein concentra-
tionwas lowered to 25mg/ml for subsequent crystallization trials. Reduc-
ing the protein concentration below 20mg/ml did not produce crystals. In
addition, the pH was lowered using 25 mM Bis-tris buffer pH 6.0, 6.5, and
7.0. Crystals of KPHMT incubated with α-kiva and either (6S)-5-meTHF
or (6S)-5-foTHF grew more regular and bigger with Bis-tris buffer pH 6-
6.5 in the precipitant solution (see Figure 10.2 E, F, G). Similar crystals
could also be produced without α-kiva and with either of the two cofactor
analogues. These crystals were screened for X-ray diffraction. Cryoprotec-
tion was carried out with glycerol similar to the protocol described above
for PEG400. X-ray diffraction screening and data indexing (Figure 10.4)
indicated that the crystals all were monoclinic and had small unit cell di-
mensions (see Section 10.4).
However, quite frequently, crystals would dissolve upon moving the
crystallization plate to 19◦C from the 4◦C incubator. This phenomenon
could not be associated with a specific crystallization condition. It was
assumed that a higher molecular weight PEG could circumvent that prob-
lem. Therefore, in order to increase the size of the crystals, PEG3350 was
substituted for PEG6000, using it at a concentration of 6-10% (w/v).
Optimization of the crystallization conditions with PEG6000 by lower-
ing the protein concentration to 20-23 mg/ml finally resulted in a con-
dition that yielded regularly shaped crystals with a clear monoclinic mor-
phology (Figure 10.2 H). The largest crystal in this drop had dimensions of
approximately 150×80×100 µm3. The protein concentration used for the
crystallization trials was 23 mg/ml and α-kiva was added in a two-fold
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excess. The composition of the precipitant solution is shown in Table 10.3.
However, X-ray diffraction data from these crystals could not be collected,
because the crystals did not cope well with the cryo-protection protocol
with glycerol, developed before (see above).
Table 10.3 Crystallization condition C for KPHMT that was incubated with α-kiva and
(6S)-5-meTHF
Component PEG6000 NaCl NaCH3CO2 Mg(CH3CO2)2 Bis-tris pH 6.0a Protein
Concentration 8% (w/v) 100 mM 100 mM 10 mM 25 mM 20-23 mg/ml
a The pH was adjusted with HCl.
10.4 X-ray diffraction screening and processing
In this study, cryo-cooling was systematically applied to screen crystal
specimens for X-ray diffraction. The crystals were mounted on the in-
house X-ray diffraction facility, as described in Subsection 8.3.1 and Sub-
section 8.3.2. Screening for X-ray diffraction was carried out with a 15-30
min exposure time, with a 1◦C oscillation angle. Always, two orientations
of the crystals rotated by 90◦Cwere examined.
Crystals of KPHMT, incubated with α-kiva and either (6S)-5-meTHF or
(6S)-5-foTHF, diffracted only weakly on the in-house X-ray diffraction fa-
cility. Because of the weak X-ray diffraction of the crystals, manual index-
ing—as opposed to auto-indexing— had to be carried out. The diffraction
spots were manually selected in DENZO and then used to calculate unit
cell dimensions. All X-ray diffraction patterns that could be screened in-
dicated a monoclinic spacegroup and very similar unit cell dimensions
of between 86-87.5 A˚ for a, 153-158.2 A˚ for b, 118-119.5 A˚ for c, and 98-
108◦ for β.
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Figure 10.3 X-ray diffraction images of crystals of KPHMT grown in the presence of
ketopantoate. The pink circles in this and the following X-ray diffraction images indi-
cate resolution limits. The corresponding real-space resolution limits are indicated. (A)
Diffraction obtained from crystals of KPHMT and ketopantoate with sodium citrate as
the buffer component of the precipitant solution. (B) Initial diffraction pattern with high
mosaicity obtained from crystals of KPHMT and ketopantoate with the precipitant con-
dition from Table 10.2. (C) Diffraction obtained from optimized crystals of KPHMT and
ketopantoate with Hepes as the buffer component with the precipitant from Table 10.2.
Indexing of this image indicated small unit cell dimensions. (D) The same diffraction
pattern as inD but in close-up view.
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Figure 10.4 X-ray diffraction images of crystals of KPHMT, incubated with α-kiva and co-
factor analogues. The crystallization conditions for these crystals were similar to the one
described in Table 10.3, but with PEG3350. (A) X-ray diffraction obtained from crystals of
KPHMT grown on the presence of α-kiva and (6S)-5-meTHF. (B) X-ray diffraction ob-
tained from crystals of KPHMT grown in the presence α-kiva with (6S)-5-foTHF. (C)
Diffraction obtained from crystals of KPHMT incubated with (6S)-5-foTHF, without α-
kiva.
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10.5 Discussion
Obtaining crystallization conditions that result in well-diffracting crystals
of KPHMT, incubated with cofactor analogues, certainly proved more dif-
ficult than could be expected from the rather positive results at the be-
ginning. A significant area of crystallization space around crystallization
conditions that were found to be optimal for either KPHMT alone or for
KPHMT, incubated with product ketopantoate or substrate α-kiva, was
explored. A set of crystallization conditions was found that appear to be
promising. However, the problemwas one to optimize crystallization con-
ditions, not to obtain crystals.
KPHMT crystals, incubated with two cofactor analogues and/or α-
kiva can now be produced. The corresponding X-ray diffraction of these
crystals extended to ∼4.0 A˚ on the in-house X-ray generator. Bringing
such kind of crystals to a synchrotron source could presumably improve
the diffraction limit. However, in order to collect a full dataset, crystals of
larger three-dimensional proportions, such as the last crystal that were
produced in this study, will be necessary. The author presumes that
with the the crystallization condition of Table 10.3 large enough KPHMT
crystals can be reproduced. Although all cofactor analogues are relatively
unstable (see Subsection 8.1.1), once the cofactor is bound it could be as-
sumed to be stabilized by protein—cofactor interactions. Whether the co-
factor analogues actually bound to the protein will only be revealed by
difference Fourier maps.
Of the three tested cofactor analogues, folic acid was not used further
because of the low solubility and because binding may be rather weak
in general, compared to both 5-foTHF and 5-meTHF. Enzyme inhibition
experiments by Saldanha (2002) indicated that the substitution at the N5
appears to be important for efficient binding to the enzyme. However, no
crystals of KPHMT could be obtained in the presence of both ketopantoate
and cofactor analogues. Presumably, the product could sterically hinder
the binding of cofactor analogues.
11 Comparative analysis of the
KPHMT crystal structure
11.1 Introduction
The features of the E. coli KPHMT crystal structure are described in the
introduction (see Section 3.4) and show that the tertiary structure adopts a
classical (βα)8 or TIM-barrel fold.
The (βα)8-barrel fold motif is the most frequently occurring enzyme
folding pattern found in the PDB, and it is anticipated that as many as
10% of the structures of all enzymes adopt this fold (Gerlt, 2000). Simi-
larly, transcriptome analysis of yeast genome expression studies showed
the (βα)8-barrel to be the most common transcriptome fold (Jansen and
Gerstein, 2000). Enzymes with this fold, so far, include examples from
five of the six primary types of enzymes as classified by the Enzyme Com-
mission and are performing a particularly wide range of often unrelated
functions (Copley and Bork, 2000; Hegyi and Gerstein, 1999; Nagano et al.,
1999; Pujadas and Palau, 1999). Most of them share no significant sequence
similarity, although the overall three dimensional structure of their (βα)8-
barrel domains are surprisingly similar (Branden, 1991). Approximately
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one-third of the known (βα)8-barrels have their polypeptide chains ar-
ranged in a single barrel domain and in most of them the homo-dimer
seems to be the functional oligomeric unit.
Notwithstanding their functional versatility, in all (βα)8-barrel enzymes
found so far, the active site is located at the C-termini of the β-strands
(Wierenga, 2001). In general, the geometry of the active site itself is pre-
dominantly shaped both by residues at the C-termini of the β-strands and
the residues of the loops connecting the β-strands with the consecutive α-
helices. These βα-loops are of variable length and residue composition,
accounting for the different functions, and it was shown that small se-
quence changes in these loops can change function (Jurgens et al., 2000).
Consequently, this fold constitutes a striking example for the separation
of catalytically and structurally relevant residues.
The abundance and stability of the fold has led to much interest and
speculation as to whether it evolved independently or whether it diverged
from a single or more limited number of progenitors. Farber and Petsko
(1990) have argued for a common ancestry of a limited number of (βα)8
barrels on the basis of similarity in the positions of the active sites as well
as other structural features. Structural evidence that a (βα)8-barrel fold
has evolved by gene duplication and fusion from an ancestral half-barrel
has recently been brought forward for N-[5-phospho-ribosyl)formimino]-
5-aminoimidazole-4-carboxamide ribonucleotide isomerase (ProFAR iso-
merase or HisA) and imidazole glycerol phosphate synthase (ImGPS or
HisF), two enzymes involved in histidine biosynthesis (Hocker et al., 2001;
Lang et al., 2000). The sequence of both proteins shows a clear internal
duplication, along with a detectable repeat related by a two-fold axis in
the structure. Copley and Bork (2000) provide evidence that 12 out of the
23 TIM-barrel superfamilies listed in the SCOP database at the time of the
analysis share a common origin and that the common ancestor was most
reminiscent of HisA. The authors also support a model of divergent evolu-
tion for most of the (βα)8-barrel enzyme families involved in pathways of
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the central metabolism. However, it is not clear if a common evolutionary
origin can be assigned to all (βα)8-barrel families. Common structure is
often taken as an indicator of common ancestry the simplicity of the core
fold. However, the absence of sequence similarity and the vast range of
functions also implies convergent evolution, as might be the case with the
(βα)8 glycosidases (Nagano et al., 2001).
As a consequence of the above mentioned, comparative analysis of
structures with a (βα)8-fold requires careful attention to details in the
structures, as the overall fold can be very similar, even though there is
no significant sequence identity among the different (βα)8 enzymes.
One approach to gain functional insights into the structure of a protein is
to compare its active site with homologous proteins and proteins known
to have similarities in the catalytic chemistry. Sequence searches using
PSI-BLAST with the KPHMT amino acid sequence failed to detect any en-
zymes similar or homologous to KPHMT. However, comparative analy-
sis of three-dimensional structures is a powerful tool in identifying evo-
lutionary relationships and in gaining insight into the mechanism. This
approach was, therefore, used to identify homologues of KPHMT and to
compare their active sites. Major parts of the analysis have also been de-
scribed elsewhere (Schmitzberger et al., 2003b; von Delft et al., 2003).
11.2 Analytical procedures
KPHMT amino acid sequence and structure searches were carried out as
described in Chapter 9, by using the homology recognition server FUGUE
and the fold recognition server 3D-PSSM . The structure of KPHMT was
compared to those of all proteins in the PDB with the DALI software. Po-
tential homologues with high Z-scores and low r.m.s.d. were then aligned
with COMPARER and the structural alignments were formatted in JOY.
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Conservation of the fold and global structural features was assessed by
inspection of the superposed coordinates of the aligned structures. Cat-
alytically important residues were identified from their conservation in
multiple sequence alignments and by visual inspection of their position
in the structures. In addition to the enzymes identified with DALI, FUGUE
and 3D-PSSM, enzymes which were classified in the same Enzyme Com-
mission group and for which structures were available were compared to
KPHMT by using the methodology described above.
The SCOP database superfamily classifications both of proteins consid-
ered homologues and of enzymes classified in the same Enzyme Commis-
sion group were investigated. All the other members of the superfamily
in which homologues of KPHMT were identified were subjected to the
comparative structural analysis described above. In that way, more dis-
tant homologues could potentially be identified and relationships within
the superfamily could be revealed. Particular attention was then paid to
the conservation of the active-site residues common to homologues and
positions in the structures of those having equivalent functions.
11.3 Structural homologues
A search of protein folds with KPHMT expectedly found similarities to
numerous proteins with a (βα)8-barrel fold motif. Closest structural simi-
larity could be observed with phosphoenolpyruvate mutase (PEPM; EC
5.4.2.9; PDB-ID: 1PYM) and isocitrate lyase (ICL; EC 5.4.2.9; PDB-ID:
1IGW). Both of these enzymes could also be detected as homologues by a
KPHMT sequence-to-structure homology search using FUGUE, with PEPM
scoring particularly high, as it also did in a search with the 3D-PSSM
server. In spite of lack of significant overall sequence similarity between
KPHMT and either of the two enzymes, structure-based sequence align-
ments with COMPARER revealed remarkable similarities both in the loca-
tions and properties of important active-site residues.
11.3 Structural homologues 138
Figure
11.1
R
epresentative
am
ino
acid
sequence
alignm
ent
of
K
PH
M
T
orthologs,including
representatives
of
bacteria,archaea
and
eukaryotes.
The
alignm
ent
is
num
bered
according
to
the
full-length
E.colisequence,w
ithout
counting
the
gaps.
Severalam
ino
acid
sequences
have
been
truncated
at
the
N
-
and
C
-term
ini
to
sim
plify
the
alignm
ent.
Invariant
residues
are
indicated
w
ith
a
star
and
conserved
residues
w
ith
a
+.
11.3 Structural homologues 139
PEPM from Mytilus edulis is a homotetrameric (dimer of dimers) en-
zyme that catalyzes the conversion of PEP to phosphonopyruvate in the
biosynthesis of phosphonates, involving cleavage of an O-P bond and for-
mation of an C-P bond (Huang et al., 1999; Kim and Dunaway-Mariano,
1996) (see Figure 11.2). The overall globular architecture of the (βα)8-
barrel is very similar to that in KPHMT. Both enzymes have an additional
N-terminal helix of the same length, prior to the (βα)8-barrel domain that
lies across the N-terminus of the barrel. The major difference in the macro-
molecular assembly lies in the helix swapping of the eighth C-terminal he-
lix in PEPM, which, together with two ensuing smaller helices, protrudes
from one subunit to pack against a neighboring subunit, a phenomenon
that is not observed in E. coli KPHMT.
Conservation in the overall sequence between KPHMT (Figure 11.1) and
PEPM (Figure 11.4) is most obvious in helix α7 and in the loop connecting
helices α7 and β6 (see Figure 3.5). The reason may be solely structural,
because this part of the (βα)8-barrel has no direct catalytic role and is not
involved in dimer formation either. Further significant sequence similarity
can be observed in strand β3, which is important for the orientation of
Asp84. The insertion in the loop region between strands β4 and α5 in
PEPM is thought to be involved in conformational change upon substrate
binding and blocks the C-terminal region of the active site in the crystal
structure. However, a similar functional region in KPHMT could not be
identified.
The most striking resemblance exists in the coordination sphere of the
active-site Mg2+ ion (see Figure 3.4) and the coordination of the ligands in
the two enzymes. Ser46 at the end of strand β2, Asp84 in strand β3, and
Glu114 at the C-terminus of β4, all of which are completely conserved in
KPHMT (see Figure 11.1), have their equivalents in the invariant residue
Ser46 at the end of β2, Asp85 in β3, and Glu114 at the C-terminus of β4 in
PEPM (Figure 11.4). Superposition and inspection of the active site shows
that these residues are in fact in the same absolute position and coordi-
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Figure 11.2 Schematic illustration of the biochemical reactions catalyzed by the enzymes
in the PEP/pyruvate superfamily. (A) Phosphoenolpyruvate mutase. (B) Isocitrate
lyase. (C) 2-dehydro-3-deoxy-galactarate aldolase. (D) Phosphoenolpyruvate carboxy-
lase. (E) Pyruvate kinase. (F) Pyruvate phosphate dikinase.
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nate the ligand and Mg2+ in exactly the same way (Figure 11.5). Asp85
coordinates Mg2+ directly in an equatorial position but is also H-bonded
to a water residue and Glu114 H-bonds to this water-residue which also
coordinates to Mg2+ equatorially. Asp45 in KPHMT has been replaced by
a water molecule, which is held in place by H-bonding to the completely
conserved residues Asp58 and Asp87 in PEPM. Asp58 also H-bonds to the
Mg2+-coordinated water in the same way as Asp45 does in KPHMT. An-
other closely similar feature is the H-bond of the carboxyl-group of oxalate
to the invariant Ser46 in PEPM, in a related way as the carboxyl-group
of ketopantoate H-bonds to the completely conserved Ser46 in KPHMT.
The carboxyl groups of the oxalate residue in PEPM coordinate axial and
equatorial positions ofMg2+ as do the carboxyl and keto-group of ketopan-
toate. However, in general, a Mg2+ ion that uses three water molecules as
a bridge to the protein, as in PEPM, is rather unusual.
Table 11.1 Statistical data on the comparison of some indicators of similarity of the en-
zymes currently assigned to the PEP/pyruvate superfamily in SCOP
Enzymea PID DALI No. of aligned R.m.s.d. FUGUE
(%) Z-score residues (A˚) Z-score
PEPM 13.5 17.1 198 3.2 14.47
ICL 16.5 14.6 201 3.8 3.35
DDGA 11.4 12.3 173 3.0 N/A
PK 16.1 11.8 179 3.5 N/A
PPDK 10.6 9.9 178 3.7 N/A
PEPC 12.9 6.2 183 3.8 N/A
a All comparisons in the table are with respect to KPHMT. Sequence identities were cal-
culated from structure-based COMPARER (Sali and Blundell, 1990) alignments. Abbrevi-
ations: PID: percentage amino acid sequence identity. For the comparison with ICL, the
E. coli structure was used, and for the multidomain proteins PEPC, PPDK, and E. coli PK,
only their (βα)8 domains were used.
PEPM shows closest structural and sequence-similarity to ICL and vice
versa (see Figure 11.4). E. coli ICL and PEPM superimpose with an r.m.s.d.
of 1.51A˚ for 221 structurally-aligned residues and the sequence identity
between the two enzymes is 20.5%. Furthermore, the homotetrameric ICL
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is structurally the second most similar enzyme to KPHMT. ICL catalyzes
the reversible conversion of isocitrate into glyoxylate and succinate, the
first step in the glyoxylate bypass pathway. The crystal structure of the E.
coli enzyme in complex with Mg2+ and pyruvate (Britton et al., 2000), the
A. nidulans enzyme in complex withMn2+ and glyoxylate (PDB-ID: 1DQU)
(Britton et al., 2001) and theM. tuberculosis enzyme complex withMg2+ and
with two inhibitors (PDB-ID: 1F8I) (Sharma et al., 2000) have been solved.
For the comparison with KPHMT in this study, the E. coli ICL structure
was used.
The conserved amino acid sequence between ICL and KPHMT overlaps
largely with the residues that are conserved between KPHMT and PEPM.
In E. coli ICL there are three α-helices before the first β-strand, of which α3
lies across the N-terminal part of the barrel. As in PEPM, the amino acids
chain folds in a series of α-helices at the C-terminus, and similarly, the α12
and α13 helices are involved in helix swapping. The conserved residues
194 to 199 in the region between β4 and α5 in E. coli ICL are disordered
in three out of four subunits. Comparison with PEPM shows that this re-
gion is spatially euqivalent to the one expected to undergo conformational
change in PEPM between strands β4 and β5 (see above).
The active site of ICL shows almost identical features to those in PEPM
(Figure 11.6), and the key active site residues in PEPM are also invari-
ant in ICL. Similarly, the mode of ligand binding is essentially the same.
The conserved Asp157 after the β3 in E. coli ICL is equivalent to Asp84 in
KPHMT andAsp85 in PEPM, as is the conserved Glu186 after β4 , which is
equivalent to Glu114 in both KPHMT and PEPM (Figure 11.4). Similarly,
the conserved Ser81 has its equivalent in both KPHMT and PEPM, with
Ser46.
The only difference in the coordination sphere of Mg2+ between PEPM
and E. coli ICL seems to be the conservative substitution of Asp87 to its
equivalent Glu159 in the E. coli ICL structure, although in A. nidulans and
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M. tuberculosis ICLs, this residue is also an aspartate (Asp170 and Asp153,
respectively).
11.4 Mechanistic comparison of KPHMT with
ICL and PEPM
Comparison of the mechanism of both ICL and PEPM with KPHMT is
not straightforward. The reaction mechanism in PEPM is not very well
understood, but it has been proposed that it involves a covalent phospho-
enzyme intermediate of the phosphoryl group with Asp58. Huang et al.
(1999) proposed that during formation of this phosphoenzyme intermedi-
ate, Mg2+ shifts toward the position of the water to the left of the Mg2+ ion
(Figure 11.6), interacting directly with the carboxylate groups of Asp85,
Asp87, and Glu114, a process for which no equivalent in KPHMT has
been found so far. What appears to be much the same in KPHMT and
PEPM is the need to stabilize an enolate intermediate. This is derived from
pyruvate in PEPM (Kim and Dunaway-Mariano, 1996) and from α-kiva in
KPHMT.
In ICL the initial step, as in KPHMT, is a proton abstraction (Figure 11.2).
As in KPHMT and PEPM, the reaction intermediate for the reverse reac-
tion in ICL involves an enolate, which then undergoes a Claisen conden-
sation. For E. coli ICL, it has been suggested that Cys195, which is located
in the loop region between strands β4 and β5 (Figure 11.4), is the base
for the proton abstraction. In M. tuberculosis ICL, a large conformational
movement of this cysteine-containing loop together with the ordering of
the final helix at the C-terminus could be observed. However, neither ICL
nor PEPM appear to use any cofactor other than Mg2+ in the reaction.
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Figure 11.4 Structure-annotated amino acid sequence alignment of KPHMT, in JOY-
format (Mizuguchi et al., 1998a), with all the enzymes currently classified in the
PEP/pyruvate superfamily. The full-length sequences of KPHMT, PEPM, E. coli ICL, and
DDGA are shown. From the three-domain E. coli PK, only the (βα)8 domain comprising
residues 1–70 and 171–345 was used (residues 70–171 have been removed; the position
of this segment is indicated by a blue box). Likewise, only the (βα)8 domain of PPDK,
including residues 534–874, was used. In order to simplify and compress the alignment,
residues 640–696 were removed and the deletion is indicated by a green box. For the ini-
tial alignments, the full-length PEPC protein was used. The following, mainly α-helical,
insertions were removed: residues 1–112 at the N-terminus, 161–232 between strands β1
and β2, 289–375 between β2 and β3, 412–464 between strands β3 and β4, and 671–883
at the C-terminus. All deletions are indicated by a red box, below the alignment.(legend
continues)
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Figure 11.4 continued The yellow and brown boxes around the residues highlight the
conserved catalytic residues among KPHMT, ICL, and PEPM and among DDGA, PEPC,
PPDK, and PK, respectively. The alignment is numbered according to the KPHMT amino
acid sequence, with every 10th residue number shown. Secondary structural elements are
also denoted according to those of KPHMT. The key to the JOY alignment is as follows:
α-helix red x
β-strand blue x
310 helix maroon x
cis-peptide breve x˘
solvent accessible lower case x
solvent inaccessible UPPER CASE X
hydrogen bond to main-chain amide bold x
hydrogen bond to main-chain carbonyl underline x
hydrogen bond to other side-chain tilde x˜
disulfide bond cedilla c¸
positive φ torsion angle italic x
11.5 Comparison with members of the
PEP/pyruvate superfamily
At the time of the analysis, the SCOP database distinguished 25 super-
families of (βα)8-barrel proteins in which the members of each superfam-
ily have a probable common evolutionary origin. Both ICL and PEPM
are assigned to the PEP/pyruvate superfamily. Other members of this su-
perfamily include E. coli 2-dehydro-3-deoxy-galactarate aldolase (DDGA;
EC 4.1.2.20; PDB-ID: 1DXF), E. coli PEP carboxylase (PEPC; EC 4.1.1.31;
PDB-ID: 1QB4), E. coli pyruvate kinase (PK; EC 5.4.2.9; PDB-ID: 1PKY)
and pyruvate phosphate dikinase (PPDK; EC 2.7.9.9; PDB-ID: 1KBL) from
C. symbiosum.
Like KPHMT, the homohexameric (trimer of dimers) DDGA is a class
2 aldolase with a single-domain (βα)8- fold (Izard and Blackwell, 2000).
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Figure 11.5Cartoon illustration of the three-dimensional superposition of the coordinates
of KPHMT (blue), E. coli ICL (grey), and PEPM (red). Shown are the secondary structural
elements around the first four β-strands comprising residues 1–130 in KPHMT, 43–224 in
ICL (for clarity the first 42 residues are omitted), and 1–150 in PEPM. Also shown are the
catalytically important residues Ser46, Asp84, and Glu114 in KPHMT, Ser46, Asp85 and
Glu114 in PEPM and Ser91, Asp157, and Glu186 in E. coli ICL in ball-and-stick represen-
tation.
The enzyme catalyzes the reversible aldol cleavage of 2-dehydro-3-deoxy-
galactarate into pyruvate and tartronic semialdehyde (Figure 11.2) in the
catabolic pathway for the utilization of D-glucarate/galactarate. The en-
zyme has a low substrate specificity, condensing a wide range of aldehy-
des with pyruvate. A DALI search with KPHMT listed DDGA only as the
31st hit in the list. However, PEPM is structurally the second most simi-
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Figure 11.6 Schematic active site representations of KPHMT and the current members of
the PEP/pyruvate superfamily. All are viewedwith the vertical coordination of the ion in
line with the vertical axis of the (βα)8 barrel. (A) KPHMT; (B) PEPM; (C) ICL; (D) DDGA;
(E) rabbit muscle PK (PDB-ID: 1A49); (F) PPDK; (G) PEPC. The crystal structure of E. coli
PEPC has been solved in complex with Mn2+, but no ligand-bound structure of PEPC is
available yet.
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lar enzyme to DDGA within the PEP/pyruvate superfamily. The two en-
zymes superimpose with an r.m.s.d. of 3.1 A˚ for 174 structurally-aligned
residues, whereas sequence identity between the two enzymes is not signi-
ficant (12.1%). DDGA shows some features common with KPHMT, such
as the N-terminal α-helix. Analogous to findings for ICL and PEPM, helix
swapping of the eighth α-helix is observed. The active site Mg2+ is directly
complexed by Glu153 in the loop after strand β5 and by Asp179 in the
α-helix after β6 (Figure 11.6). The cocrystallized pyruvate occupies two
Mg2+ binding sites and H-bonds to Ser178. Two water molecules complete
the coordination sphere, one of which H-bonds to Glu49, which aligns
with Asp45 of KPHMT (Figure 11.4). Consequently, the overall Mg2+ and
ligand coordination bears some resemblance to that of KPHMT, but with
inverted symmetry. The absolute position of themetal ion hasmoved from
between strands β3 and β4 to a position between strands β5 and β6. How-
ever, not only the absolute position but also the position of the aspartate
and glutamate residues relative to each other are different in DDGA. The
possibility of a circular permutation was investigated. Nonetheless, no ev-
idence for such an event could be found. A circular permutation in which
β-strands are joined and the barrel is opened at another place would not
explain why the relative positions of Asp and Glu have been exchanged.
The first step in the reaction catalyzed by DDGA involves enolization
of pyruvate (Figure 11.2) in an aldol reaction chemically very similar to
the one in KPHMT. However, no base close enough for the proton abstrac-
tion could be identified in the active site of the enzyme. Instead, a phos-
phate, which was observed in the active site in the ligand-free structure,
is thought to accept the proton of the pyruvate’s methyl group (Izard and
Blackwell, 2000).
PEPC, E. coli PK, and PPDK are not very similar, structurally, to KPHMT.
However, investigation of the structural similarity relationship between
the first three and DDGA shows high structural similarity between them,
with closest structural similarity between DDGA and PK (Figure 11.4). PK
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Figure 11.7 Cartoon illustration of a the superposition of the three-dimensional coor-
dinates of DDGA (steel blue), PEPC (magenta), PPDK (green) and E. coli PK (brown).
Shown are the secondary structural elements around β-strands 3–6 in the range of
residues 70–208 in DDGA, 391–571 in PEPC, 613–775 in PPDK, and 61–271 in PK (residues
398–412 in PEPC, and residues 618–700 in PPDK were omitted for clarity). The catalyt-
ically important residues Glu153 and Asp179 in DDGA, Glu745 and Asp769 in PPDK,
Glu506 and Asp543 in PEPC, and Glu223 and Asp246 in PK are shown in ball-and-stick
representation.
in turn is structurally the most similar enzyme to both PEPC and PPDK.
The homotetrameric PK, a three domain protein with a (βα)8-barrel core
domain, catalyzes the conversion of PEP to pyruvate coupled to the syn-
thesis of ATP (Larsen et al., 1998; Mattevi et al., 1995) (Figure 11.2). The ho-
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motetrameric PEPC catalyzes the irreversible carboxylation of PEP to form
oxalacetate and inorganic phosphate (Kai et al., 1999; Matsumura et al.,
1999), whereas PPDK catalyzes the the interconversion of ATP, phosphate,
and pyruvate into AMP, pyrophosphate, and PEP, respectively (Herzberg
et al., 1996, 2002) (Figure 11.2).
Structure-based sequence alignment of the (βα)8 domain and superposi-
tions of the active site show that the Mg2+-coordinating residues in PEPC,
PK, and PPDK are in identical positions (Figure 11.7) and align with those
in DDGA (Figure 11.4). The mode of binding of the α-ketoacid moiety of
the co-crystallized ligands to Mg2+ is essentially the same in DDGA, PK
and PPDK (Figure 11.6). PEPC, PPDK, and PK, together with PEPM, also
share the ligand PEP as their substrate or product. Whereas PK uses one
ADP molecule and PPDK uses one ATP molecule in the course of the re-
action, PPDC does not have any second substrate.
11.6 Comparison with class 2 aldolases and
THF-binding enzymes
Apart from 2-dehydro-2-deoxy-galactarate aldolase, structures of four
class 2 aldolases, all from E. coli, are available. These include fructose-1,6-
bisphosphate aldolase (Hall et al., 1999; Plater et al., 1999) and tagatose-
1,6-bisphosphate aldolase (Hall et al., 2002), both adopting a (βα)8-fold.
Moreover, there are L-fuculose-1-phosphate aldolase (Dreyer and Schulz,
1996) and L-ribulose-phosphate 4-epimerase (Luo et al., 2001). As seen
in the SCOP database, the latter two enzymes do not adopt the (βα)8-
fold and belong to the class 2 family in the class 2 superfamily within the
α and β (α/β)-fold.
The dimeric fructose-1,6-bisphosphate aldolase and the tetrameric
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tagatose-1,6-bisphosphate aldolase are assigned to the class 2 aldolase
family in the aldolase superfamily in SCOP. In each of these structures,
the catalytic Zn2+ metal ion has an environment different from that of
the Mg2+ coordination site found in KPHMT. However, although the ca-
talysis of all of these class 2 aldolases involves essentially the same che-
mical mechanism as in KPHMT, comparison of their active sites, overall
three-dimensional structures, and functions with the respective proper-
ties of KPHMT did not show any significant analogies. None of the class
2 aldolases uses a second substrate that is even remotely similar to 5,10-
meTHF. As the class 2 aldolases appear to be spread out across folds and
superfamilies, membership in this functional group is not a particularly
helpful criterion in understanding structure and function in KPHMT.
The identity of the second substrate or electrophilic donor was also not
a basis for classification, as folate binding is not a trait of any existing (βα)8
superfamily.
11.7 Conclusions
Comparison of the structure of KPHMT with the structures of PEPM
and ICL has shown considerable similarity in the overall folds and,
more importantly, convincing similarity in their active sites. The two
Mg2+-coordinating carboxylate-containing residues, together with a serine
residue that interacts with the ligand, are completely conserved through-
out the three enzymes. Additionally, an enolate is an intermediate in each
of the reactions catalyzed by the these enzymes. On these grounds, it is
proposed that KPHMT should be assigned to the PEP/pyruvate super-
family and should form a family of its own within this superfamily.
However, DDGA, PEPC, PPDK and PK, which are all in the
PEP/pyruvate superfamily, show a different active site architecture, which
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appears as a distorted mirror image to the one found in KPHMT. It seems
difficult to imagine that a circular permutation can explain such a change,
and the evolutionary step behind such an alteration could not determined.
Based on the latter observation, it is conceivable that there should be a sub-
division within the PEP/pyruvate superfamily into two groups; one com-
prising KPHMT, PEPM and ICL and the other comprising DDGA, PEPC,
PPDK and PK. DDGA appears to be a link between the two groups, as it
shares significant structural similarity to members of both groups.
Nonetheless, at this stage not much can be infered from this for the
mechanism in KPHMT. KPHMT being a member of the PEP/pyruvate
superfamily is yet another example of the catalytic proficiency of the en-
zymes of this particular superfamily and of the functional plasticity of the
(βα)8-fold in general. Although functionally distinct and mechanistically
diverse, members of the PEP/pyruvate superfamily seem to exploit the
same chemical strategy, namely, the use of a catalytic Mg2+ ion in a very
specific way, namely as an electron sink, and to position and orient the
substrate, which always resembles an α-ketoacid moiety. However, apart
from KPHMT, only PK and PPDK use a second substrate in the reaction.
The enzymes in the PEP/pyruvate superfamily appear to have evolved
divergently, while conserving modes of binding to substrates and produc-
ing similar reaction intermediates but not maintaining a similarity in their
mechanisms, such as proton abstraction. Also, selection for a specific co-
factor does not seem to have played any role. The analysis thus appears
to stand in disagreement to recent studies by Teichmann et al. (2001b) that
supported the theory that chemistry and cofactor binding are more likely
to be conserved during evolution than substrate binding. However, it is
not possible to determinewhether any enzymemay have evolved from an-
other one within the PEP/pyruvate superfamily. There may have been a
common ancestor which no longer exists. Given that pantothenate is likely
to have existed in the prebiotic soup and that the pantothenate pathway
is part of primary metabolism, it seems reasonable to argue that KPHMT
must be one of the oldest members of this superfamily.
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Added note The analysis has now also received independent support by
the recent SCOP classification of KPHMT into this superfamily and into a
family of its own within this superfamily.
11.8 Implications of the analysis for the evolu-
tion of the pathway
The sequence and structure analysis of KPHMT, described above, com-
pletes this kind of analysis of the enzymes in the pantothenate pathway.
Similar approaches for ADC by Castillo et al. (1999), for KPR by Matak-
Vinkovic et al. (2001), and for PS by von Delft et al. (2001) have identified
enzymes related to them.
Interestingly, none of the four enzymes in the pantothenate pathway
have significant similarities in their active sites or tertiary structure to each
other. ADC has a double-ψ fold, while KPR is a two domain protein with
an N-terminal NAD(P) binding Rossmann-fold domain, classified in the
NAD(P) binding Rossmann-fold domain in SCOP, and an entirely helical
C-terminal domain. Although the N-terminal domain of the two domain
protein PS, which is classified in the nucleotidylyl transferase superfamily
in SCOP, also adopts a (β/α) mononucleotide binding or Rossmann fold,
its architecture is very distinct. Consequently, the enzymes in the panto-
thenate pathway can not have evolved according to the Horowitz theory
of retrograde evolution, but appear to have been recruited in a manner
that would be consistent with the patchwork theory (see Section 1.4). A
respective analysis of the four E. coli enzymes of the pantothenate path-
way has been described by Lobley et al. (2003).
In addition, none of the enzymes in the whole pantothenate and Coen-
zyme A pathway (see references in Section 2.2) adopts a (βα)8- or TIM-
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barrel fold, which supports the assumption that KPHMT may have been
recruited far away from the immediate pathway neighborhood, across
from an already existing pathway.
With the KPHMT structure in hand, FUGUE searches with the amino
acid annotated sequences of fully sequenced A. thaliana 1 (The Arabidop-
sis genome initiative, 2000) and S. cerevisiae2 (The Yeast genome directory,
1997) genomes were carried out, jointly with Dr Harald Ottenhof and
Hyun Gweon. Essentially, the KPHMT structure was aligned with each
annotated protein sequence in the database, and the proteins, whose se-
quences produced the best alignments, were examined further. The ob-
servation of two KPHMT sequences in A. thaliana and one in S. cerevisiae
confirmed the previous observation, based on PSI-BLAST searches, of the
existence of KPHMT in these two organisms. The same methodology was
also applied to the ADC structure. However, no convincing alignments
were found for a potential ADC sequence in these organisms. The latter
results provide further support for the absence of ADC in lower eukaryotic
organisms and plants. From some of these organisms, alternative ways to
supply β-alanine are known (see Subsection 2.1.1).
1http://arabidopsis.org/
2http://mips.gsf.de/genre/proj/yeast/index.jsp
12 Crystal structure solution of
ADC enzymes
12.1 Background
Before I started research on the project, Dr Michael Witty had purified a
fraction of unprocessed ADC (pro-ADC) by adding an additional purifica-
tion step withMonoQ anion-exchange chromatography to the purification
scheme as described by Ramjee et al. (1997). Drs Diana Matak-Vinkovic
and Mladen Vinkovic had obtained crystals from this purified sample and
collected X-ray diffraction data. In addition, they crystallized an ADCmu-
tant where Ser25 had been mutated to Ala (S25A), collected X-ray diffrac-
tion data and solved the structure. I started where they left the project,
refining the pro-ADC and S25A crystal structures and crystallizing other
site-directed mutants of ADC. Dr Michael Witty had constructed a set of
such site-directed mutants of ADC, had cloned them into pBluescript vec-
tor, and could overexpress them in SJ16 E. coli cells.
Four of these mutants have a substitution at the cleavage site:
Gly24→Ser (G24S), Ser25→Thr (S25T) and Ser25→Cys (S25C). Two are in-
sertion mutants, one with an alanine inserted between Glu23 and Gly24
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(A24a-G24b) and one with an alanine inserted between Ser25 and Cys26
(S25a-A25b), in order to analyze the effect of the ψ-loop size. One, a
His11→Ala (H11A) mutation, was made to investigate the possible role
of this residue from an adjacent subunit in Hα proton abstraction from the
ester intermediate. Furthermore, the invariant Arg54 was mutated to a
lysine (R54K), the invariant Tyr58 to a phenylalanine (Y58F), and the con-
served Lys9 to glutamine (K9Q).
Dr Brent Nabbs, subsequently subcloned all of these mutants into
pRSETA vector, that could be used with T7 RNA polymerase-based E.
coli expression systems, such as BL21 C41 cells. After a suitable overex-
pression and purification protocol had been devised byMichael Webb and
myself, crystallization trials with all those site-directed mutants were pur-
sued.
The crystallization of A24a-G24b and S25C, as well as H11A and S25a-
A25b was then continued by Mairi Kilkenny and Carina Lobley, respec-
tively who solved the crystal structures of these mutants. The comparative
structural investigation described further in Chapter 13, will also include
the analysis of those structures. The major part of the results has also been
described by Schmitzberger et al. (2003a).
12.2 Overexpression and purification of ADC
mutants
Native ADC, on initial purification, comprises amixture of pro-enzyme, or
pi-chain, and processed α- and β-chains (Ramjee et al., 1997), because the
enzyme self-processes over time. Further chromatography of this puri-
fied protein by Dr Michael Witty on MonoQ anion-exchange resin yielded
three peaks (Figure 12.1, A), the second and third of which again com-
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Figure 12.1 (A) Chromatography graph of the three separated peaks (I, II and III), rep-
resenting native ADC in different self-processing states. The optical absorbance at 280
nm was monitored (y-axis), and the x-axis shows the elution volume. (B) Corresponding
SDS-PAGE of the three chromatography peaks ADC in different self-processing states.
The relative positions of the α- and pi-chain in this gel are indicated with a yellow and
red bar, respectively. Abbreviations: Loa.: loaded native ADC sample; FT: flow-through
of the MonoQ anion-exchange chromotography; Peak I: pro-ADC; Peak II: mixture of pi-
chain and α-chain; Peak III: mixture of pi-chain and α-chain. In the last two, the β-chain
is present, but cannot be detected on SDS-PAGE. Both figures are courtesy of Dr Michael
Witty.
prised a mixture of pi-, α-, and β-chains, as observed on SDS-PAGE (Fi-
gure 12.1, B). In contrast, the first peak (peak I) was essentially unpro-
cessed ADC, althoughWestern blotting revealed a trace amount of α-chain
(Schmitzberger et al., 2003a). Re-chromatography of peak I on MonoQ
resin again resulted in the three peaks, showing that the unprocessed en-
zyme from peak I, over time, converts into the processed enzyme of peaks
II and III (Dr Michael Witty, personal communication). This fractionation
of ADC was possible, because ADC processed significantly more slowly
(Chopra et al., 2002; Ramjee et al., 1997) than any other self-processing sys-
tems, described in the literature to date. However, as observed previously
for recombinant ADC, after storage at 4◦C, the peak I fraction processed
further, demonstrating that it was active and not merely a denatured frac-
tion. This fraction (pro-ADC) therefore provided the opportunity to deter-
mine the structure of unprocessed ADC, which was nevertheless compe-
tent for processing.
When I started on the project, I initially attempted to purify R54K and
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S25T from pBluescript vector, as described in Subsection 7.3.1. This purifi-
cation protocol has been adapted from the protocol for native ADC (Ram-
jee et al., 1997) and modified by Dr Michael Witty. However, the purifi-
cation protocol proved difficult to apply for the ADC mutants, was very
time- and labour-expensive and did not yield sufficient amounts of pure
protein.
As a consequence, for the site-directed histidine-tagged ADC mutants
encoded on pRSETA plasmid, a reliable overexpression and purification
protocol had to be developed , to allow ”high-throughput” preparation
of pure protein for crystallization. A standard overexpression protocol as
described by Sambrook et al. (1989) was found to be sufficient (see Sec-
tion 7.2), and enabled a high-level of overexpression (see Section 7.2).
Jointly with Michael Webb an efficient two-step purification strategy, as
described in Subsection 7.3.2, was devised. The purification approach was
much faster, more efficient, and less error-prone than the previous purifi-
cation of non-histidine tagged mutants (Subsection 7.3.2). This purifica-
tion method allowed purification of up to 80 mg of protein per litre of
E. coli culture. After analysis of the produced protein samples by mass-
spectrometry (data not shown), crystallization could be pursued within
four days of the start of the overexpression. Attempts to cleave off the
histidine-tag with a thrombin protease resulted in proteolysis of the pro-
tein (MichaelWebb, personal communication), indicating that the protease
cleaved the protein at an internal cleavage site in addition to the thrombin
cleavage site at the end of the histidine-tag, and thus was not suitable in
our case.
The affinity purification on Ni2+-NTA resin proved to be a very power-
ful purification step and on its own resulted in a protein sample of high
purity (Figure 12.2). Nonetheless, to improve homogeneity and to remove
contaminants, purification with gel-filtration was carried out. Superdex
75 resin gave noticeably worse results than Superdex 200, with a trailing
peak. However, purification on Superdex 200 resin yielded a homoge-
neous protein sample (Figure 12.2, E).
12.2 Overexpression and purification of ADC mutants 159
Figure 12.2 (A) Representative 10-20% gradient tricine-PAGE for ADC mutants that self-
process after purification on Ni-NTA resin and (B) after gel-filtration. The relative po-
sition of pi-, α-, and β-chain in this gel are indicated with a red, yellow, and blue bar,
respectively. Fractions, combined for crystallization, are indicated with a black bar above
the gel. The faints band above the pi-chain represents undissociated ADC multimers. (C)
Representative 10-20% gradient tricine-PAGE for ADCmutants that do not process, after
purification on Ni-NTA resin and (D) after gelfiltration. Faint bands coorresponding to
traces of β- and α-chains. (E) Representative gelfiltration purification graph with the x-
axis showing the elution volume in ml, whereas the y-axis shows the optical absorbance
for 280nm: blue; for 230nm: red; for 260nm: maroon.
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The following ADC mutants were overexpressed and purified success-
fully: A24a-G24b, G24S, H11A, S25a-A25b, S25C, S25T, R54K, and Y58F.
All overexpressed ADC mutant protein samples were predominantly
found in the soluble fractions of the crude lysis. In contrast, K9Q, was
largely insoluble. Whereas A24a-G24b, G24S, S25a-A25b, and S25T did not
show any self-processing activity within the time span of the purification,
as judged by tricine-PAGE and mass-spectrometry analysis. H11A, R54K,
S25C, and Y58F were capable of forming significant amounts of α- and β-
chains in solution, within the time-span of the purification, as judged by
the occurrence of pi-, α-, and β-chains on the tricine-PAGE and by mass-
spectrometry analysis. Representative tricine-gels for the enzymes that do
self-process and those that do not self-process are shown in Figure 12.2
C,D and A,B, respectively. However, very faint bands, corresponding to
trace amounts of α- and β-chains were detected for all mutants in solu-
tion, except S25A-A25b and S25A, on prolonged storage and incubation
(Michael Webb, personal communication). There was no apparent differ-
ence betweenADCmutants that self-processed and those that did not with
respect to the migration on gel-filtration (Figure 12.2 E). A small peak be-
fore the main peak was characteristic of the purification on Superdex 200
resin (see Figure 12.2). Analysis of tricine-PAGE indicated that similar to
the main peak, this peak contained ADC.
Previous experimenters (Dr von Delft, personal communication) re-
ported that the protein is very stable and can be kept at 4◦C for up to a
year and could then still be crystallized. Therefore a storage temperature
of 4◦Cwas chosen for the protein.
12.3 Crystallization of ADC mutants
For crystallization screening, the protein solution was diluted to protein
concentration of 5-9 mg/ml. All crystallization trials were carried out at
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19◦C with vapour diffusion technique as described in Section 8.1 with a
1:1 ratio of precipitant to protein solution. The crystallization drops had a
final volume of 1-3 µl.
Initial crystallization screening for R54K and S25T, without a histidine-
tag, resulted in a large number of small crystals, with maximal dimen-
sion of 40 µm under several conditions. The most promising conditions
appeared to be a precipitant solution of 8-9% (w/v) PEG2000 MME, 10
mM NaCH3CO2, pH 5.0. However, any attempts to increase the size of
the crystals by micro-seeding or macro-seeding were unsuccessful. Seeds
were also taken from older S25A crystals, but had no apparent positive ef-
fect on the crystal size. Similarly, adding compounds such as dioxane,
ethanol, and dimethylsulfoxide did also not lead to any improvement.
Most probably, this was a result of the problems with the purity of the pro-
tein from the initial purification protocol (Subsection 7.3.1). X-ray screen-
ing in-house was attempted, but failed to produce any significant diffrac-
tion pattern.
Therefore, after histidine-tagged mutants had been overexpressed and
purified, crystallization trials were pursued with those. As soon as pos-
sible after the purification, in general within 1-3 days, the ADC mutants
were crystallized. Initial screening with (NH4)2SO4 as the main precipitant
was successful and produced crystals for G24S, S25C, S25T, S25a-A25b,
and Y58F.
S25T crystallized in two crystal forms. Initial crystallization trials pro-
duced hexagonal prismatic crystals with pyramidal ends at the top and
bottom that would form both in 1.2-1.4 M (NH4)2SO4, 0.1 MMES pH 6.0 as
well as in 1.2M unbuffered (NH4)2SO4 (crystal formA) (see Figure 12.3 A).
A different crystal form of bi-pyrimidal hexagonal morphology would
grow in 2.4 M sodium malonate, NaOH, pH 4.0 (crystal form B) (see Fi-
gure 12.3 B). The latter form had been observed before for native ADC by
von Delft (2000). Two crystal forms were also obtained for G24S, although
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both would grow in the same condition. Crystals of a similar morphology
as crystal form B of S25T would grow in 1.4-1.6 M (NH4)2SO4, 0.1 M citric
acid pH 4.0. In the same condition, prisms similar to crystal form A of
S25T would also grow (G24S crystal form A) (see Figure 12.3 C).
The pH of both crystallization conditions for G24S and S25T was also
close to the pH 4.6 at which processed ADC was crystallized (Albert et al.,
1998). Crystals would usually grow within seven days to a size of up
to 0.6×0.6×1 mm3 for S25T crystal form B and to about half that size
for S25T crystal form A and both crystal forms of G24S. Y58F crystals of
the same morphology as crystal form B of S25T grew to dimensions of
about 100×50×80 µm3 in 1.4 M (NH4)2SO4, 0.1 M citric acid pH 4.0. How-
ever, these crystals were rather unstable and never diffracted to more than
2.9 A˚ at a synchroton source. A full dataset could not be collected on them.
For cryo-protection the crystals were successively incubated for 3-5 min
in mother liquor solutions with 1, 5, 10, 15, 20, and 25% (v/v) glyerol and
after being mounted in cryo-loops, they were stored in liquid N2. Special
care had to be taken to follow a step-wise protocol to increase the con-
centration of glycerol in order to keep crystal mosaicity low and to ensure
diffraction to high resolution. S25T crystals of form B were cryoprotected
in a similar way by gradually increasing the sodium malonate concen-
tration to 3.2 M, since sodium malonate is a suitable cryoprotectant itself
(McPherson, 2001). 3.2 M sodium malonate, NaOH, pH 4.0 was added to
the drop with the crystal in small amounts and, eventually, the crystal was
transferred to a drop with the final concentration (i.e. sodium malonate at
3.2 M).
Crystals for pro-ADC had previously been obtained by Drs Diana
Matak-Vinkovic and Mladen Vinkovic in 1.6 M (NH4)2SO4 pH 5.5, and
for S25A in 1.5 M (NH4)2SO4, 0.15 M Tris/HCl pH 8.0. A24a-G24b and
S25C, as well as H11A and S25a-A25b were all crystallized in 1.4-1.6 M
(NH4)2SO4 pH 4.0, by Mairi Kilkenny and Carina Lobley, respectively.
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Figure 12.3 Crystal morphology of the crystallized ADC mutants. (A) S25T crystal form
A (B) S25T crystal form B (C) G24S crystal form A (D) S25C crystals.
Apart from S25T, which was cryo-protected with sodium malonate, all
mutant crystals as well as pro-ADC crystals were cryo-protected with the
same compound, namely glycerol.
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12.4 X-ray diffraction data collection of ADC
mutant crystals
The initially obtained crystal form B of S25T diffracted up to 3.2 A˚ at the in-
house X-ray data collection facility and 2.6 A˚ minimum Bragg spacing at
Daresbury SRS. However, the X-ray diffraction pattern was highly mosaic
and the X-ray data quality was limited by the low resolution. Scaling of
the data indicated that the Bravais lattice was still hexagonal, however
unit cell dimensions (see Table 12.1) indicated a different unit cell and a
different space group.
Crystal form B of S25T ADC diffracted up to 1.4 A˚ maximum resolution
at the SRS, however at the first synchroton journey X-ray diffraction data
to a resolution of 1.56 A˚ was collected, because of time-limitations. Sub-
sequently, on a second data collection with more time to carefully set up
data collection, X-ray diffraction data to 1.26 A˚ were collected.
In the latter case, X-ray diffraction data were collected with X-rays of a
wavelength of 0.978 A˚ in two steps. To record the high-resolution reflec-
tions a data collection with a short detector-to-crystal distance (95 mm)
with long X-ray exposure time (16 sec), for good signal-to-noise ratio was
chosen. Additionally, the data collection setup was adjusted for a short
beamstop to crystal distance, to minimize background scattering of the X-
rays. Subsequently, the low resolution data were collected, starting from
the same angle as before, with a long detector-to-crystal distance (180 mm)
and short X-ray exposure time (5 sec) with the beam stop far away from
the crystal to collect low-resolution reflections. For both data collection
steps, a total of 100◦ with 0.5◦ oscillation angle increments was collected,
to achieve high data redundancy.
One problem which arose from the rather large unit cell dimension in
one orientation (see Section 12.5), was that reflections started to overlap
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Figure 12.4 (A) An auto-indexed X-ray diffraction pattern of S25T. Rejected reflections
are shown as red circles and partially recorded reflections are indicted by yellow circles.
(B) Illustration of the peak separation problem at short detector-to-crystal distance. Par-
ticularly, at low resolution the peaks are poorly separated. (C) Illustration of how the
background box parameter (white rectangular box) was adjusted to enable indexing of
the dataset.
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Table 12.1 Properties of the different S25T crystal forms
Space Unit cell dimensions Molecules per Maximum Mosaicity Data collection
group a (A˚) c (A˚) asymmetric unita resolution (A˚) (◦) facility
P63 102.4 180.7 4 3.20 1.40 In-house
P63 102.5 180.7 4 2.60 1.20 SRS-14.2
P6122 70.1 215.4 1 1.56 0.25 SRS-14.2
P6122 70.5 215.3 1 1.26 0.45 SRS-14.2
a Onemolecule comprises twoADC subunits, the searchmodel for themolecular replace-
ment
(see Figure 12.4 B). This posed a serious problem for data processing, as
overlapping spots cannot be distinguished and are consequently rejected
by the processing software. One way to circumvent this, would have been
to orient the c-axis with the incident beam, at the risk of a lower com-
pleteness of the dataset. For this study, care was taken to find a good
initial orientation of the crystal, in which the longest unit cell axis, would
be oriented such as to allow high resolution data collection, but not be
oriented coincident with the X-ray beam. Secondly, in order to allow in-
dexing and scaling of the data, the background box in the input script for
DENZO had to be made narrower, as shown in Figure 12.4 C. This then
even enabled indexing of the low-resolution reflections (Figure 12.4 A).
However, when scaling the two datasets together, most of the low resolu-
tion reflections from the high-resolution data collection were discarded,
because they were of lower quality than those from the low-resolution
pass. Both datasets combined resulted in almost 100% X-ray diffraction
data completeness with high data redundancy. For the X-ray diffraction
dataset, used for the refinement, reflections up to a nominal resolution of
1.29 A˚ were included for scaling.
X-ray data collection of G24S crystals was relatively straightforward. A
total of 100◦ of X-ray diffraction data was collected, with a 0.5◦ oscillation
increment, 10 sec X-ray exposure time, and with X-rays of 1.488 A˚ wave-
length. The crystal form similar in morphology to crystal form B of S25T
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diffracted up to 2.0 A˚ whereas the other crystal form only diffracted to a
maximum resolution of 2.6 A˚. X-ray diffraction data were collected from
both forms, but only the higher resolution data was eventually used, be-
cause of the higher data quality. Presumably because of the long wave-
length the crystals diffracted to ∼2.0 A˚, but the X-ray diffraction data was
of good quality. Complete data statistics for the X-ray diffraction data col-
lection are shown in Table 12.3.
12.5 Structure solution of ADC mutants
In order to solve the structure of crystal formA of S25T, molecular replace-
ment, as described in Section 8.4, with the previously solved ADC struc-
ture (Albert et al., 1998) was carried out. Residues 20-26, comprising the ψ-
loop region, were removed in order to reduce the bias from the molecular
replacement probe for the subsequent refinement. Four clear rotation and
translation solutions for the dimer search probe could be unequivocally
determined, locating two tetramers in the asymmetric unit (Table 12.2).
Table 12.2 Rotation and translation function solutions for the Patterson search for S25T
ADCa
α (◦) β (◦) γ (◦) Txfract Tyfract Tzfract R-factor Correlation
coefficient
24.00 17.34 23.98 0.4214 0.9357 0.0000 47.2 32.8
10.64 109.91 122.43 0.6901 0.6704 0.9048 44.9 40.6
44.81 93.23 233.65 0.0354 0.4010 0.2398 42.8 46.9
34.36 70.54 302.20 0.7309 0.9541 0.7644 40.7 53.7
a The translation functions are listed in the sequence in which they were found. All
solutions were clearly distinguishable from the highest background peak
Refinement of the protein structure model was continued until an Rcryst
of 30 and an Rfree of 36, at 2.6 A˚ resolution. Placement of water molecules
and further refinement proved difficult because of the low resolution. The
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electron density maps of this structure were difficult to interpret, but in-
dicated an unprocessed cleavage site. Higher resolution data was clearly
necessary to obtain a clear picture. A better model could eventually be
calculated with the X-ray diffraction data, collected from crystal form B at
1.56 A˚ and 1.29 A˚ resolution, respectively (Section 12.3).
The indexed, integrated, and scaled X-ray diffraction data from crystal
form B as well as from the data of G24S indicated that the protein crystal-
lized in an isomorphous form in the same space group as the previously
solved ADC structure. The unit cell dimensions were within 3% of the val-
ues of the parameters of the pro-ADC crystals. Consequently, the structure
could be solved by directly using the native ADC structure in the refine-
ment with CNS, and to calculate difference Fourier maps. This confirmed
that the space group is P6122 with two subunits (subunit A and B) in the
asymmetric unit, which were related by the crystallographic two-fold axis
to form the tetramer. Similarly to the molecular replacement approach
above, residues 20-26, comprising the ψ-loop region, were removed prior
to using the structure as amodel. The structure of S25Twith the 1.29 A˚ res-
olution data could not be directly solved with the processed ADC struc-
ture as a search model. This may have been due to the fact that the sum of
the coordinate differences were too large for convergent refinement with
simulated annealing. Therefore, the already partially-refined model de-
rived from the 1.56 A˚ dataset was used as the initial model, and with this,
refinement started to converge.
The crystal structure of S25A was solved in tetragonal space group I422
by Drs Diana-Matak Vinkovic andMladen Vinkovic. In this case, the crys-
tallographic four-fold axis coincides with the internal four-fold axis of the
tetramer. Pro-ADC, as well as the other ADC mutant structures A24a-
G24b, H11A, S25a-A25b, and S25C all crystallized in space group P6122.
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12.6 Structure refinement andmodel building of
ADC enzymes
Refinement and model building of the four structures, G24S, pro-ADC,
S25A, and S25T was carried out as described in Section 8.5 and Section 8.6.
Model building proved very difficult in the ψ-loop region preceding the
cleavage site. Electron density for the side-chains of residue His21, Tyr22,
and Glu23 only appeared at very low contour level, in general below 1.0σ.
Even when contoured at 0.6σ the electron density maps were less than
clear, indicating strong disorder of these residues in the crystal.
In order to improve the electron density maps several approaches were
pursued. Non-crystallographic symmetry averaging of the two subunits
in the asymmetric unit in conjunction with solvent flattening (Section 8.5)
was applied, but failed to make the electron density maps significantly
clearer. In the last cycles of the refinement, TLS groups were defined ac-
cording to secondary structure elements, as calculated by DSSP and JOY.
This improved electron density maps in general but hardly in the disor-
dered region. However, it led to a better data fit of the model, as judged
by the decrease in the Rfree value. Because of the lack of electron density,
an alanine instead of the correct amino acid, known from the sequence,
was modeled when the electron density was particularly poor. Overall
refinement was continued until convergence of the Rfree.
Characteristic for the histidine-tagged mutants, in subunit A the last 3-5
residues from the histidine-tag, prior to the N-terminal residue in the ADC
sequence, could be observed andmodeled in the electron density maps. In
the previously solved ADC structure (Albert et al., 1998), residues Arg116–
Ala126 at the C-terminus of the α-chain were not modelled. However, in
subunit A of G24S the mainchain atoms, and, partly, the side-chains, of
eight additional residues (Arg116, Thr117, Ala118, Lys119, Ala120, Ile121,
Pro122, Val123) at the C-terminus of the protein could be modelled. The
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Table 12.3 X-ray diffraction data collection-, refinement-, and stereochemistry- statistics
for the final models of the refined crystals structures of pro-ADC, G24S, S25A, and S25T
Pro-ADC G24S S25A S25T
Data collection
Space group P6122 P6122 I422 P6122
a=b 71.0 71.4 73.1 70.5
Unit cell parameters (A˚)
c 216.4 219.1 111.1 215.3
overall 62-1.95 25-2.0 25-1.95 60-1.29
Resolution range (A˚)
highest res. shella 2.01-1.95 2.05-2.00 2.02-1.95 1.30-1.29
No. of unique reflections 24 605 23 414 11 321 81 391
Multiplicity 17.9 30.9 9.3 52.5
overall 5.9 7.8 4.0 9.7
Rsymb highest res. shella 29.0 34.5 32.8 77.0
overall 24.5 33.8 36.6 25.7
Average 〈I〉/σ〈I〉
highest res. shella 3.2 5.0 4.2 4.4
overall 96.4 98.6 95.2 99.0
% completeness
highest res. shella 89.3 90.5 92.7 97.9
Estimated mosaicity (◦)c 0.35 0.27 0.67 0.45
Wilson B (A˚2) 24.8 24.9 26.7 15.3
Refinement
overall 15.9 16.5 15.8 15.3
Rcrystd highest res. shella 19.6 18.7 17.3 23.7
overall 19.5 18.5 20.5 16.6
Rfree highest res. shella 23.8 23.0 20.6 25.1
working set 22 229 21 839 10 244 76 434
No. of reflections
test set 1183 1180 518 4045
protein 1793 1876 902 1865
No. of non-H atoms water 274 237 141 387
ligand 5 10 0 22
Model quality
Estimated coordinate error (A˚)e 0.12 0.13 0.13 0.04
R.m.s.d. bonds (A˚)f 0.014 0.016 0.017 0.011
R.m.s.d. angles (◦)f 1.60 1.57 1.56 1.45
most favoured region 217 225 110 219
No. of residuesg in generously allowed region 5 6 5 5
disallowed region 1 2 0 0
a highest resolution shell
b Rsym =
∑
h
∑
i
||Ihi|−|Ih||∑
h
∑
i
|Ihi| (see Equation 8.2)
c Calculated with SCALEPACK (Otwinowski, 1991).
d Rcryst =
∑
h
||Fo|−|F c||∑
h
|Fo| (see Equation 8.3)
e Estimated coordinate error (see Section 8.7) of the structure based on the Rfree, calculated
with REFMAC (Murshudov et al., 1997).
f R.m.s.d. calculated with WHATCHECK (Hooft et al., 1996a).
g Distribution of the number of residues in the Ramachandran plot. φ/ψ distributions
were calculated with RAMPAGE (Lovell et al., 2003).
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final protein model structures were assessed as described in Section 8.7.
Crystallographic statistics and Ramachandran diagrams of the main-chain
torsion angle distribution for the final models are shown in Table 12.3 and
Figure 12.5, respectively. Final 2Fo-Fc electron density maps of the cleav-
age site and its immediate environment will be illustrated in Section 13.2.
The three-dimensional coordinates as well as the observed structure fac-
tors have been deposited in the PDB-databank under the ID codes 1PPY
(pro-ADC), 1PQF (G24S), 1PQE (S25A), and 1PQH (S25T).
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Figure 12.5 Ramachandran diagram of the φ/ψ angle distribution. (A) pro-ADC.
(B) G24S. (C) S25A. (D) S25T. Both axis are in units of ◦. All diagrams were calculated
with RAMPAGE (Lovell et al., 2003).
13 Structural analysis of ADC
enzyme crystal structures
13.1 Introduction
Protein self-processing is an important intramolecular post-translational
mechanism to activate enzymes, as described in Section 4.2. General and
specific features of the self-processing biochemistry have been illustrated
in Figure 4.1. A more detailed scheme of the self-processing mechanism
in ADC, as it is currently understood, is shown in Figure 13.1. Although
no direct evidence has yet been provided for the oxyoxazolidine interme-
diate, chemical knowledge and experiments in model systems imply the
existence of it (Iwai and Ando, 1967).
ADC seemed to be an adequate, and representative model system to
study the mechanism of self-processing in more detail by high-resolution
crystal structure analysis, because structural information for both the pro-
cessed cleavage site and the ester intermediate of the enzyme have already
been available (Albert et al., 1998). Although the analysis of these struc-
tures suggested several residues important for the self-processing cataly-
sis, it could not determine amino acids that could serve as catalysts des-
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Figure 13.1 Schematic representation of the self-processing reaction, as it is currently un-
derstood, applied to ADC. Base 1, acid 1, and base 2 are designated as :B1, H-A 1, and
:B2 respectively.
ignated base 1, acid 1, and base 2 in the mechanistic scheme Figure 13.1.
Consequently, one of the main objectives of this study was to attempt to
identify such functional residues. Another purpose of this studywas to in-
vestigate the roles of the evolutionarily conserved cleavage site residues,
Gly24 and Ser25, in self-processing by crystallographic studies of site-
directed mutants.
This study represents the first comprehensive structural investigation of
a cleavage site of a self-processing enzyme. Importantly, the first native,
cleavage site of a self-processing enzyme that has not been mutated will
be described, along with a detailed structural comparison with the solved
ADC mutant structures, mentioned in Section 12.6.
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13.2 Structural features of pro-ADC and ADC
mutants
Pro-ADC The global model of the crystal structure of pro-ADC is ba-
sically identical to the processed ADC structure solved by Albert et al.
(1998), apart from the significant differences at and around the cleavage
site. This also applies to the structure models of all the ADC mutants
discussed below (see Table 13.1). Subunits A and B of processed ADC and
that of pro-ADC superposewith amain-chain r.m.s.d. of 0.22 A˚ and 0.19 A˚,
respectively, for residues 1–16, 26–71, and 77–115. Care had to be taken to
generate accurate and precise superpositions to obtain realistic estimates
of the global and local differences. Therefore, residues 16–26 around the
ψ-loop region as well as residues 72–77 around the 310 helical region were
omitted for producing superposed coordinates. This superposition pro-
cedure was also followed for comparison of the ADC mutant structures
described below and in Table 13.1. Obviously, this procedure also had to
take into account the 3-5 residues that were modelled at the N-terminus of
the histidine-tagged mutants. Once a suitable global structural superposi-
tion had been acquired in this way, r.m.s.ds for individual residues could
be calculated and compared. The two subunits of pro-ADC in the asym-
metric unit superpose with a Cα atom r.m.s.d. of 0.29 A˚ for superposed
coordinates of residues 1–16 and 26–71 and 77–115, indicating that they
are virtually identical in this region.
Pro-ADC is able to process (Section 12.2), but the model for the cry-
stal structure showed an unprocessed cleavage site. 2Fo-Fc Fourier maps
showed clear electron density, above 1σ contouring level, for the peptide
bond between Gly24 and Ser25 (see Figure 13.2 A) from the start of the
refinement. Fitting an ester at partial occupancy, as has previously been
carried out with the processed ADC structure (Albert et al., 1998), in a po-
sition similar to the ester in apo-ADC was investigated. However, a better
fit of the experimental data by doing so could not be obtained, and thus the
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Figure 13.2 Stereo-illustration of the 2Fo-Fc electron density maps (grey colour), of the
self-cleavage site and its environment, contoured at 1.2 σ. All figures are from sub-
unit A in a similar orientation and show Asp19–Cys26, Ser70–Asn72, Thr57, Tyr58 and
Lys9, His11, Arg54 from an adjacent subunit. The mutations are shown in bold letters.
(A) Pro-ADC. (B) A24a-G24b. (C) G24S (D) H11A. See Figure 3.4, Figure 4.5, and Fi-
gure 4.3 for colour scheme. All Figures prepared with PYMOL (DeLano, 2002).
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Figure 13.3 Stereo-illustration of the 2Fo-Fc electron density maps (grey colour), of the
self-cleavage site and its environment, contoured at 1.2 σ. All figures are from subunit
A, except in S25C, in a similar orientation and show Asp19–Cys26, Ser70–Asn72, Thr57,
Tyr58 and Lys9, His11, Arg54 from an adjacent subunit. The mutations are shown in
bold letters. (A) S25a-A25b. (B) S25A. (C) S25C. (D) S25T. See Figure 3.4, Figure 4.5, and
Figure 4.3 for colour scheme. All Figures prepared with PYMOL (DeLano, 2002).
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peptide bond was modelled as unprocessed. The structure of the cleavage
site, comprising the evolutionarily completely conserved residues Gly24
and Ser25 (Figure 13.4), is almost identical in the two subunits (residues
Gly24, Ser25, and Cys26 superpose with a main-chain r.m.s.d. of 0.12 A˚).
Interestingly, Gly24 makes a kink with a positive φ, and adopts a con-
formation with φ/ψ angles of 97/13◦ and 92/6◦, respectively in the two
subunits.
Residues His21, Tyr22, and Glu23 of the solvent accessible ψ-loop, pre-
ceding Gly24, were disordered in both subunits. The B-factors in this re-
gion of the loop are up to more than two times as high as the average (see
Table 13.2). There are significant differences in the conformations for the
two subunits in this region and also for the highly conserved 310 helical
region between Asn72 and Ala76 (Figure 13.5), which lies adjacent to the
loop.
The 310 helical region of subunit B of pro-ADC superposes better with
both subunits of processed ADC (all atom r.m.s.d. of 0.45 A˚ and 0.52 A˚, re-
spectively for residues Asn 72–His 77) and so subunit B probably presents
a more realistic model. Consequently, for the comparison with the other
ADC mutant structures this subunit was used as a reference (Table 13.1).
However, the side-chains of Asn72 appear disordered in both subunits of
pro-ADC. Whereas in subunit B, Asn72 could be modelled in a similar po-
sition as in processed ADC, in subunit A it is in a position further away
from the Ser25 hydroxyl (see Figure 13.2 A). Instead, the hydroxyl group
of Ser25 H-bonds to the main-chain carbonyl of Tyr22. The latter residue,
lies in between Asn72 and Ser25, preventing interaction.
G24S Electron density was well defined for the Gly24→Ser mutation at
2σ contouring level in 2Fo-Fc maps from the start of the refinement. Signi-
ficant conformational differences of the amide bonds between both Glu23
and Ser24 as well as Ser24 and Ser25 with respect pro-ADC are observ-
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able. The Ser24 carbonyl H-bonds with the side-chain hydroxyl of Tyr58
(Figure 13.2 C). The Glu23 carbonyl points in the opposite direction as it
does in the pro-structure (Figure 13.6 A) and H-bonds to Ser25 Oγ, instead
(Figure 13.2 C). Ser25 is in the generously allowed region of the Ramachan-
dran plot with a mean φ-angle of 179◦ and a mean ψ-angle of 173◦. The
distance of the Nδ of Asn72 to the Oγ of Ser25 is larger than in pro-ADC
(Table 13.1) and a water molecule was found in between the two residues.
The two Ramachandran outliers (see Figure 12.5 B) are Arg16 from each
of the subunits, the reason for which is presumably a sulphate molecule in
the active site (see Figure 13.2 C). Although the sidechains of residues 21-
23 are disordered (Table 13.2), the conformations for themodelled residues
of the ψ-loop are very similar in between the two subunits.
S25A Similarly to the Gly24→Ser mutation, the Ser25→Ala mutation
was clearly visible at 2σ contouring level, in 2Fo-Fc electron density maps
from the start of the refinement. The amino acid substitution resulted in
some minor, but important, conformational changes. The carbonyl group
of Gly24 H-bonds with the Nδ of Asn72 (distance 3.05 A˚) (Figure 13.3 B).
The conformation of Gly24 is now a more extended one, without the kink
observed in the pro-ADC structure (Figure 13.6 A). In contrast, the confor-
mation and position of the Ala25 are identical to that of Ser25 in pro-ADC
(Table 13.1). Whereas residues in the 310 helix and Asn72 are in identi-
cal positions as in subunit B of pro-ADC, there are differences in the co-
ordinates for residues 19–24. Electron density for the ψ-loop region pre-
ceding the active site is better defined than for pro-ADC, except for the
side-chains of His21, Tyr22, and Glu23 (Figure 13.3 B).
S25T The near-atomic resolution 2Fo-Fc electron density map of the S25T
ADC mutant showed the Ser25→Thr mutation clearly at 2σ contouring
level in subunit A from the start of the refinement. However, in subunit B
the side-chain is disordered, to a certain extent, and B-factors between 42
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and 50 A˚2 for the side-chain atoms indicate possible rotational flexibility
around the Cβ.
The S25T mutation caused the most dramatic change in Cα coordinates
of all ADC mutants. The whole loop from Leu20 until Cys26 is in a posi-
tion shifted towards the 310 helix, relative to its position in pro-ADC (Fi-
gure 13.3 D). The Gly24 and Thr25 residues do not superpose with Gly24
and Ser25 in the pro-ADC structure (Figure 13.6 B). Also there are no H-
bonds between Gly24 carbonyl and Thr57 Oγ nor between Thr25 Oγ and
Asn72 Nδ. Cys26 appears to be forced out of its normal environment,
adopting two different, alternate conformations. Also the S25T mutation
causes a kink between residues Leu20 and Glu23, which are very tightly
packed, so that the Asp19 Oδ H-bonds to the mainchain oxygen of Glu23.
A malonic acid residue, H-bonding to Arg54, occupies the region that be-
comes the active site after self-processing (Figure 13.3 D).
A detailed description of the structural features of A24a-G24b (PDB-
ID: 1PYQ), H11A (PDB-ID: 1PT1), S25a-A25b (PDB-ID: 1PTO), and S25C
(PDB-ID: 1PYU) will be given elsewhere by Mairi Kilkenny and Carina
Lobley. However, the respective electron density maps of the final mod-
els of A24a-S25b, H11A, S25C, and S25a-A25b are shown in Figure 13.2
and Figure 13.3. These will be relevant for the subsequent comparative
analysis that was carried out and for the discussion of the results that fol-
lows below. A summary of the relevant structural features of the cleavage
site that were analyzed in this study, together with processing activity in
solution1, of all ADC structures is given in Table 13.3.
1Information for self-processing activity, on prolonged storage, was provided by
Michael Webb.
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13.3 Interactions at the cleavage site
Specific H-bond interactions at the cleavage site have been identified in
mutated precursors of the proteasome (Ditzel et al., 1998) and glycosylas-
paraginase (Xu et al., 1999). These were assumed to guarantee optimal
conformation of the cleavage site and assist the self-processing catalysis
by stabilization of reaction intermediates.
In this study, comparative analysis of the various ADC structures shows
that residues in positions 24 and 25 in the two ADC subunits in the asym-
metric unit superpose very well, with the exception of those in S25a-A25b,
where two conformations are seen for the Ser25a carbonyl in the two sub-
units. However, the coincidence in position of residues 24 and 25 in the
two subunits is in contrast to residues 21-23 in the ψ-loop preceding the
cleavage site. The following interactions appear to be important for sta-
bilizing the conformation of the Gly24-Ser25 peptide bonds (Figure 13.2
A):
• strong H-bonds of the Gly24 carbonyl to the Oγ of the invariant
Thr57 (see Figure 13.4) and to a water molecule;
• an H-bond between the Ser25 carbonyl and the main-chain nitrogen
of Asn72;
• an H-bond between the Glu23 main-chain carbonyl oxygen and the
Nζ of the conserved Lys9 (see Figure 13.4) from an adjacent subunit.
The H-bond to the Thr57 Oγ appears to be important for orienting the
carbonyl, and additionally may polarize the Gly24 carbonyl bond. To-
gether with the well-ordered water molecule (Figure 13.2), Thr57 forms
an oxyanion hole that is likely to stabilize the developing negative charge
on the exo-cyclic oxygen (see Figure 13.1). The water molecule, whose
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position is stabilized by two H-bonds to the Nη1 and Nη2 of the invari-
ant Arg54 (Figure 13.4), is at a distance of 2.60 and 2.66 A˚ , for subunit A
and B, respectively from the Gly24 carbonyl oxygen in the pro-ADC struc-
ture. It is consequently, at an equal distance from the oxygen as the Thr57
Oγ. This water molecule is also in the exactly same place in the processed
ADC structure, and the crystal structures of the A24a-G24b and S25AADC
mutants. A sulfate molecule is located in the same position as the water
molecule in the H11A, S25a-A25b and S25C structures, whereas in S25T a
malonic acid residue can be found in this locus.
In all ADC structures, including all ADC mutants, pro-ADC and the
processed ADC structure, Thr57 is in the same, generously allowed, re-
gion of the Ramachandran plot (see Table 13.1 and Figure 12.5), as is often
found in catalytically important residues. Its conformation and position
is maintained unchanged before and after the self-processing, as indicated
by the structures of processed ADC (Albert et al., 1998) and pro-ADC.
Asn72 is almost completely conserved (see Figure 13.4) and only in the
thermophilic bacterium T. maritima is it a tyrosine. Although a closer look
at the alignment shows that there is asparagine in the T. maritima sequence
just two residues before the other aligned asparagine residue. Asn72 is
followed by a sequence of conserved residues forming a 310 helix (see Fi-
gure 13.5), whose role appears to be mainly structural and could serve to
restrict the possible conformations of the ψ-loop. Disorder in the ψ-loop
region in some ADC structures appears to be correlated with disorder in
the 310 helical region, which may be due to H-bond interactions.
13.4 Conformational constraints
Detailed knowledge of the differences in the conformations of the cleavage
site in the various structures can be helpful in understanding the relevance
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Figure 13.5 Structure-annotated amino acid sequence of ADC in JOY-format (Mizuguchi
et al., 1998a). See legend to Figure 11.4 for a key to the JOY-format.
of the conformation for self-processing. Because all ADC structures are
globally isomorphous (Table 13.1) this model system could be particularly
well suited for studying such conformational differences. Apart from the
crystallization of S25T, the same precipitants for crystallization and the
same cryoprotection conditions were used for all mutants. Of the residues
around the cleavage site, only His11 is likely to have a pKa between 4
and 8 , and consequently no major pH-dependent conformational changes
can be expected in this region, in the pH range in which pro-ADC and
the ADC mutants were crystallized (Section 12.3). Therefore, it is likely
that the differences between the structures are predominantly due to the
changes in the amino acid sequences and the corresponding differences in
interactions in the protein.
In pro-ADC, Gly24 of the unprocessed cleavage site has a positive φ (Ta-
ble 13.3) and is in a left-handed α-helical conformation. Any other residue
in this position with the same conformation as this Gly would almost cer-
tainly introduce steric clashes. Consequently, in the structure of the in-
active G24S mutant, the Ser24 carbonyl is in a different conformation (Fi-
gure 13.6 A), positioned away from Thr57.
However, introducing a residue before Gly24, as in A24a-G24b, does not
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alter the conformation of the cleavage site significantly (Figure 13.6 B), and
apparently leaves the geometry as well as the interactions of the cleavage
site, observed in pro-ADC, intact (Figure 13.2 B). Nevertheless, this mu-
tant interestingly does not process. As a consequence, in addition to the
interactions and geometry of the cleavage site other factors appear to be in-
fluential for processing. Strain in the loop has been assumed to contribute
to the self-processing reaction in pyruvoyl-dependent HisDC (Gallagher
et al., 1993), GyrA intein splicing (Klabunde et al., 1998) and glycosylas-
paraginase (Xu et al., 1999). In the latter case significant deviations in the ω-
(the dihedral angle around the rotation of C-N bond) and τ -angles (the an-
gle between N-Cα and Cα-C) of the peptide bond of the cleavage site were
observed. In pro-ADC no evidence for strain in the form of significant de-
viations in ω- and τ -angles from themean ideal values (Table 13.4), and/or
unusual peptide conformations in the peptide bonds of Glu23-Gly24 and
Gly24-Ser25 could be observed.
Table 13.4 ω- and τ -angles for Glu23 and Gly24 in subunits A and B of pro-ADCa
Residue ω (◦) τ (◦)
A 177.9 114.9
Glu23
B 182.0 115.5
A 181.7 114.7
Gly24
B 184.8 112.9
aThe values were calculated with DANG (Rossmann et al., 2001, p.729-731).
Nonetheless, in the eight structures of ADC presented here, side-chains
of His21, Tyr22 and Glu23 in the ψ-loop are most often disordered (Fi-
gure 13.2 and Figure 13.3) and/or found in different conformations in
the two subunits, even though the position of Gly24-Ser25 is constrained.
Making the loop longer as in A24a-G24b and also in S25a-A25b lead to
increased conformational heterogeneity, as indicated by the very different
main-chain positions the residues in the ψ-loop adopt in the two subunits.
Presumably, the added residue in A24a-G24b renders the loop incapable of
stabilizing reaction intermediates of the self-processing reaction. Whereas
a single defined conformation of the loop itself, does not seem to be essen-
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tial, the results suggest that a certain degree of conformational flexibility
may be an important factor in allowing the processing to proceed.
The second insertion mutant S25a-A25b, like A24a-G24b, is also inac-
tive. However, in this mutant the cleavage site is moved out of its normal
environment. Ala25b is in exactly the same place as Ser25 in pro-ADC
and Ala25 in S25A (Figure 13.6 A). Significantly, removal of the side-chain
hydroxyl of Ser25 in pro-ADC, as in both the inactive S25A mutant and,
effectively also in the S25a-A25b mutant causes a change in the confor-
mation of the Gly24 and S25a carbonyl, respectively. In both structures
the carbonyl is rotated ∼180◦ from its position in pro-ADC (Figure 13.6
A), H-bonding to Asn72 instead of Thr57. This conformational change re-
sults in a more extended conformation of Gly24. If the Ser25 hydroxyl was
present, as in pro-ADC, steric hindrance with the Gly24 carbonyl would
most likely prevent such a conformation.
The more bulky side-chain of a threonine in the position of Ser25, as in
the inactive S25T mutant, appears to force Gly24, Thr25, and Cys26 out
of their normal environment and further to the left from the perspective
in Figure 13.3 D. There are no H-bonds between the Gly24 carbonyl and
the Thr57 Oγ. The structural differences in the mutant represent the most
pronounced change in the position of the cleavage site in all mutant struc-
tures. However, it cannot be entirely excluded that the conformational
change in S25T is partly caused by the malonic acid residue. This residue
is located in the area that becomes the active site upon cleavage (see Fi-
gure 13.3 D).
In the structure of the active but unprocessed, H11A mutant, which is
able to self-process, the conformation of the cleavage site is similar to that
of pro-ADC, with the exception of the Gly24 carbonyl, which H-bonds to
Oζ of Tyr58 instead of the Oγ of Thr57. The removal of the imidazole
group created a cavity that is occupied by Glu23, whose Cα position is
1.75 A˚ further towards residue 11 comparedwith the position in pro-ADC.
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Figure 13.6 Illustration of the superposition of the three-dimensional coordinates of
Glu23 to Cys26 of pro-ADC with the respective residues in the ADC mutants (superpo-
sition procedure as in the legend to Table 13.1). From all structures subunit A was used,
except from pro-ADC. Colour scheme, in general, as before (Figure 3.4 and Figure 4.5);
additional colour scheme as follows: (A) Carbon: pro-ADC, white; G24S, dark grey; S25a-
A25b, black; S25A, light-grey. Note the almost identical position of the S25a and Gly24
carbonyl in S25a-A25b and S25A, respectively. (B) Carbon: pro-ADC, white; A24a-G24b,
light-grey; H11A, dark grey; S25T, black. Note the shift in the cleavage site in H11A,
relative to pro-ADC.
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Glu23 is occupying the space of the removed imidazole ring. However,
Gly24 is H-bonding to the Tyr58 (mean distance: 2.97 A˚) instead of H-
bonding to Thr57. A sulfate and a water molecule are occupying the space
between Gly24 and Thr57. Nevertheless, the transition state for processing
of this mutant could be similar to that for pro-ADC with the carbonyl of
Gly24 H-bonded to Thr57. This could explain the normal self-processing
activity in this mutant. Such a conformation appears to be readily acces-
sible from the observed ground state structure without major rearrange-
ment.
Other experimenters (Ditzel et al., 1998; Tolbert et al., 2003a,b) had before
modelled the nucleophile (Ser or Thr) in place of the substituted amino
acid and had based their hypotheses about self-processing on such struc-
tures. However, this analysis clearly demonstrates that deducing the con-
formation and geometry of the cleavage site from the structures of the
inactive S25A and S25T mutants, by computationally modelling a serine
in place of alanine or threonine, would have most likely led to incorrect
models for the native, unprocessed peptide bond. As a consequence, the
oxyanion hole would, presumably, not have been identified. Even very
modest changes in the active site, as in H11A, can result in a different
observed ground state of the protein. The differences in the structures in-
dicate that small but important changes apparently account for the loss of
processing activity. Tight conformational constraints, including H-bonds
and steric effects, define the optimal geometry of the cleavage site. Seem-
ingly conservative substitutions can lead to significant conformational
changes, to which self-processing in ADC is very sensitive.
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13.5 Molecular mechanism of self-processing in
ADC
Based on the structure of the native cleavage site and knowledge of the
three dimensional coordinates for the ester as well as the pyruvoyl group
(Albert et al., 2000), a mechanism for the cleavage reaction can be pro-
posed. The N→O acyl shift is initiated by a nucleophilic attack of the
Ser25 Oγ on the carbonyl carbon of Gly24. For this, the Gly24 carbonyl
bond presumably is held in the conformation similar to the one observed
in the pro-ADC structure in which it forms H-bonds to both the Oγ of
Thr57 and the water molecule.
Molecular orbital constraints, which dictate the optimal trajectory
for nucleophilic attack by the Ser25 hydroxyl, require the angle be-
tween the NSer—CGly=OGly peptide plane and the OGly24=CGly24—OγSer25
plane to be approximately orthogonal (Figure 13.7 B). In conjunction
with the orthogonal angle between the Gly24-Ser25 peptide plane and
the OGly24=CGly24—OγSer25 plane, the angle between the two vectors
OγSer25—CGly24 and CGly24=OGly24 (OγSer25—CGly24=OGly24 angle) ideally
should lie between 100 and 110◦(Figure 13.7 A). Bu¨rgi et al. (1973) reported
that this is the most favourable angle (Bu¨rgi-Dunitz angle), at which the
nucleophile approaches the carbonyl.
However, in pro-ADC the angle between the the NSer—CGly=OGly pep-
tide plane and the OGly24=CGly24—OγSer25 plane is less than 10◦. In addition,
the Ser25 Oγ is more than 4 A˚ away from the Gly24 carbonyl carbon (see
Table 13.1). Consequently, considerable rearrangement of the Ser25 hy-
droxyl towards the Gly24 mainchain carbon is necessary in order to allow
attack of the nucleophile on the carbon, and for the cleavage reaction to oc-
cur. Furthermore, a certain degree of conformational flexibility, described
above, of the preceding loop appears to be required.
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Figure 13.7Optimal trajectory for nucleophilic attack. (A) Illustration of the Bu¨rgi-Dunitz
angle. (B) End-on view of the C—O bond indicating the orthogonal angle between the
NSer—CGly=OGly peptide plane and the OGly24=CGly24—OγSer25 plane.
It has been assumed that a specific residue or water molecule, base 1 of
Figure 13.1, would act as a general base to enhance the nucleophilicity of
the Ser25 Oγ. However, the residues in close vicinity that could directly
or indirectly mediate this effect, Tyr58 and Asn72 (see Table 13.1, for dis-
tance comparison), have each been shown by mutagenesis to phenylala-
nine and alanine, respectively, not to be vital for self-processing (Michael
Webb, personal communication). Both mutants were, apparently, capable
of forming significant amounts of α- and β-chains on PAGE. Similarly, the
hydroxyl group of the invariant Tyr58 (Figure 13.4) is a highly unlikely
residue for the Hα proton abstraction, since the constructed Y58F muta-
tion is able to form α- and β-chains in similar amounts as native ADC, as
judged by tricine-PAGE (data not shown). Also, the Oη of Tyr58 is more
than 4.4 A˚ away from the Ser25 Oγ in the pro-ADC structure. Likewise,
although the Tyr22 side-chain is disordered in most of the ADC crystal
structure, the likely position of the Oη of Tyr22 appears too far away in
the structure models. Consequently, it is possible that in the hydrophilic
environment of the Ser25 Oγ there is no specific residue for a general base.
Instead, solvent, not observable in the electron density maps, may serve
this role.
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As described in Section 13.3, the Gly24 carbonyl forms H-bonds to both
the Oγ of Thr57 and the water residue (see Figure 13.8 A), which may
help self-processing by polarizing the carbonyl and making it more sus-
ceptible to a nucleophilic attack. Subsequent to the initial nucleophilic
attack, a transient oxyoxazolidine intermediate with a tetrahedral Gly24
carbon is formed. In ADC the resulting negative charge on the oxygen
could be stabilized by H-bonds to the water molecule and/or the Thr57
Oγ, which together effectively form the oxyanion hole. Assuming that the
oxygen anion is in a position similar to that of the Gly24 carbonyl oxygen
in pro-ADC, the oxyanion hole is ideally positioned to provide stabiliza-
tion. Subsequent breakdown of the oxyoxazolidine intermediate necessi-
tates protonation of the nitrogen by acid 1 (Figure 13.1), which may come
from the water molecule or the Thr57 Oγ. The resulting partial negative
charge at the Thr57 Oγ could be stabilized by either an H-bond to the
main-chain amine of the invariant Tyr58 (Figure 13.4), which is at a dis-
tance of 2.79 A˚ to the Thr57 Oγ in the subunit with the ester intermediate
of processed ADC (Albert et al., 1998). Alternatively the water molecule,
which in turn interacts with the Nη1 and Nη2 of Arg54, could stabilize the
negative charge.
The Thr57 Oγ may perhaps then act as the base 2 (Figure 13.1), for the
subsequent Hα proton abstraction of the ester intermediate (Figure 13.8
B). The Thr57 Oγ is at a distance of 3.51 A˚ from the assigned hydrogen
in the ester form in the apo-ADC structure (Figure 13.8). Thr57→Ala
and Thr57→Val mutants were completely unable to self-process (Webb,
M.E., personal communication) consistent with its central role. Another
possible base could be the mainchain carbonyl oxygen of Tyr58, which is
3.18 A˚ away from the assigned Hα hydrogen.
Apart from themain-chain H-bond between Asn72 and residue 25, none
of the interactions identifiable in the cleavage site prior to processing is
present any more in the structure of the ester intermediate in processed
ADC (Albert et al., 1998). This indicates the conformational rearrange-
ments that have taken place. Upon breakdown of the ester, Gly24 at the
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Figure 13.8 Stereo-illustration of the three states of self-processing ADC. (A) The un-
processed cleavage site of pro-ADC (subunit B). (B) The ester intermediate observed at
half occupancy in the processed ADC structure (Albert et al., 1998); indicated by a green
dashed line is a possible line of the Hα proton abstraction by the Thr57 Oγ. (C) The cleav-
age site of processed ADC with the pyruvoyl group (Albert et al., 1998). The Cα atom of
Gly24 is now ∼8 A˚ away from its position in pro-ADC. All figures were prepared with
PYMOL (DeLano, 2002).
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carboxyl terminus of the β-chain, moves away (Figure 13.8 C). It has a
strikingly different position in the pro-enzyme and active ADC enzyme
structure with a Cα atom difference of 7.6 A˚ and 8.0 A˚ , in subunits A
and B of processed ADC, respectively (subunit B of pro-ADC was super-
posed on subunits A and B of processed ADC). This difference illustrates
the conformational change the loop undergoes upon self-processing. After
the Gly24 residue had moved away from the pyruvoyl N-terminus of the
α-chain, the active site for the decarboxylation of L-aspartate is formed.
13.6 Explanation for processing activity in the
ADC mutants
The suggested model of the molecular mechanism for self-processing can
provide a rationale for why S25A, G24S, S25T, A24a-G24b, and S25a-A25b
do not process and why H11A and S25C do. The S25A mutant lacks the
Oγ and so cannot process. In G24S the conformation of the Gly24 carbonyl
is altered significantly, such that the H-bonds between the Gly24 carbonyl
and Thr57 and the water molecule are not present. The same applies to
S25T, where the Gly24 carbonyl oxygen is more than 5.8 A˚ away from
the Thr57 Oγ. The insertion mutants A24a-G24b and S25a-A25b do not
process because of the altered conformational freedom of the loop. Addi-
tionally, in S25a-A25b the Gly24 carbonyl is too far away to interact with
Thr57.
The H11A structure appears to be able to access a similar transition state
as in pro-ADC, in order to process. S25C does process in solution and the
fraction that crystallized contained predominantly the processed α- and
β-chains. The free Cys at the N-terminus of the α-chain of processed S25C,
observed in the structure, arises, presumably, by non-productive hydrol-
ysis of the more reactive thioester intermediate. The latter may be espe-
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cially susceptible to hydrolysis under the acidic crystallization condition
around pH 4. The lower pKa of the thiol-group of cysteine compared to
the hydroxyl-group of serine may explain why this structurally conserva-
tive substitution affects protein self-processing in ADC strongly.
13.7 Comparison with other self-processing sys-
tems
Protein self-processing occurs as a protein maturation event in evolution-
ary unrelated eukaryotic and prokaryotic enzymes. The cleavage site
is comprised of Glu-Ser in pyruvoyl-dependent AdometDC and Ser-Ser
in both pyruvoyl-dependent ArgDC and HisDC. In pyruvoyl-dependent
phosphatidylserine decarboxylase the cleavage site is formed of Gly-Ser,
whereas in subunits of pyruvoyl-dependent glycine-, proline-, and sar-
cosine reductase, it consists of Asn/Thr-Cys (Bednarski et al., 2001; van
Poelje and Snell, 1990). Ser→Cys and Ser→Thr mutants of the cleav-
age site Ser in HisDC, AdometDC, and phosphatidylserine decarboxy-
lase were able to process at significantly reduced rates (Vanderslice et al.,
1988; Xiong et al., 1997). Abortive chain cleavage without pyruvoyl-
formation, which occurred in these mutants in HisDC, was most likely
the result of hydrolysis of the ester, similar to S25C ADC. Instead of the
pyruvoyl group, a cysteine or threonine was retained at the N-terminus
of the α-chain, indicative that the ester-intermediate was hydrolyzed.
A Ser81→Ala mutation in HisDC cleaved extremely slowly and mis-
cleavage occurred between residues 80 and 81 (Gelfman et al., 1991).
In the unprocessed structure of Ser53→Ala mutant of precursor ArgDC
the modelled Ser53 side-chain was positioned to attack the si-face of the
Ser52 carbonyl (Tolbert et al., 2003a). It was proposed that the Ser52 side-
chain could function as part of an oxyanion hole. Based on the analysis
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in this study, described above (Section 13.4), an alternative conformation
of this carbonyl in the native cleavage site H-bonding to the Oγ of the in-
variant Asn47 seems plausible. In order to H-bond to Asn47 the carbonyl
would have to adopt a conformation pointing in a direction almost oppo-
site to that in the S53A mutant structure. This would provide a role for
Asn47, which is one of only three invariant residues in ArgDC (Tolbert
et al., 2003a), in the self-processing mechanism.
In AdometDC, the side-chain amine of a His is assumed to be base 2
for the Hα proton abstraction (Ekstrom et al., 1999), but no oxyanion hole
could be identified. In the precursor Ser68→Ala mutant structure the
Glu carbonyl of the Glu-Ser cleavage site is H-bonding to the Sγ of the
variant Cys82 (Tolbert et al., 2003b). Based on this study on ADC and
on comparison with other systems this conformation may not be con-
sidered representative of the native cleavage site and led to a different
interpretation. A conformation with the carbonyl pointing in the oppo-
site direction would provide a role for the Oγ of the invariant Ser229
as part of an oxyanion hole. In contrast to Cys82 (Xiong et al., 1999),
the hydroxyl group of Ser229 was shown by mutagenesis to be essen-
tial for processing (Xiong and Pegg, 1999). A Ser229→Cys mutant pro-
cessed slowly, whereas a Ser229→Thr mutant processed normally (Xiong
and Pegg, 1999). However, Ser66→Ala, Glu67→Gln, Ser69→Ala, mutants
around the Glu67-Ser68 cleavage site had little effect on self-processing
(Stanley and Pegg, 1991; Stanley et al., 1989). Putrescine is known to stim-
ulate the self-processing reaction in certain eukaryotic AdometDCs, al-
though the putrescine binding site is well separated from the cleavage site
(Ekstrom et al., 2001).
The Oγ of an invariant Ser (Ser129) forms part of an oxyanion hole in
the β-subunit of the proteasome (Ditzel et al., 1998) and that potentially
polarizes the Gly carbonyl. The Ser129→Ala mutation completely abol-
ished processing, whereas Thr→Ser and Thr→Cys mutants were able to
process at reduced rates (Seemuller et al., 1996). The Gly of the conserved
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Gly-Thr cleavage site makes a kink in the Thr1→Ala precursor mutant
structure, similar to that in pro-ADC. The computationally modelled Thr
Oγ is positioned at a distance of 3.1 A˚ from the Gly mainchain carbon.
Interestingly, a conserved Thr, whose Oγ can form part of an oxyanion
hole, as in ADC, was also identified in the hedgehog protein, in inteins,
and in the Ntn glycosylasparaginase. The completely conserved Thr326 is
located in close proximity to the cleavage site in the hedgehog protein cry-
stal structure (Hall et al., 1997). In common with inteins, which are most
likely evolutionary related to hedgehog proteins, this threonine forms part
of a conserved (TxxH) amino acid sequence motif (see Subsection 4.2.2).
The Oγ of the conserved Thr72 in the GyrA intein crystal structure, H-
bonds to the carbonyl which is attacked by the nucleophile (Klabunde
et al., 1998) and is in a similar position both in the structures of VMA29-
intein Cys1→Ala mutant (Poland et al., 2000) and in the VMA1-derived
intein precursor quadruple mutant (Mizutani et al., 2002). However, again
extrapolating from ADC, the carbonyl in the latter two may not be in its
native conformation, since it either lacks any close H-bonding donors or
else points away from the side-chains of the conserved Thr or His, which
could contribute to an oxyanion hole.
In the unprocessed Trp11→Phe mutant crystal structure of F.
meningosepticum glycosylasparaginase (Xu et al., 1999) the Thr170 Oγ and
a water residue H-bond to the carbonyl oxygen of Asp151 in the cleavage
site, and appear to form an oxyanion hole. The relative position of the
Thr170, the Asp151 carbonyl, and the oxyanion hole are strikingly similar
to the respective arrangement in ADC (Figure 13.9). The Asp151 carbonyl
oxygen forms two H-bonds, one to the water residue, which is at a dis-
tance of 2.9 A˚, and another to the Thr170 Oγ, which is 2.7 A˚ away from
the carbonyl oxygen. Similarly to ADC, a developing negative charge on
the Thr170 could, in principle, be stabilized by H-bonding to a mainchain
amine. The mainchain amines of Ser171 and Gly171 are both at a distance
of 2.9 A˚ from the Thr170 Oγ.
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Figure 13.9 Stereo-illustration of the cleavage site and its environment of F. meningosep-
ticum glycosylasparaginase Trp11→Phe mutant (PDB-ID: 9GAF) (Xu et al., 1999). Shown
are residues His150, the cleavage site residues Asp151 and Thr152 (carbon atom colour,
grey, as before), Thr170-Gly172 (on the right) and the Trp11→Phe mutation. Figure pre-
pared with PYMOL (DeLano, 2002).
The unprocessed T152C mutant structure of glycosylasparaginase
indicated conformational strain within the peptide bond, that is normally
cleaved. The peptide bond significantly deviates from planarity and
has an ω-angle of 160◦ instead of the ideal 180◦. Mutagenesis studies of
Thr170→Ala/Cys/Ser showed a strong decrease in self-processing activ-
ity for the Thr170→Ala and Thr170→Cys mutants and confirmed the key
role of this residue for self-processing (Guan et al., 1998). Asp151 in the
conserved Asp151-Thr152 cleavage site makes a kink that has similarity to
that of Gly24 in ADC. Thr152→Ser and Thr152→Ser mutants were able to
process at reduced rates (Guo et al., 1998; Liu et al., 1998), whereas Asp151
appears to be essential for processing. Of the site-directed mutants
Asp151→Ala/Arg/Asn/Gly/Gln/Glu/His/Leu/Val/Met/Pro/Ser/Thr
only the Asp151→Gly mutant was capable of self-processing (Guan et al.,
1998). Nonetheless, Asp151 was suggested to be able to act as the base
(base 1 in Figure 13.1) (Xu et al., 1999). However, results on H. sapiens
glycosylasparaginase, indicate that a water molecule could act as the
general base (Saarela et al., 2004).
It was found that small amino acids, such as glycine, reversibly inhibit
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the reaction of the T152C and W11F precursor mutants (Guan et al., 1998;
Xu et al., 1999). In contrast, no inhibition was observed for the wildtype
enzyme form. The glycine H-bonds to the Nη1 and Nη2 of the conserved
Arg180 via its carboxyl group. The corresponding arginine (Arg211) in the
H. sapiens glycosylasparaginase crystal structure (Oinonen et al., 1995) also
H-bonds to the two oxygens of the γ-carboxyl of L-aspartate (the mode of
binding is presumably the same with the natural substrate asparagine).
Notably, a similar interaction exists between the γ-carboxyl group and
Arg54 in the structure of ADC in complex with β-alanine (see Figure 4.3).
The structures of Ser→Ala mutants of the Gly-Ser cleavage site in
the Ntn cephalosporin acylase (Kim et al., 2002) and the Ntn glutaryl-7-
aminocephalosporanic acid acylase (Kim et al., 2003) indicated that a wa-
ter molecule could function as the base to increase the nucleophilicity of
the Ser Oγ. In both enzymes the main-chain nitrogen of a histidine could
stabilize a developing negative charge. Site-directed mutagenesis and
activity studies showed that changing the Gly-1 prohibited the enzyme
from self-processing (Li et al., 1999a). A Ser→Thr replacement did not af-
fect the processing rate in glutaryl-7-aminocephalosporanic acid acylase,
whereas a Ser→Cys mutant showed reduced processing (Lee and Park,
1998). Whereas a Ser→Thr mutant did self-process in cephalosporin acy-
lase, a Ser→Cys mutant was not able to self-process at a significant rate (Li
et al., 1999b).
Similarly as in ADC, in the trimeric ArgDC and HisDC the active site is
located at the subunit interface. This is in contrast to the dimeric Ado-
metDC, where the cleavage site is located far away from the interface.
Although multimeric assembly does not appear to be a general require-
ment for self-processing, it was shown to be necessary for the proteasome
(Seemuller et al., 1996) and glycosylasparaginase (Tikkanen et al., 1996).
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13.8 Conclusions
Based on comparison with other self-processing systems, there does ap-
pear to be a preference for the location of the self-cleavage site in between
two β-strands or at the beginning of a β-strand. Although no single struc-
tural motif is used by the self-processing enzymes for the cleavage site,
glycine is the most common residue preceding the nucleophile in self-
processing systems, presumably due to its conformational adaptability. In
contrast to glycosylasparaginase and the GyrA intein, no evidence for the
role of strain in self-processing could be found in ADC. However, the an-
alysis described above, sounds a cautionary note about both the interpre-
tation and the relevance of models and mechanisms, based solely on the
structure of Ser→Ala or Ser→Thr mutants, in other self-processing sys-
tems. As shown in this study, the cleavage site of such models may not
adopt the conformation it does in the native cleavage site, prior to self-
processing.
So far, a specific molecule or residue for a general base, base 1, could be
identified in cephalosporin acylase, glutaryl-7-aminocephalosporanic acid
acylase, in the proteosome, and in glycosylasparaginase, but not in any of
the other self-processing enzymes. In all four structures, (ordered) water
appears to be able to act as the general base for the proton abstraction of
the nucleophile. No such ordered water molecule could be observed in the
model for the pro-ADC crystal structure. This could suggest that general
base catalysis by a specific residue may not be a requirement for the initial
nucleophilic attack. More likely, however, solvent water could serve this
function.
At physiological or neutral pH the equilibrium between amides and es-
ters strongly favours the amides in a general open chemical system (Elliott,
1952). Nonetheless, chemical model systems have shown that the equilib-
rium between amide bond and ester can be on the side of the ester, when
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the amine is protonated (Iwai and Ando, 1967). Self-processing enzymes
may additionally facilitate the N→O/S rearrangement by polarization of
the attacked carbonyl bond and by stabilizing the oxyoxazolidine inter-
mediate in an oxyanion hole. Comparison with other self-processing sys-
tems implies that the oxyanion hole is a crucial, general requirement for
self-processing. Therefore, stabilization of the oxyoxazolidine intermedi-
ate could be the important step to drive the reaction. Interestingly, this
stabilization in most of the self-processing enzymes is different from the
oxyanion hole identified in serine proteases, which is formed mainly by
hydrogens from main-chain nitrogens rather than oxygens. This could be
a consequence of the multiple roles the stabilizing groups have in self-
processing systems, to both polarize the carbonyl bond in the first step in
the reaction and stabilize the resulting negative charge in the second step.
In addition to the electrochemical rules the oxyanion hole serves it may
also ensure the correct orientation of the carbonyl bond, and the oxyoxazo-
lidine intermediate, so that amino acid residues are optimally positioned
for the subsequent Hα proton-abstraction.
Solvent, an ordered water molecule, and the catalytic Thr57 residue
could be sufficient to catalyze the self-processing reaction in the context
of the protein in ADC. There appear to be overall similarities of the mech-
anism of self-processing mechanism in ADC with that known from serine
proteases, such as the tetrahedral intermediate and general acid-base ca-
talysis. In contrast, other features, such as a charge-relay system with a
catalytic triad seem to be absent.
The reason why Ser25 is invariant, may be explained by the fact that
the thioester, presumably formed in the Ser25→Cys mutant, is too reac-
tive. However, considering the slow-processing rate, and the possible mis-
processing (see Subsection 4.2.1) of ADC, the self-processing reaction in
ADC may not be particularly optimized, although ADC appears to have
considerable conformational specificity for the reaction.
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Self-processing of ADC in E. coli was reported to be significantly faster
in vivo than in vitro (Michael Witty, personal communication). The reason
for this may be an external self-processing factor. A small molecule could
bind to the pocket H-bonding to the Nη1 and Nη2 of Arg54, instead of
the water molecule (see Figure 13.8), possibly providing additional stabi-
lization of reaction intermediates, such as the oxyoxazolidine intermedi-
ate. This cavity appears to be particularly attractive for small molecule,
because a sulfate residue was found in the H11A, S25a-A25b, and S25C
structures. In S25T, a malonic acid residue was positioned there. A similar
cavity exists in glycosylasparaginase, and a glycine molecule binds to this
region in the T152C and W11F crystal structures. Although, in the later
case glycine inhibits rather than stimulates the reaction.
However, this study has shown that functionality of residues for the
self-processing reaction and the catalysis carried out by the enzyme over-
lap. This appears to be the case for Arg54, which H-bonds to the water for
the self-processing reaction, and to the γ-carboxyl group of L-aspartate for
the decarboxylation reaction.
The results of this study on E. coli ADC appear to be relevant to ADCs
from pathogenic bacteria, such as H. pylori (Kwon et al., 2002) and M. tu-
berculosis (Chopra et al., 2002), which are potential drug targets, since the
key residues are invariant throughout all sequences (Figure 13.4). Further
structural information on the cleavage reaction is useful in understand-
ing the respective biochemistry and can aid in producing drugs to prevent
protein maturation. The molecular mechanism of ADC is likely to have
significant parallels in other self-processing systems. However, high res-
olution crystal structures of intermediates and true precursors from other
systems will be necessary to determine whether the geometrical restraints
and principlemechanism that were proposed in ADC are the same in other
systems.
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Although this study could potentially identify interactions that are key to
the self-processing reaction, a more thorough understanding of the molec-
ular mechanism will doubtlessly require additional data. The mechanistic
model of the self-processing reaction presented in Section 13.5 is mainly
based on crystallographic results of the structures of pro-ADC and the
site-directed mutants. It is consequently limited by what can be reliably
interpreted from such kind of data. The limitation particularly applies to
the static representation of the model, that does not reflect the dynamic
elements of the reaction.
From this study the following issues appear to be in need to be ad-
dressed: The proposed chemical and structural role both of Thr57 and the
water molecule have to be confirmed and, importantly, discerned, in detail
(the Thr57 Oγ and the water are equidistant from the oxygen of the Gly24
carbonyl group, (Section 13.3, Table 13.1)). Does the Thr57 Oγ indeed pro-
vide the acid (acid 1 in Section 13.5) and/or the base 2; or is its role merely
a structural one to orient the carbonyl-group. Is there a chemical role for
the water? Does it, as suggested (Section 13.3, Section 13.5), stabilize the
exocyclic oxygen in the oxyoxazolidine intermediate, and/or provide the
acid 1? And/or is its role a structural one, or a combination of both?
Based on the analysis in this study, an Asn72→Ala site-directed amino
acid mutation of ADC was already constructed and the respective crystal
structure solved (Carina Lobley and Michael Webb, personal communica-
tion). The structure model revealed a processed cleavage site with a Ser
instead of a pyruvoyl-group at the N-terminus of the α-chain. This does
imply a role for Asn72 in the self-processing reaction. Nonetheless, a direct
functional role for the Oδ1 or Nδ2 of Asn72 as base 1 seems improbable.
The Oδ1 is likely to carry a fractional negative charge and the Nδ2 is usu-
ally not a strong enough general base. However, it needs to be investigated
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whether the role of Asn72 is mainly structural, as this study suggests, or
whether it includes chemical effects. In addition, ongoing work, presently
underway, attempts to solve crystal structures of Thr57 mutants, such as
Thr57→Ala, Thr57→Val, and Thr57→Ser mutants. An Arg54→Ala mu-
tant would be interesting to study, since the water molecule could be dis-
placed from its position without the stabilizing interactions with the Nη1
and Nη2 of the invariant Arg54.
Although conventional site-directed mutagenesis studies, such as car-
ried out for this study, can suggest a particular role for a residue, the evi-
dence is not comparable with the kind of evidence an atom-specific mech-
anistic understanding would require. However, more subtle and system-
atic investigation may in principle be done by incorporation of unnatural
amino acids. These have successfully been used as probes for enzyme
function and protein structure, before (Cook et al., 1995). Implementation
of such amino acids in the protein is possible by nonsense suppression.
The respective methodology for the incorporation of unnatural amino
acids has been reviewed by Dougherty (2000). It is essentially based on
site-directed mutagenesis of the codon, encoding the residue one intends
to alter, to a stop-codon. An aminoacyl transfer-RNA, with the appropri-
ate anticodon, is then chemically acylated with the unnatural amino acid
and added to the translation system (often an in vitro system).
In the case of ADC it would be interesting to apply this technique in or-
der to study the effect of polarity of the Thr57 sidechain on self-processing.
One could exchange the Oγ of Thr57 to a less nucleophilic atom, such as
a nitrogen, and carry out activity assays and crystallographic analysis of
this mutant. Furthermore, a Thr57 mutant with an additional carbon on
the oxygen could potentially be of interest, to test the implication of the
Oγ hydrogens in acid-base catalysis. Likewise, an amino acid could be
synthesized where the side-chain atoms Oδ1 or Nδ2 of Asn72 are both, or
individually, changed to a carbon atom. One could possibly distinguish
steric and chemical effects of such an isosteric mutant in more detail. Ad-
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ditionally, the nonsense suppression technique could be applied to incor-
porate an ester, instead of the backbone amide, for Asn72 and Cys26, by
acylating the respective α-hydroxy acids instead of the α-amino acids with
aminoacyl transfer-RNAs. In this manner the importance of the backbone
interactions of Asn72-Ser25 and also Cys26-Tyr58 for the conformation of
Ser25, and, consequently, for self-processing could be determined.
However, the static, time-averaged representation of the state that con-
ventional crystallography, with a monochromatic X-ray source, can pro-
vide may not be able to unequivocally answer the questions raised above.
More direct, chemical evidence would be desirable. Following the events
of proton donation and proton abstraction, as indicated in the chemical
scheme of (Figure 13.1), directly, is difficult by any biophysical and bio-
chemical means. Radioactive labelling experiments with deuteriumdo not
seem to be feasible, as the deuteriumwould presumably quickly exchange
with solvent. In contrast, obtaining a three-dimensional representation
of the oxyoxazolidine intermediate (Figure 13.1) of the reaction could be
amenable. Identification of the interactions of the intermediate could then
provide more reliable evidence for a molecular mechanism.
For this purpose, a time-resolved crystallographic technique known as
Laue diffraction (reviewed by Ren et al. (1999)) may help to collect X-ray
data in a short enough time. This technique could be combined with a
chemically protected Ser25 residue. Incorporation of the serine, the Oγ of
which could be protected with for instance a o-nitrobenzyl group, would
be carried out with nonsense suppression as described above. Photoly-
sis by light then releases the nitrobenzyl group and reveals the previously
protected functionality. This technique has indeed already been carried
out with a serine residue, for elucidation of self-processing in inteins, by
Cook et al. (1995). Protection of Ser25 in ADC may be necessary to ini-
tiate the reaction only after the protein has been crystallized and after
the crystals have been brought to the X-ray data collection facility. The
self-processing reaction would then be started at a specific time point.
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Rapid reaction initiation (at the femtosecond scale), to deprotect the serine
residue, can be accomplished by applying a short laser pulse. Laser sys-
tems with nanosecond and femtosecond pulses have been implemented
at ID09 beamline, at the European synchrotron radiation facility, and syn-
chronized with the X-ray pulses (see references in (Ren et al., 1999)). Reac-
tion initiation by this method and immediate Laue diffraction data collec-
tion have successfully been applied by Stoddard et al. (1990). In this case,
an active-site serine residue of chymotrypsin was protected as a cinnamic
acid ester, photolyzed, and X-ray data were collected. For ADC, an iden-
tical experiment as for the native enzyme could also be carried out with a
Ser25→Cys ADC mutant, which may be more reactive with respect to the
initial step. The higher electron density of the sulfur, may additionally as-
sist in interpretation of the possible intermediate. Particularly, at medium
resolution it is sometimes difficult to discern oxygen atoms from carbon
atoms in electron density maps.
The results of such experiments, as implied by the parallels of the self-
processing reaction of ADC with other systems (Section 13.7), may indeed
have a far-reaching impact on the understanding of the molecular mecha-
nism of self-processing.
Part IV
Concluding remarks
209
IV. Concluding remarks 210
Crystallization of KPHMT with cofactor analogues Several crystalliza-
tion conditions for KPHMT in the presence of two cofactor-analogues
and/or α-kiva were obtained. However, for most of them the quality of
the crystals was limited, as the X-ray diffraction extended to ∼4.0 A˚ on
the in-house X-ray generator. Eventually, crystallization conditions were
found that yielded KPHMT crystals that were larger in all three dimen-
sions. Reproducing these crystals could improve the X-ray diffraction
limit, and consequently may enable successful data collection. Calculat-
ing Fourier-maps will be imperative to determine the mode of binding of
the cofactor to the enzyme.
Comparison of the KPHMT structure Based on the sequence analysis,
and structure analysis of the KPHMT (βα)8-fold, it was possible to classify
KPHMT into a superfamily in the SCOP database, to draw conclusions
about the evolutionary relationship of the enzymes within this superfam-
ily, and to gain insight into both the conservation of ligand binding to
the catalytic Mg2+, as well as similarities and differences in the molecular
mechanism. It was shown that KPHMT is a member of the PEP/pyruvate
superfamily, forming a family of its own within. Based on the analysis
of the members of this superfamily, a subdivision into two groups in this
superfamily appeared conceivable. This analysis completed the structural
analysis of the four E. coli enzymes of pantothenate biosynthesis.
Structure solution of ADC enzymes Jointly with Michael Webb, a fast
purification protocol for eight ADC mutants has been devised. This al-
lowed crystallization of several of these ADC mutants. In this study, a full
X-ray diffraction dataset was successfully collected on two ADC mutants,
G24S and S25T, for the latter at near atomic resolution. Their crystal struc-
tures were solved by molecular replacement, and/or directly by using the
previously solved ADC structure as a search model. Together with the al-
ready solved pro-ADC and S25A structures, these structures were refined
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to comparably low Rcryst and Rfree values, the structure models assessed,
and deposited in the PDB.
Structural analysis of ADC enzymes The four ADC structures together
with the ADC structures of A24a-G24b, H11A, S25a-A25b, and S25C,
were the subject of a detailed comparative analysis. The results of the
investigation imply that specific conformational constraints govern the
self-processing reaction. Geometrical data from the cleavage site of the
pro-ADC structure indicate that considerable rearrangement of the Ser25
hydroxyl towards the Gly24 carbonyl carbon is necessary for the self-
processing reaction to occur. The conformational freedom in the loop
preceding the cleavage site appears to play a determining role in the re-
action. Comparison of the structural features with other self-processing
systems shows significant similarity, particularly with the enzyme glyco-
sylasparaginase. The results of the analysis suggest that the Thr57 Oγ and
a water molecule form an oxyanion hole that could stabilize the oxyox-
azolidine intermediate in the self-processing reaction. Furthermore, the
Thr57 Oγ and this water could play key roles in the mechanism, by sup-
porting acid-base catalysis during the reaction. In order to gain further
insight into the mechanism, and, particularly, to discern steric and electro-
chemical effects, a series of experiments has been suggested.
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A Crystallization of morphine
dehydrogenase
A.1 Introduction
Apart from structural research on the two enzymes in the pantothenate
pathway, studies on the crystallization of morphine dehydrogenase were
carried out. This project was in close collaboration with Dr Amrik Basran
and Prof. Neil Bruce, whose laboratory (Institute of Biotechnology, Uni-
versity of Cambridge) the research on this enzyme was initiated in.
Morphine dehydrogenase is a monomeric enzyme with a molecular
mass of ∼32 kDa (Bruce et al., 1991). It catalyzes the NADP+-dependent
oxidation of morphine and codeine to morphinone and codeinone, re-
spectively. The enzyme was isolated from a P. putida M10 strain, found
in opiate factory waste liquor (Bruce et al., 1990). This bacterial strain ap-
parently can grow onmorphine as the sole source of carbon. The oxidation
of morphine tomorphinone (Figure A.1) bymorphine dehydrogenase was
observed to be the first step in the catabolism of morphine in this organ-
ism. The enzyme appears to have an absolute requirement for the NADP+
cofactor for activity (Bruce et al., 1991).
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The gene, encoding morphine dehydrogenase, was found to be located
on a large plasmid (165 kb), from which it appears to be constitutively ex-
pressed by the bacterium (Bruce et al., 1990). The gene was cloned and se-
quenced (Willey et al., 1993), and, subsequently, morphine dehydrogenase
was recombinantly overexpressed in E. coli (Walker et al., 2000). Amino
acid sequence analysis indicated that the enzyme belongs to the aldo-
ketoreductase family of alcohol dehydrogenases (Bruce et al., 1994). It was
shown to be closely homologous to eighteen proteins, and highest simi-
larity was observed with 2,5-dioxo-D-gluconic acid reductases. The pro-
tein was purified to high homogeneity in a two-step protocol with affin-
ity chromatography on Mimetic orange 3 A6X, a specific dye for NADP+-
binding enzymes, and gel-filtration (see Bruce et al. (1991) for a detailed
purification procedure). During the whole purification procedure the pro-
tein solutions were supplemented with at least 2 mM DTT, and kept at
4◦C and/or on ice. For crystallization trials in this study, the protein was
purified and supplied by Dr Amrik Basran.
Morphine dehydrogenase was made the basis of a biochemical assay for
the detection of opiates in urine (Holt et al., 1995). Moreover, the enzyme
certainly has a high potential for future biomedical applications, such as
the production of semisynthetic opiate drugs. Rational engineering of
Figure A.1 Schematic illustration of the oxidation of morphine to morphinone catalyzed
by morphine dehydrogenase.
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the protein, based on structural information, could aid this aim. Conse-
quently, the purpose of this study was to crystallize morphine dehydroge-
nase, either on its own and/or with its cofactor NADP+.
A.2 Experimental procedures and results
Initially, crystallization screening focused on crystallization of morphine
dehydrogenase on its own. The enzyme was dialyzed into 5 mM DTT, 25
mM Hepes pH 7.4 at 4◦C, with a dialysis tubing with a molecular weight
membrane cut-off of 25 kDa. The addition of DTT appeared important
because the enzyme was found to rapidly lose activity if thiol-protecting
agents were not added. Crystallization trials were carried out as soon as
possible after the end of the dialysis, usually on the same day. Samples
for later usage were frozen with 20%(v/v) glycerol at −80◦C. The pro-
tein concentration was assessed as described in Subsection 7.3.1, using the
theoretical absorption coefficient of morphine dehydrogenase at 280 nm
(280 = 37 530 M-1 cm-1 or 1.173 ml mg-1 cm-1) (caclculated with the Prot-
param utility1 (Gill and von Hippel, 1989) from the Swissprot-Expasy in-
ternet server).
Morphine dehydrogenase was reported to be unstable at 4◦C with re-
spect to its activity (Bruce et al., 1991). Therefore, all crystallization trials
were carried out at 4◦C as well as at 19◦C, with a protein concentration of
14-38mg/ml. However, in spite of extensive crystallization screeningwith
a number of commercially available crystallization screens, no crystals
could be obtained. Therefore, subsequent screening focused on crystal-
lization of the protein, in the presence of NADP+ and a non-hydrolysable
analogue, thionicotinamide adenine dinucleotide phosphate.
The cofactor and cofactor analogue were initially dissolved in 1 M
1http://ca.expasy.org/tools/protparam.html
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NaCH3CO2 pH 5.5 (adjusted with HCl) to potentially prolong the lifetime
of the cofactor. NADP+ is reported to be stable for a longer time at acidic
pH. Later, the cofactor was dissolved in in MilliQ water, which did not
have any apparent impact on the crystallization, compared with dissolu-
tion in NaCH3CO2. For crystallization trials the protein was incubated
with the cofactor solution on ice, in a protein:cofactor ratio of 1:2-6, for for
at least 45 min, prior to setting up crystallization trials.
Several crystallization conditions of morphine dehydrogenase in the
presence of NADP+ could be found. Crystals usually appeared after 3-4
weeks. The crystallization trays at 17◦C were covered with foil to mini-
mize exposure to light. Likewise, the trays at 4◦C were in an incubator
impenetrable to visible light.
The largest three-dimensional crystals (Figure A.2) could be obtained
with a precipitant solution of 1.5 and 1.9 M sodium malonate, NaOH, pH:
5.0. The protein concentrations used were 17 and 29.8 mg/ml, with a pro-
tein: NADP+ ratio of 1:3. Crystals grew, at 4◦C only, as needles with a
maximum length in one dimension of 170 µm (Figure A.2 A,B). Using a
protein concentration of 17 mg/ml yielded fewer, but larger crystals.
A second promising precipitant condition was 30% PEG8000, 0.1 M Na-
cacodylate, 0.2 M (NH4)2SO4, pH 6.5 (condition 14 of the Molecular Di-
mensions Structure screen 1). The protein concentrations were 17 and 29.8
mg/ml, with a protein:NADP+ ratio of 1:4. The crystals grew at 17◦C only,
as needles (Figure A.2 C). However, no significant difference in the size of
the crystals could be observed by using a protein concentration of 17 or
29.8 mg/ml.
Both of the above mentioned crystallization conditions could be repro-
duced, however, as mentioned above, the response time from setting up
crystallization trials to obtaining crystals was 3-4 weeks.
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Figure A.2Morphology of themorphine dehydrogenase crystals obtained in the presence
of NADP+. (A), (B) Crystals grown with sodium malonate as a precipitant, (C) Crystals
grown with 30% PEG8000, 0.1 M Na-cacodylate, 0.2 M (NH4)2SO4, pH 6.5 as precipitant
solution. (D) Crystals grown with ammonium formate, 20% PEG3350, pH: 6.6.
Ammonium formate, 20% PEG3350, pH: 6.6 (solution 23 of the Hamp-
ton PEG/ion screen) was another successful precipitant to give crystals
for morphine dehydrogenase. A protein: NADP+ ratio of 1:4, with a pro-
tein concentration of 17 and 29.8 mg/ml, was used. Crystals grew as fine
needles (Figure A.2 D) at 17◦C only.
Several crystals, grown of morphine dehydrogenase in the presence of
NADP+, with sodium malonate (1.5+1.9 M, pH 5.0) as precipitant, have
been cryoprotected with sodium malonate, and were frozen in liquid N2.
These await screening at a synchroton X-ray source. Further optimization
of the obtained crystallization conditions is currently underway, and it is
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hoped to increase the size of the crystals. One problem, so far, was the
rather long response time for the crystallization experiments. Crystals ap-
pear to grow rather slowly and could only be observed 3-4 weeks after
the crystallization trials were set up. Optimization of the crystallization
conditions could possibly reduce the time until crystals emerge.
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